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Abstract 
 
This thesis includes an extensive review of preparation of bicyclo[4.3.0]nonane 
derivatives. Bicyclo[4.3.0]nonanes can be prepared by several methods. The most 
important preparation method of bicyclo[4.3.0]nonanes is intramolecular Diels-Alder 
cycloaddition (IMDA). Several biologically active natural and unnatural compounds 
contain bicyclo[4.3.0]nonanes in their molecular framework. The synthetic efforts toward 
natural compounds such as pulo’upone, isopulo’upone, indanomycin, stawamycin, 
cochleamycin A, ikarugamycin and lepicidin A are surveyed in this thesis. The second 
part of the review includes preparation methods for bicyclo[4.3.0]nonane derivatives.  
The synthesis part of this thesis presents my own results of synthetic efforts on amaminol 
A. Amaminol A was obtained as the side product from the synthesis of amaminol A 
diastereomer. Although amaminol A was obtained as the side product, the developed 
route allows the preparation of amaminol A as the major product by changing the 
stereochemistry of the employed organocatalyst. The bicyclo[4.3.0]nonane part of 
amaminol A was obtained utilizing two different types of IMDA’s. These were chiral 
auxiliary induced and organocatalytic IMDA cycloadditions. Many active organic 
molecules include vicinal amino alcohol moieties in their molecular framework. The 
preparation of vicinal amino alcohols from α-amino ketones was also studied in this 
thesis. Chelation type reduction was found to give the highest diastereoselectivities with 
N-tert-butylcarbamate protected α-amino ketone.  
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Abbreviations and definitions 
 
Ac   acetyl 
AIBN   2,2’-azobis(2-methylpropionitrile) 
BBEDA   N,N-bis(benzylidene)-ethylenediamine 
9-BBN   9-boranbicyclo[3.3.1]nonane 
BHT   2,6-di-tert-butyl-4-methylphenol 
BINAL 2,2’-dihydroxy-1,1’-binaphthyl 
aluminium hydride 
BMS   borane dimethyl sulfide 
BOC   tert-butyloxycarbonyl 
BOM   benzyloxymethyl 
t-Bu   tert-butyl  
Bn   benzyl 
Bzl, Bz   benzoyl 
Bu   n-butyl  
Burgess reagent   CH3OC(O)NSO2N(CH2CH3)3 
CAN   ceric ammonium nitrate 
CBS   Corey-Bakshi-Shibata oxazaborolidine 
Cbz   carbobenzyloxy 
CDI   1,1-carbonyldiimidazole 
m-CPBA   m-chloroperbenzoic acid 
CSA   camphorsulfonic acid 
 dba   dibenzylideneacetone 
DBB   di-tert-butylbisphenyl 
DBNE   (+)-N,N-dibutylnorephedrine 
DBU   1,8-diazabicyclo[5.4.0]undec-7-ene 
DCC   1,3-dicyclohexylcarbodiimide 
DDQ 2,3-dichloro-5,6-dicyano-1,4-
benzoquinone 
Dess-Martin oxidation oxidation employing Dess-Martin 
periodinane {C6H4-
C(O)OI[OC(O)CH3]3-} 
DEAD diethyl azodicarboxylate 
DHP   dihydropyran 
DHQ   dihydroquininyl 
DHQD   dihydroquinidinyl 
DIBAL-H   diisobutyl aluminum hydride 
DIC   diisopropylcarbodiimide 
DIPEA   diisopropylethylamine 
DMAP   4-dimethylaminopyridine 
DME   1,2-dimethoxyethane 
DMF   dimethylformamide 
DMS   dimethylsulfide 
DMSO   dimethylsulfoxide 
E   entgegen (trans) 
ee   enantiomeric excess 
Et   ethyl 
 Fmoc   9-fluorenylmethoxycarbonyl 
(M)HMDS   (M = Li, Na, K) hexamethyldisilazide 
HMPA   hexamethylphosphorictriamide 
HOBT   hydroxybenzotriazole 
HWE   Horner-Wadsworth-Emmons 
IBX   o-iodoxybenzoic acid 
IMDA Intramolecular Diels-Alder 
cycloaddition 
LDA   lithium diisopropylamide 
MCPBA, m-CPBA  meta-chloroperoxybenzoic acid 
Me   methyl  
Mes   mesityl (2,4,6-trimethylphenyl) 
Ms   methanesulfonyl 
MS molecular sieves 
MTBE   methyl tert-butylether 
NACAA nicotinic-chromic anhydride betaine 
reagent 
NBS   N-bromosuccinimide 
NIS   N-iodosuccinimide 
NMO   N-methylmorpholine N-oxide 
NPSS   N-(phenylsulfenyl)succinimide 
PCC   pyridinium chlorochromate 
PDC   pyridinium dichromate 
Ph   phenyl 
 PHAL   phthalazine 
PhH   benzene 
PhMe   toluene 
Piv   pivaloyl 
PMB   para-methoxybenzyl 
PPTS   pyridinium p-toluenesulfonate 
PTSA, p-TsOH   p-toluenesulfonic acid 
i-Pr   isopropyl 
Pyr   pyridine  
rfx   refluxing conditions  
r.t.   room temperature 
L-Selectride   lithium tri-sec-butylborohydride  
SEM   [(trimethylsilyl)ethoxy]methyl 
Sia   siamyl 
TBAF   tetrabutylammonium fluoride 
TBDMS, TBS   tert-butyldimethylsilyl 
TBDPS   tert-butyldiphenylsilyl 
TES   triethylsilyl 
Tf   trifluoromethanesulfonyl 
TFA   trifluoroacetic(yl) acid 
TFAA   trifluoroacetic anhydride  
THF   tetrahydrofuran 
THP   tetrahydropyranyl 
TMS   trimethylsilyl 
 Ts   para-toluenesulfonyl 
Z   zusammen (cis) 
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1 Introduction 
 
This work was initiated in 2000 at the Helsinki University of Technology. The work was 
financially supported by a grant from Neste Foundation. The inspiration for this work 
was born from the fact that there are not that many synthetically prepared, nature like, 
cytotoxic compounds against murine leukemia cells. Amaminols A and B were recently 
isolated from an unidentified tunicate of the family Polyclinidae (1) and found to be 
cytotoxic against murine leukemia cells.    
2 Amaminol A and B 
 
Isolation and identification of amaminols A 1 and B 2 was reported in 2000 by Sata and 
Fusetani (1). Amaminols A 1 and B 2 were found to be cytotoxic against P388 murine 
leukemia cells with an IC50 value of 2.1 µg/mL. Amaminols A 1 and B 2 contain an 
interesting trans-fused hexahydroindene substructure (colored with red in Figure 1), 
which has most likely been formed by an intramolecular Diels-Alder reaction from a 
triene in nature.  
OH
NH2
OH
NH2
1 2  
 
Figure 1. Structure of amaminols A 1 and B 2. 
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Amaminol A 1 and B 2 contain six chiral centers and four of them can be created by 
stereoselective intramolecular Diels-Alder reaction. The remaining two chiral centers can 
be derived from an amino acid. Amaminol A 1 and B 2 are closely related to aliphatic 
amino alcohols, which are isolated from marine sponges, Xestospongia sp. and Leucetta 
microraphis. Other related aliphatic compounds are isolated from tunicates, Didemnum 
sp. and Pseudodistoma crucigaster. 
2.1 Aliphatic amino alcohol relatives of amaminol A and B 
 
Amaminol A 1 and the related amino alcohols are biogenetically derivable from (S)-
alanine 3 and amaminol B 2 related amino alcohols are derivable from (R)-alanine 4 
(Figure 2).   
OH
NH2
R
OH
NH2
R
O
NH2
OH
(S)-alanine (3)
OH
NH2
R
OH
NH2
R
O
NH2
OH
(R)-alanine (4)
(S,S) (S,R)
(R,R) (R,S)  
 
Figure 2. Biogenetic formation of amaminol A 1 and B 2 related amino alcohols from 
(S)-alanine 3 and (R)-alanine 4. 
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Gulavita et al. (2) has isolated two diastereomeric aliphatic 2-aminotetradeca-5,7-dien-3-
ols 5 and 6 from a sponge, Xestospongia sp. (Figure 3). These are formed biogenetically 
from (S)-alanine 3. 
4OH
NH2
OH
NH2
4
5 6  
 
Figure 3. (2S)-Aminotetradeca-5,7-dien-3(S/R)-ol (5/6). 
 
Jiménez et al. (3) have isolated (S,S)-amino alcohols 7-9 from Xestospongia sp. (Figure 
4). Their structures differ only in the degree of saturation of the chain. (S,S)-amino 
alcohols 7-9 are biogenetically derived from (S)-alanine 3. 
 
OH
NH2
5
OH
NH2
5
OH
NH2
5
7 8 9  
 
Figure 4. (S,S)-Amino alcohols 7-9 isolated from sponge Xestospongia sp.  
 
 
A few years later Kong et al. (4) isolated two polyunsaturated (S,R)-amino alcohols 
leucettamol A 10 and B 11 from Leucetta microraphis (Figure 5). These are also 
biogenetic products of (S)-alanine 3. 
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3
OH
NH2OH
NH2
Leucettamol A (10)
3
OH
NH2OH
NH2
OH
Leucettamol B (11)
2 HCl
2 HCl
 
 
Figure 5. Structures of leucettamol A 10 and B 11. 
 
(R)-Alanine 4 derived amino alcohols have been isolated from tunicates. Jares-Erijman et 
al. found polyunsaturated (R,S)-amino alcohols 12-14 from Pseudodistoma crucigaster 
tunicate (5). These amino alcohols were named as crucigasterins (Figure 6). 
OH
NH2
Crucigasterin 277 (12)
OH
NH2
Crucigasterin 275 (13)
OH
NH2
Crucigasterin 225 (14)  
Figure 6. Structure of crucigasterins 12-14. 
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2.2 Cyclic relatives of amaminol A and B 
 
In this chapter, cyclic relatives of amaminol A 1 and B 2 are presented. The compounds 
are restricted so that only bicyclo[4.3.0]nonane derivatives are presented (see Figure 7 
red colored part). Furthermore, natural compounds having substituents at positions 1, 2, 
3, 4 and 5 are presented. The reason for the predefinition is that there are over a thousand 
compounds, which hold substituted bicyclo[4.3.0]nonane as substructure and it would be 
enormous if not possible to present all of them in this thesis. The biological activity of the 
presented compounds are also presented if available. If the partial or total synthesis of the 
presented natural compound is published, it is also covered in the following chapters. 
R
R
R
R R
R = H, alkoxy or alkyl group
12
3
4 5
 
Figure 7. Structure of substituted bicyclo[4.3.0]nonane. 
 
2.2.1 Pulo’upone and isopulo’upones    
 
(-)-Pulo’upone 15 (Figure 8) was isolated by Scheuer and Coval in 1985 from cold dried 
animals in Hawaii (6). Despite the enormous work that has been done in synthesizing 
pulo’upone it’s biological activity has not been fully determined and justified. 
Pulo’upones include substituted trans-fused endo-bicyclo[4.3.0]nonane structure. 
(-)-Isopulo’upone 17 was found later in 1993 by Spinella et al. from Navax inermis and 
its prey Bulla gouldiana (7). (-)-Isopulo’upone 17 has been found to be very toxic below 
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10 ppm to mosquito fish Gambusia affinis and it is toxic against brine shrimp Artemia 
salina with LD50 = 2.2 ppm (7). Isopulo’upones 17/18 are a isomers of pulo’upones 
15/16. 
O
N
(-)-pulo'upone (15)
O
N
(+)-pulo'upone (16)
O
N
(-)-isopulo'upone (17)
O
N
(+)-isopulo'upone (18)  
 
Figure 8. Structures of pulo’upones 15/16 and isopulo’upones 17/18. 
 
In the following chapters, the total syntheses of pulo’upones 15/16 and isopulo’upone 
17/18 are presented in a chronological order. The chapters are divided according to the 
research groups. 
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2.2.1.1 Burke 
 
Burke et al. published the first total synthesis of pulo’upone 15/16 in 1988 (8). However, 
this synthesis route lead to racemic product. Burke et al. used retrohetero Diels-Alder 
reaction (RHDA) to construct substrate in situ for intramolecular Diels-Alder reaction of 
pulo’upones 15/16 (Scheme 1). Burke  et al. used cyclic chiral aldehyde 19 as the starting 
material for oxidation. The formed acid was transformed to acid chloride, which allowed 
the formation of phosphonate for HWE (Horner-Wadsworth-Emmons) reaction (11). 
HWE olefination proceeded in high yield (91%) to afford an iodo diene derivative. 
Reduction of the enone gave a mixture of diastereomers allyl alcohols 20a/b, which were 
both transformed to lactone 21 by two separate methods. After conversion of the lactone 
to trimethylsilyl ketene acetal, thermal RHDA and hydrolysis afforded a separable 
mixture of endo/exo-cycloadducts 22a/b. The endo-adduct 22a was reduced, oxidized 
and methylated to give a diastereomeric mixture of carbinols 23. Treatment with picolyl 
cuprate and Swern oxidation finalized the synthesis of racemic pulo’upone (15/16). 
O
N
OHC
CO2iPr
a-e
CO2iPr
I
X
Y
X = OH, Y = H, f
X = H, Y =OH, g
O
O
I
h
HO2C
I
HO2C
I
(22a) 4.2
I
HOi,j
k,l
(-/+)-pulo'upone (15/16)
: (22b) 1
19
20a,b
21
23
+
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Scheme 1. Reagents and conditions: a) H2Cr2O7, H2O/acetone, 25 °C, 30 min; b) 
(COCl)2, PhH, 25 °C, 12 h; c) MeP(O)(OMe)2, n-BuLi, MgBr2⋅OEt2, -78 °C -> -30 °C 
(62 % for 3 steps); d) E-5-iodo-4-pentenal, NaH, THF, 0 -> 25 °C (91 %); e) NaBH4, 
CeCl3, MeOH, 25 °C (98 %); f) NaOH, H2O/THF; H+; Ph3P, DEAD, PhMe, -30 °C (63 
%); g) NaOH, H2O/THF/MeOH; H+; morpho CDI, DMAP, CH2Cl2, 0 -> 25 °C (88 %); 
h) LiHMDS, Me3SiCl, Et3N, -100 -> 25 °C, remove THF in vacuo, add xylenes; 140 °C, 
12 h, aq. HCl (71 %); i) DIBAL-H, PhMe, 25 °C; j) (COCl)2, DMSO, Et3N, THF, -78 °C 
-> -35 °C; MeMgBr, Et2O, -78 °C (72 %); k) picoline, n-BuLi, THF, 0 °C; CuCN, THF, -
78 °C; l) (COCl)2, DMSO, Et3N, CH2Cl2, -60 °C (71 %).  
 
2.2.1.2 Oppolzer 
 
Oppolzer et al. used asymmetric intramolecular Diels-Alder (IMDA) reaction to 
synthesize (-)-pulo’upone (9). Chiral camphor sultam derivative was used for the chiral 
induction. HWE reaction of silylated aldehyde 24 with ethyl crotonic phosphonate 25 
afforded the conjugated E,E-diene 26 in low yield (47 %). (Scheme 2). Further reduction 
and acetylation afforded the silylated diene acetate 27. SN2 reaction of dienylacetate 27 
with magnesiumbromo dioxolane derivative 28, followed by hydrolysis and silylation 
sequence, afforded the diene aldehyde 29. The sultam auxiliary was connected to the 
main skeleton by a HWE olefination of the chiral phosphonate 30 with diene aldehyde 
29. The produced (E,E,E)-trienylsultam was subjected to Lewis acid (dimethylaluminium 
chloride) promoted IMDA. The IMDA reaction was very slow and two portions of 
Me2AlCl was required to obtain full conversion. Endo-adduct 31 was obtained from 
IMDA with good yield and high enantioselectivity (71 %, 93 %ee). The sultam auxiliary 
was cleaved by desilylation and lactonization gave tricyclic lactone 32. Lactone 32 was 
opened by methylation and further derivatized by tosylation, iodination and cyanation. 
Nitrile 33 was reduced with DIBAL-H to produce lactol 34, which was subjected to 
Wittig olefination. Reduction of the resulting methyl enoate and selective acetylation of 
the allylic alcohol gave allylacetate 35 as a mixture of E:Z-isomers (94:6) and C15-
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epimers (3:1). Coupling of allylacetate 35 with di-(2-pyridyl)copperlithium and Swern 
oxidation of the alcohol group gave pure (-)-pulo’upone 15. 
O
N
(-)-pulo'upone (15)
OTBDMSO
CO2Et(EtO)2P
O
a COOEt b,c OAc
O
OBrMg
d-f
N
SO2 O
P
O
OEt
OEt
g,h
O
N
SO2
i,j
O
O
k-n
O
CN
o
O
p-r
OH
s,t
HO
OAc
OTBDMS
O
OTBDMS
OTBDMS
OTBDMS
+
24
25
26 27
28
29
30
31
32 33 34
35
15
 
Scheme 2. Reagents and conditions: a) aldehyde 24, LDA, THF, -78 °C -> r.t.; then 
phosphonate 25, -40 °C, 10 min, -> r.t. (47 %); b) DIBAL-H, hexane/Et2O (1:1), 0 °C, 2 
h; r.t., 1 h; c) Ac2O, pyr, r.t., 2 h (94 % over 2 steps); d) Li2CuCl4, Grignard reagent 28, 2 
h, -10 °C, 30 min (62 %); e) 0.4 M HCl, acetone/H2O (2:1), r.t., 5 h; f) TBDMSCl, NEt3, 
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DMAP, r.t., 2 h (63 %); g) phosphonate 30, DBU, aldehyde 29, LiCl, CH3CN, r.t., 2 h 
(89 %); h) Me2AlCl, CH2Cl2, -20 °C, 80 h, Me2AlCl, -10 °C, 50 h (63 %); i) BF3⋅Et2O, 
CH2Cl2, r.t., 1 h, j) LiH, DMF, r.t., 16 h (89 % over 2 steps); k) MeLi, lactone 32, Et2O, -
78 °C, 30 min; l) TsCl, pyr, 0 °C, 10 h, +10 °C, 5 h (80 % over 2 steps); m) NaI, acetone, 
35 °C, 3 h; n) n-Bu4NCN, CH2Cl2, 40 °C, 2 h (86 % over 2 steps); o) DIBAL-H, Et2O, 0 
°C, then r.t., 1 h (75 %); p) Ph3P=CHCOOMe, 60 °C, 6 h; q) DIBAL-H, -70 °C, CH2Cl2; 
r) Ac2O, pyr, DMAP, 0 °C, 2 h, r.t., 1 h (79 % over 3 steps); s) 2-bromopyridine, n-BuLi, 
Et2O, -60 °C, CuI, n-Bu3P; t) (COCl)2, DMSO, CH2Cl2, -60 °C, 2 min, then alcohol 35, -
50 °C, 25 min, NEt3, -60 °C, 10 min, r.t., 15 min (81 % over 2 steps). 
 
2.2.1.3 Takano 
 
The second synthesis of pulo’upones 15/16 using asymmetric IMDA reaction was 
reported by the Takano group (10). They used the chiral oxazolidinone 41 developed by 
Evans group (79) to induce the asymmetric IMDA cycloaddition. The synthesis of the 
main skeleton started from para-anisyl ether 36 by removing the tetrahydropyranyl 
protecting group with para-toluene sulphonic acid (Scheme 3). Oxidation with 
pyridinium chlorochromate followed by HWE olefination (11) afforded the dienyl ester 
37 in moderate yield (45 %). Reduction and acetylation gave dienylacetate 38. An SN2 
reaction with the Grignard reagent 28 gave a diene ketal. This was subjected to 
hydrolysis to aldehyde 39 and HWE reaction to produce triene ester. Ester was 
hydrolyzed in basic conditions to trienyl acid 40. Chiral oxazolidinone 41 was attached 
via a lithium salt to the trienyl acid chloride, which was prepared previously from the 
acid 40 with oxalyl chloride. The amide formation was surprisingly low yielding (59 %). 
Dimethylaluminium chloride was used as the Lewis acid to promote IMDA 
cycloaddition. The cycloadduct 42 was obtained in moderate yield (52 %) after 
chromatographic purification. Removal of the chiral auxiliary was not obtained by 
hydrolysis with inorganic bases. However, the chiral oxazolidinone 41 was removed by 
deprotecting the p-anisyl group with cerium ammonium nitrate followed by generation of 
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the lithium alcoholate with n-butyl lithium, which enabled lactonization. Methylation of 
the carbonyl group was obtained in low yield (12 %). However, the synthesis of (+)-
pulo’upone 16 was continued by PCC oxidation and Wittig reaction of the resulting 
aldehyde with the lithium salt of 2-(2-pyridyl)ethyltriphenylphosphonium iodide. The 
E:Z-selectivity of the Wittig reaction was 1:3.  
O
N
(+)-pulo'upone (16)
ArO
a-c COOEt d,e
OAc
O
OBrMg
f,g h,i
O
OTHP
HO O
HN
O
O
Ph
j,k
N
O
O
O
Ph
l,m
O
O
n-p
OAr OAr
OAr
OAr
ArO
36 37 38
28
39 40
41
42 43
(Ar = p-anisyl)
 
Scheme 3. Reagents and conditions: a) p-TsOH, MeOH, r.t. (95 %) b) PCC, MS 3Å, 
CH2Cl2, r.t., 15 min; c) triethyl 4-phosphonocrotonate, LHMDS, THF, -40 -> r.t., 12 h 
(45 % over 2 steps); d) DIBAL-H, Et2O, -78 °C, 1 h; e) Ac2O, pyr, r.t., 14 h (97 % over 2 
steps); f) Grignard reagent 28, cat. Li2CuCl4, -30 °C, 2 h (74 %); g) AcOH-H2O-THF, 80 
°C, 4 h; h) methyl diisopropylphosphonoacetate, t-BuOK, THF, -20 °C, 5 h (74 % over 2 
steps); i) 10% NaOH, MeOH, THF, r.t., 10 h (57 %); j) (COCl)2, PhMe, r.t., 20 h; then 
oxazolidinone 41, n-BuLi, THF, -78 °C, 1.5 h (59 %); k) Me2AlCl, CH2Cl2, -30 °C, 5 h 
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(52 %); l) CAN, CH3CN-H2O, 0 °C, 15 min; m) n-BuLi, THF, 0 °C, 1 h (76 %); n) MeLi, 
THF, -78 °C, 1 h (12 %); o) PCC, MS 3Å, CH2Cl2, r.t., 15 min (95 %); p) 2-(2-
pyridyl)ethyltriphenylphosphonium iodide, n-BuLi, THF, 0 °C, 5 h (11 %). 
 
Takano et al. synthesized (-)-pulo’upone 15 by an improved method, in which they used 
DIBAL-H for reducing lactone 44. This was followed by methylation and oxidation to 
afford ketoaldehyde 45 in 42 % overall yield (Scheme 4) (10). (-)-Pulo’upone 15 was 
synthesized with this method and using otherwise same reactions as in the synthesis of 
(+)-pulo’upone 16. 
O
N
(-)-pulo'upone (15)
O
O
a-c
O
O
d
44 45
 
Scheme 4. Reagents and conditions: a) DIBAL-H, THF, -78 °C; b) MeLi, THF-Et2O, -78 
°C -> r.t. (70 % over 2 steps); c) PCC, MS 3Å, CH2Cl2, r.t., 30 min (60 %); d) 2-(2-
pyridyl)ethyltriphenylphosphonium iodide, n-BuLi, THF, 0 °C, 5 h (11 %).  
 
2.2.1.4 Evans 
 
Total synthesis of (-)-isopulo’upone 17 was reported in 1997 by the Evans group (12). A 
novel catalytic IMDA reaction was utilized to prepare the bicyclo[4.3.0]nonane part of (-
)-isopulo’upone 17. Evans et al. prepared the precursor for the IMDA cycloaddition 
starting from vinyl iodide 47 and vinyl stannane 48 (Scheme 5).  The terminal alcohol 
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group was oxidized by Swern oxidation. The resulting aldehyde was subjected to HWE 
reaction to afford the trienimide 51 intermediate with an E:Z-selectivity of 27:1. Chiral 
C2-symmetric Cu(II) complex 46 derived from (S,S)-tert-butylbis(oxazoline), copper 
chloride and hexafluoroantimonate (Figure 9) catalyzed IMDA of trienimide 51 to give 
the endo-cycloadduct 52  in high yield (81 %). The cycloaddition catalyzed by 46 gave 
cycloadduct 52 with excellent diastereo- and enantioselectivity (>99:1 endo/exo; 96 
%ee). The hindered imide 52 was opened by thioesterification in high yield (90 %). 
Lindlar’s catalyst accompanied with triethylsilane and 1-decene allowed reduction of the 
thioester without concomitant reduction of the endocyclic double bond. Methylation gave 
an 8:1 mixture of diastereomers and further desilylation and oxidation afforded aldehyde 
53. Wittig reaction using tributylphosphonium bromide and n-butyllithium was used to 
prepare (-)-isopulo’upone 17 in 90 % yield as an isomeric mixture (E:Z, 12:1). The 
synthetic route developed by Evans group is clearly the shortest and highest yielding 
synthetic path to prepare iso- and pulo’upone type compounds. 
 
O
N N
O
Cu
Me3C CMe3
2+
2 SbF6
-
46  
 
Figure 9. Evans C2-symmetric copper(II) catalyst 46. 
 
 
 
 
 
 
 
27 
 
O
N
(-)-isopulo'upone (17)
HO
SnBu3
TBSO
I a,b TBSO
N O
OO
(MeO)2P
O
c
TBSO
O
O
NO
O d
O
NO
O
OTBS
e-h,b
O
O
N
PBu3Br
i
47
48
49
50
51 52
53
54
 
Scheme 5. Reagents and conditions: a) Pd2(dba)3⋅CHCl3, DMF, r.t., 16 h (72 %); b) 
(COCl)2, DMSO, Et3N, -78 -> -40 °C; c) NaHMDS, THF, r.t., 26 h (77 % over 2 steps); 
d) 5 mol-% Cu(II)catalyst 46, CH2Cl2, r.t., 24 h (81 %); e) LiSEt, THF, 0 °C, 15 min (90 
%); f) Et3SiH, 5% Pd/CaCO3/quinoline, 1-decene, acetone, r.t., 2 h; g) MeMgCl, THF, -
78 °C; h) 1% HCl/EtOH, r.t., 10 min (90 % over 3 steps); i) tributylphosphonium 
bromide, n-BuLi, THF, -20 °C, then aldehyde 53, r.t., 45 min (90 %). 
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2.2.1.5 Hase 
 
Hase et al. have prepared racemic isopulo’upone 17/18 using a thermal IMDA 
cycloaddition of a tetraene ketone (13). Preparation of the precursor for IMDA reaction 
started from 2-picolinaldehyde 55 (Scheme 6). Wittig reaction of 55 with 5-(2-
tetrahydropyranyloxy)-pentylphosphonium potassium salt 56 produced an E:Z-mixture 
(3:7) of stereoisomers. The undesired Z-isomer was transformed to the E-isomer 57 by 
daylight lamp irradiation of the stereoisomer mixture in the presence of 
diphenyldisulfide. After removing the protecting group (THP), the alcohol was oxidized 
with NACAA 64 to aldehyde 58. HWE reaction of the aldehyde 58 with crotyl 
phosphonate 59 gave trienyl ester. Reduction and acetylation of the ester derivative 
afforded trienyl acetate 60 for chain elongation. Copper catalyzed (Li2CuCl4) reaction of 
the acetate 60 with the Grignard reagent 61 and hydrolysis of the resulting acetal afforded 
the triene aldehyde 62 in 55 % yield. The relatively low yield was probably due to 
isomerization and hydrolysis of the diene acetate 60 during the Grignard reaction. Wittig 
olefination of aldehyde 62 produced a triene ketone ready for the thermal IMDA. A long 
reaction time was required for complete conversion to afford endo-cycloadduct 17/18 in 
86 % yield. 
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CHO Ph3P OTHP
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a,b N
THPO
c,d N
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(EtO)2P CO2Et
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(-/+)-isopulo'upone 17/18
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64  
Scheme 6. Reagents and conditions: a) K2CO3, H2O, dioxane (90 %); b) hν, PhSSPh (99 
%); c) 1 M HCl, 10 h (85%); d) NACAA, CH2Cl2, pyr, 20 min, r.t. (70 %); e) 
phosphonate 59, LiHMDS, THF, -78 °C, then aldehyde 58, THF, -60 → r.t. (68 %); f) 
LiAlH4, Et2O, -30 °C, 1 h (90 %); g) Ac2O, pyr, r.t. (98 %), h) Grignard reagent 61, 
Li2CuCl4, THF, -30 °C, 3 h; i) 10 % H2SO4, acetone, r.t., 1 h (55 % over 2 steps); j) 
phosphorane ylide 63, CH2Cl2, 40 °C, 48 h (76 %); k) PhMe, 48 h, 110 °C (86 %). 
 
Hase et al. have also prepared racemic pulo’upone 15/16 using the thermal IMDA 
cycloaddition for tetraenyl ketone (14). Preparation of the precursor for IMDA reaction 
started from 4-pentyn-1-ol 65 (Scheme 7). 4-Pentyn-1-ol 65 was reacted with DIBAL-H 
and iodine to afford 5-iodo-4E-penten-1-ol. After tetrahydropyran protection of the 
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alcohol, vinyl iodide 66 was reacted with 2-picolinylcuprate 67 to afford a 
pyridylhexenol derivative. After removing the protecting group (THP), the resulting 
alcohol was oxidized to aldehyde 68. HWE reaction of aldehyde 68 with crotyl 
phosphonate 59 gave trienyl ester. Reduction and acetylation of ester derivative afforded 
trienyl acetate 69 ready for chain elongation. Reaction of acetate 69 with Grignard 
reagent 61 catalyzed by copper salt (Li2CuCl4) and hydrolysis of the resulting acetal 
afforded trienyl aldehyde 70 geared up for Wittig reaction. After Wittig reaction of 70 
with 71, the synthesis was completed by heating the resulting tetraene ketone at 110 °C 
for 2 days. Thermal IMDA afforded a racemic mixture of pulo’upones 15/16 in high 
yield (86 %). 
N
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(-/+)-pulo'upone 15/16
OH
Cl
65 66
67
68
69
70
71
59 61
 
 
 
 
 
 
 
 
 
31 
 
Scheme 7. Reagents and conditions: a) DIBAL-H, PhMe, alcohol 65, hexane, -30 °C, 
then 2 h, 50 °C, THF, I2, -50 °C → r.t., 1 h (54 %); b) DHP, HCl, 0 °C → r.t., 3 h; c) n-
BuLi, 2-picoline, THF, -60 → -50 °C, 30 min, CuCN, -60 → -15 °C, 10 min, vinyliodide 
66, THF, -70 → -30 °C, 3 h; d) HOAc-THF-H2O, 45-50 °C, 12 h (64 %); e) NACAA, 
CH2Cl2, pyr, r.t., 20 min (70 %); f) crotylphosphonate 59, THF, LiHMDS, -78 → -50 °C, 
then aldehyde 68, THF, -50 → r.t. (50 %); g) LiAlH4, Et2O, -30 °C, 1 h (88 %); h) Ac2O, 
pyr, r.t. (95 %); i) Grignard reagent 61, Li2CuCl4, THF, -30 °C, 3 h (55 %); j) 10 % 
H2SO4, acetone (95 %); k) phosphorane salt 71, K2CO3, dioxane, H2O, 95 °C, 12 h (70 
%) ; l) PhMe, 48 h, 110 °C (86 %). 
2.2.2 Pyrroloketoindanes 
 
Pyrroloketoindane compounds have been isolated from Streptomyces species (Figure 10). 
This family of natural products include indanomycin (X-14547A) 72, (15) 16-
deethylindanomycin (A83094A) 73 (16), homoindanomycin 74 (17) and cafamycin 75 
(18). Indanomycin 72 is a carboxylic acid ionophore produced by Streptomyces 
antibioticus, NRRL 8167 (15). Pyrroloketoindanes 72-75 have a trisubstituted trans-
fused endo-bicyclo[4.3.0]nonane substructure. Pyrroloketoindanes are named according 
to their pyrrole part.  
O
N
H
R1
O
R2
COOH
72 R1 = Et, R2 = Me
73 R1 = H, R2 = Me
74 R1 = Et, R2 = Et
75 R1 = H, R2 = Et
H
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Figure 10. Pyrroloketoindanes 72-75 isolated from Streptomyces. 
Synthetic efforts towards homoindanomycin 74, cafamycin 75 or A83094A 73 have not 
been reported. The synthesis efforts towards pyrroloketoindanes have mainly focused to 
indanomycin 72. Indanomycin 72 has potent in vitro activity against Gram-positive 
bacteria, exhibits both antineoplastic and antihypertensive properties, and is an effective 
ruminant growth promotant by improving feed utilization (19). Indanomycin 72 is also 
capable to bind mono-, di- and trivalent metal cations, making them miscible in organic 
solvents. 
 
2.2.2.1 Indanomycin 72 
 
Indanomycin 72 has been synthesized by several research groups. The synthetic efforts 
are presented in the following chapters. The chapters are divided according to research 
groups.  
 
2.2.2.1.1 Roush 
Roush et al. (20) have reported the first synthesis of trans-fused hexahydroindene 
structure of indanomycin 72. Their idea was to prepare the hexahydroindene structure by 
endo-selective Lewis acid promoted IMDA. The synthetic sequence for the precursor of 
IMDA cycloaddition is presented in Scheme 8. Alkylation of 76, followed by 
decarboxylation afforded ester dioxolane 78. Aldehyde 79 was obtained by reduction - 
oxidation sequence. Alkylation of aldehyde 79 was followed by mild hydrolysis to afford 
diene aldehyde 80 in moderate yield (70 %). Wittig reaction and hydrolysis of the 
dioxolane gave triene ester aldehyde 81. The pyrrole part was obtained by Wittig reaction 
of aldehyde 81 with phosphorane pyrrole. IMDA was promoted by ethylaluminum 
chloride to afford a racemic mixture of cycloadducts 82 in moderate yield (71 %). The 
overall process was not very high yielding due to moderate yielding intermediate steps. 
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Scheme 8. Reagents and conditions: a) NaOEt, EtOH, rfx, 13 h (53-55 %); b) LiCl, H2O, 
DMSO, rfx (83 %); c) LiAlH4 (93-100 %); d) PDC, CH2Cl2 (67-70 %); e) 
CH3OCH=CHC≡CH, n-BuLi, THF, -78 °C to r.t., 3 h; then EtOH, LiAlH4, 3 h, 23 °C; 
then 1M HCl, 2-3 h, 23 °C (70 %); f) (Ph)3PCHCOOMe, C6H6, rfx (81 %) ; g) H3O+ (79 
%); h) (Ph)3PCHCO-pyrrole, CH2Cl2, r.t., 3 days (57 %); i) EtAlCl2, CH2Cl2, 0 °C to r.t. 
in 1.5 hours (71 %). 
Roush et al. have also reported a different approach to synthesize indanomycin 72. The 
synthesis was based on the idea that the coupling of the two halves is made before the 
IMDA reaction. The pentaene model compound was prepared and successfully cyclized 
to trans-fused hexahydroindene cycloadduct 90 in moderate yield (53 %). The pentaene 
intermediate was prepared as presented in the Scheme 9 (21). Aldehyde 83 was subjected 
for HWE reaction and the formed ester 84 was reduced. Substitution of the hydroxyl 
group with bromine was followed by phosphonate 85 formation. Further HWE reaction 
afforded tetraene 87, which was hydroborated with 9-BBN. Alkaline hydrogen peroxide 
treatment hydrolyzed the borane to afford a primary alcohol intermediate. Swern 
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oxidation of the terminal alcohol was followed by Wittig reaction with pyrrole 
phosphorane under thermal conditions, which leads simultaneously to IMDA 
cycloaddition. The ratio of endo-90 to exo-cycloadducts were 53:17. The endo-
cycloadduct was isolated by chromatography in 53 % yield. 
OHC
O
N
H
Et
H
H
racemic
CO2Et(EtO)2P
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a
EtO2C
b-d (MeO)2P
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CHO
e f-h
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(Ph)3P
i
83
59
84 85
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Scheme 9. Reagents and conditions: a) LDA, THF, - 40 °C (95 %); b) LiAlH4, Et2O, 0 °C 
(92 %); c) Ph3PBr2, CH3CN, 0 °C; d) (MeO)3P, PhMe, 110 °C (78 % over 2 steps); e) 
phosphonate 85, aldehyde 86, DME, KOt-Bu, DME, 0 °C, 1.5 h (95 %); f) 9-BBN, THF, 
0 °C; g) NaOH, H2O2 (84 %); h) TFAA, DMSO, DIPEA, CH2Cl2, - 78 °C -> 23 °C (80 
%); i) ylide 89, CH2Cl2-MeOH (2:1), 40 °C, 39 h (53 %).  
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Roush et al. synthesized optically pure indanomycin 72 by creating the chiral center (C8) 
in the five membered ring of bicyclo[4.3.0]nonane system by a reaction between chiral 
aldehyde 94 and boronate 93 (22). Boronate 93 was prepared from commercially 
available 4-pentynol 65 according to Scheme 10. Silylation of 4-pentynol 65 was 
followed by lithiation of the triple bond and iodination to afford iodo alkyne. Reduction 
by hydroboration-protonolysis gave Z-alkenyl iodide 91. Second lithiation and reaction 
with pinacol (chloromethyl)boronate 92 afforded intermediate boronate 93, which was 
reacted without purification with D-glyceraldehyde acetonide 94. The double bond of 95 
was reduced with diimide and the acetonide was hydrolyzed. The resulting triol was 
oxidized to afford aldehyde 96. Diene ester was obtained by reaction between aldehyde 
96 and the lithium anion of triethyl 4-phosphonocrotonate 59. Subsequent reduction with 
lithium aluminium hydride, bromination and reaction with sodium diisopropyl phosphite 
afforded phosphonate. Finally, desilylation by fluoride ion afforded hydroxyl 
phosphonate 97 in moderate yield (39 % over 3 steps). 
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d
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Scheme 10. Reagents and conditions: a) TBDPSCl, imidazole, DMF, 23 °C (95 %); b) n-
BuLi, THF, -78 °C, then I2, -78 -> -30 °C, 2 h (95 %); c) 9-BBN, THF, 23 -> 70 °C, 4 h, 
then AcOH, 25 °C, 30 min (65-70 %); d) t-BuLi, Et2O, -78 °C, 1 h, then boronate 92, -78 
°, then 23 °C; e) aldehyde 94, CH2Cl2, 23 °C, 12-24 h (55 %); f) NH2NH2, NaIO4, 
CH3OH, 23 °C; g) AcOH-CH3OH-H2O (4:1:1), 60 °C, 1 h; h) NaIO4, THF (78 % over 3 
steps); i) phosphonate 59, LDA, THF, -78 -> 23 °C; j) LiAlH4, Et2O (82 % over 2 steps); 
k) Ph3PBr2, CH3CN, 0 °C; l) NaP(O)(O-iPr)2, C6H6; m) HF, CH3CN (39 % over 3 steps). 
Reaction of phosphonate 97 with the unsaturated aldehyde 98 afforded tetraene. (Scheme 
11) Swern oxidation of the resulting terminal alcohol and reaction with pyrrole 
phosphorane 89 gave optically pure indanomycin as the methyl ester derivative 100 in 
moderate yield (51 %) (22). 
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Scheme 11. Reagents and conditions: a) phosphonate 97, DME, KO-t-Bu, 0 °C, E:Z 
(11:1) (83 %); b) DMSO, TFAA, -78 °C, DIPEA (80 %); c) ylide 89, ClCH2CH2Cl, 40 
°C, 3 days, then  60 °C, 1 day (51 %). 
 
2.2.2.1.2 Nicolaou 
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Nicolaou et al. (23) have also prepared trans-fused hexahydroindene part of indanomycin 
72 by an IMDA reaction. However, this method afforded a racemic mixture of 
cycloadducts 110. They prepared the precursor for cycloaddition in the following manner 
(Scheme 12). Ethylation of δ-valerolactone 101 was followed by reduction to elaborate 
lactol 102. Lactol 102 was opened by silylation to afford siloxy aldehyde 103. HWE 
reaction of 103 with 104 furnished dienoate 105 in very high yield (95 %). Further 
transformations afforded diene aldehyde 106. Wittig reaction of aldehyde 106 produced 
triene ester 107, which was heated in toluene to afford the cycloadduct 108. Deprotection 
with fluoride gave cyclic lactone 109. The pyrrolyl carbonyl moiety was obtained by 
alkylation with the Grignard reagent derived from MeMgCl and pyrrole in toluene. 
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Scheme 12. Reagents and conditions: a) LDA, EtI, THF-HMPA, -78 °C (80 %); b) 
DIBAL-H, CH2Cl2, - 78 °C (100 %); c) t-BuMe2SiCl, imidazole, DMF, 25 °C (70%); d) 
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LDA, THF, - 78 °C (95 %); e) DIBAL- H, CH2Cl2, - 78 °C (99 %); f) t-BuPh2SiCl, 
imidazole, DMF, 25 °C; g) AcOH-THF-H2O, 25 °C, 1 h (70 % over 2 steps); h) 
CrO3⋅pyr⋅HCl, CH2Cl2, 25 °C; i) (Ph)3P=CHCO2Me, PhMe, 25 °C (90 % over 2 steps); j) 
PhMe, 130 °C, 48 h (70 %); k) n-Bu4NF, THF, 25 °C (100 %); l) pyrrole, MeMgCl, 
PhMe, 110 °C (80-90 %). 
 
Nicolaou et al. (24) have also prepared the optically active tetrahydropyran ring part of 
indanomycin 72 by starting from benzyl protected epoxide 111 (Scheme 13). Epoxide 
111 was opened by alkylation and debenzylated with hydrogenolysis. Selective formation 
of the acetonide afforded hydroxyl acetonide 113 in high yield (98 %). The right side of 
tetrahydropyran ring was obtained by tosylation, substitution by iodine and reaction with 
triphenylphosphine to produce ylide 114 for Wittig reaction. The left side of 
tetrahydropyran ring 115 was obtained from the same hydroxyl acetonide 113 by benzyl 
protection, hydrolysis of the acetonide, t-butyl acetal formation, tert-butyldiphenyl silyl 
protection, DIBAL-H reduction and oxidation. Acetonide fragment 114 and aldehyde 115 
were connected by Wittig reaction. Hydrolysis of the acetonide, selective tosylation, 
epoxide formation under basic conditions, desilylation and hydrogenation of the double 
bond afforded epoxy alcohol 117 set for ring formation. Ring closure was achieved 
effectively (95 %) by using camphorsulphonic acid. The final ester product 119 was 
prepared by oxidation of the alcohol, alkylation with ethylmagnesium bromide, 
debenzylation, Jones oxidation and esterification.  Nicolaou et al.  have prepared 
optically pure trans-fused hexahydroindene part of indanomycin 72 by using the SAMP 
hydrazone 120 to create the correct enantiomer at the C6-position (Scheme 14).(24) The 
lactone 109 was obtained using the same synthetic route as in the Scheme 12. 
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Scheme 13. Reagents and conditions: a) LiCuMe2, Et2O, - 78 °C -> - 40 °C, 10 % Pd/C, 
EtOH, 25 °C (100 % over 2 steps); b) (MeO)2CMe2-C6H6 (5:1), CSA, 25 °C, 15 h, then 
CSA, MeOH, 25 °C (98 %); c) TsCl, pyr, 0-25 °C (100 %); d) NaI, acetone, 25 °C, 48 h 
(85 %); e) PPh3, CH3CN-(EtO)3CH (4:1), 75 °C, 48 h (80 %); f) NaH, BnBr, DME, 0-65 
°C (90 %); g) amberlite IR-120, ethylene glycol-DME (2:1), 45 °C (80 %); h) 
(Me)3CCOCl-pyr, 0-25 °C; i) imidazole, t-BuPh2SiCl, DMF, 0-25 °C; j) DIBAL-H, 
CH2Cl2, - 78 °C (85 % over 3 steps); k) CrO3⋅pyr⋅HCl, 4 Å MS, CH2Cl2, 25 °C (85 %); l) 
DMSO, dimsylsodium, PhH, 25 °C (77 %, E/Z (2:1)); m) amberlite IR-120, ethylene 
glycol-DME (2:1), 45 °C (80 %); n) TsCl-pyr, - 20 -> 25 °C (75%); o) NaOMe, MeOH, 
25 °C (100 %); p) n-BuN4F, THF, 25 °C (100 %); q) 5% Pd/C, H2, EtOAc (70 %); r) 
CSA, 25 °C (95 %); s) CrO3⋅pyr⋅HCl, NaOAc, CH2Cl2, 25 °C (80 %); t) EtMgBr, PhMe, 
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- 78 °C (80 %); u) 10 % Pd/C, H2, EtOH (100 %); v) Jones reagent, acetone, - 40 -> - 20 
°C (90 %); x) CH2N2, Et2O, 0 °C. 
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Scheme 14. Reagents and conditions: a) LDA, Et2O, 0 °C, 17 h (85 %); b) O3, CH2Cl2, - 
78 °C, 15 min (100 %); c) as in the Scheme 12 (steps d-k). 
 
Nicolaou et al. achieved the first total synthesis of indanomycin 72 in 1981 by coupling 
allylic bromide tetrahydropyran 123 and phenyl sulfone 124 in high yield (97 %) 
(Scheme 15).(25) Allylic bromide 123 was prepared from the previously synthesized 
ketone 119 via sequence: alkylation with vinyl magnesiumbromide, bromination and 
simultaneous rearrangement with phosphorous tribromide. Phenyl sulfone derivative 124 
was prepared by using the following sequence of reactions: opening of the lactone 109 
with a thiol nucleophile, esterification, reduction and selective oxidation with diphenyl 
diselenide and hydrogen peroxide. After Julia coupling (29) of allylic bromide 123 with 
phenyl sulfone 124, the resulting adduct was desulfurized with Triton B to give the 
diene intermediate. Esterification and oxidation of the hydroxyl end to acid provided 
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ester acid 125. The acid 125 was activated as pyridyl sulfide for the formation of the acyl 
pyrrole 126. 
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Scheme 15. Reagents and conditions: a) CH2=CHMgBr, THF, - 78 °C (95 %); b) PBr3, 
Et2O, - 10 °C (E/Z, 13:5) (90 %); c) LiH, PhSH, DMF, 110 °C, 3 h; d) CH2N2, Et2O, 0 
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°C; e) LiAlH4, Et2O, 0 °C (95 % 3 steps); f) Ph2Se2, H2O2, Et2O-CH2Cl2 (5:1), 0-15 °C, 8 
h (82 %); g) TBDMSCl, Et3N, DMAP, CH2Cl2 (95 %); h) sulfone 124, LDA, THF, - 78 
°C, 10 min, HMPA, - 78 °C, 5 min, bromide 123, THF, - 78 °C, 30 min (97 %); i) 40 % 
Triton B, MeOH, 45 °C, 24 h; j) CH2N2, Et2O, 0 °C (80 % over 2 steps); k) Jones reagent, 
acetone, - 10 °C, 2 h (85 %); l) 2,2’-dipyridyl disulfide, Ph3P, PhMe, 25 °C, 24 h; m) 
pyrrole, MeMgCl, PhMe-THF, - 20 °C, PhMe, - 78 °C (90 % over 2 steps). 
 
2.2.2.1.3 Ley 
 
Ley et al. (26) prepared the bicyclo[4,3,0]nonene part of indanomycin 72 starting from 2-
ethyl-δ-valerolactone 126 (Scheme 16). Lactone 126 was reduced to lactol with DIBAL-
H. Resulting lactol was protected by TBDMS-group and reacted with the lithium anion of 
ethyl-4-diethylphosphonocrotonate 59 to give diene ester 128 in good yield (72 % over 3 
steps). The ester group was reduced with DIBAL-H and the formed alcohol was protected 
as a MEM ether. Selective removal of silyl protection and PCC oxidation gave aldehyde 
129 in high yield (96 %). Further reaction of 129 with phosphorane 130 gave the triene 
ester 131. IMDA cycloaddition afforded the desired endo-cycloadduct in nearly 
quantitative yield (>90 %). Removal of MEM-protection resulted in the formation of 
lactone 109. Relatively stable lactone 109 was converted to hydroxypyrrole 110 with 
pyrryl magnesium bromide at 100-105 °C. 
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Scheme 16. Reagents and conditions: a) DIBAL-H, PhMe, -78 °C; b) TBDMSCl, 
imidazole; c) LDA, phosphonate 59 (72 % over 3 steps); d) DIBAL-H, PhMe, 0 °C; e) 
MEMCl, DIPEA, CH2Cl2 (96 % over 2 steps); f) TBAF, THF; g) CrO3, pyr, CH2Cl2, 25 
°C (96 % over 2 steps); h) ylide 130, CH2Cl2, 25 °C (95 %); i) PhMe, rfx, 36-70 h; j) 
ZnBr2, CH2Cl2 (60 % over 2 steps); k) pyrrole 132, PhMe, 100-105 °C (73 %). 
 
Ley et al. (27) were the second group to complete the total synthesis of indanomycin 72. 
They prepared the tetrahydropyran ring of indanomycin by a laborious route from 1,6-
anhydro-β-D-glucose. Methylation, detosylation and acylation sequence gave the bridged 
intermediate 134 from tosylate 133, which had previously been prepared from 1,6-
anhydro-β-D-glucose (Scheme 17). Ring opening with iodotrimethylsilane, followed by 
DBU treatment gave the unsaturated pyran derivative 135. Chirality transfer was 
accomplished using the Claisen ester-enolate rearrangement developed by Ireland et al. 
(28). In this step, enolization, silylation, warming, desilylation and methylation sequence 
afforded the unsaturated pyran ester alcohol derivative in good overall yield (67 %). 
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Hydrogenation gave the saturated pyran ring derivative 136. The diastereomeric aldehyde 
137 was elaborated from alcohol 136 by substitution of the hydroxyl group by iodine, 
elimination to obtain a double bond, hydroboration of the resulting double of bond, 
oxidative hydrolysis of borane and oxidation of the resulting alcohol. Finally, alkylation 
of the aldehyde 137 and oxidation of the resulting alcohol gave ethyl ketone 138.  
O
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Scheme 17. Reagents and conditions: a) MeMgCl, CuBr⋅SMe2, THF, -10 °C, 4 days (86 
%); b) LiBHEt3, THF, 20 °C, 24 h (95 %); c) n-BuLi, THF, -78 °C, then EtCOCl, 20 °C, 
2 h (97 %); d) Me3SiI, PhMe, -35 °C, 4 h, then DBU, -> r.t. (75 %); e) LDA, THF, -50 
°C, 1 h, then Me3SiCl, Et3N, 20 °C, 15 min, 50 °C, 4 h, n-BuNF, CH2N2 (67 %); f) PtO2, 
H2, EtOAc, 20 °C, 2 h (60 %); g) Ph3P, imidazole, I2, PhH, 80 °C, 1.5 h (85 %); h) AgF, 
pyr, 20 °C, 24 h (96 %); i) BH3⋅THF, THF, 20 °C, 48 h, then NaOH, H2O2 (55 % over 2 
steps); j) PCC, CH2Cl2, 20 °C, 48 h (62 %); k) EtMgBr, THF, -30 °C, 15 min; l) H2CrO4, 
acetone, 20 °C, 15 min (96 % over 2 steps).  
 
The previously prepared lactone 109 (26) was resolved to obtain the 
bicyclo[4.3.0]nonene part of indanomycin 72 (27). Reaction of racemic 109 with S-
phenylethylamine in the presence of 2-hydroxypyridine gave a separable diastereomeric 
mixture of lactams 139a,b (Scheme 18). Hydrolysis of lactam 139b returned optically 
pure lactone 109. The unreactive lactone 109 was opened by a reaction with lithiated 
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SEM-pyrrole 140 at 100 °C. The unsaturated aldehyde pyran derivative 142 was 
elaborated from 138 by using the method developed by Nicolaou et al. (24). The 
connection of the pyran derivative 142 and bicyclo[4,3,0]nonane fragment 141 was 
accomplished using Lythgoe-Kocienski modification of the Julia reaction (29). Highly 
stereoselective sodium amalgam reduction of the intermediate 143 afforded the diene 
intermediate. Cleavage of N-SEM protection and hydrolysis of ester group completed the 
synthesis of indanomycin 72. 
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Scheme 18. Reagents and conditions: a) PhCHMeNH2, 2-hydroxypyridine, PhMe, 110 
°C, 6 h (49 %); b) 0.5 M H2SO4, dioxane-H2O, 80 °C, 1 h (98 %); c) pyrrole 140, DME, 
0-20 °C, 5 min (62 %); d) NPSS, n-Bu3P, C6H6, 20 °C, 3 h; e) H2O2, (PhSe)2, CH2Cl2-
Et2O, 20 °C, 7 h (56 % over 2 steps); f) n-BuLi, THF-HMPA, -78 °C, 45 min, then 
PHCOCl, 20 °C, 2 h; g) Na-Hg, THF-MeOH, -20 °C, 3 h (53 % over 2 steps); h) n-
BuNF, THF, 0-20 °C, 45 min (72 %); i) NaOH, MeOH-H2O, 60 °C, 3 h (90 %).  
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2.2.2.1.4 Boeckman 
 
Boeckman et al. (30) have also reported an enantioselective synthesis of indanomycin 72. 
The pyran subunit was prepared starting from chiral aldehyde 144 (Scheme 19). 
Alkylation of chiral aldehyde 144 gave a diastereomeric mixture of alcohols 145. 
Ozonolysis of the terminal olefin and base catalyzed epimerization of the secondary 
methyl group produced a mixture of anomeric lactols (α:β) with a ratio of (1:3). 
Substitution with thiophenol in the presence of boron trifluoroetherate gave the α-
(phenylthio)pyran 146. Reductive lithiation generated an axial α-lithiopyran, which was 
condensed with 1-methoxy-1E-penten-3-one to afford a 1,2-adduct. Unsaturated pyran 
aldehyde 147 was generated as a 3:1 mixture of E:Z-isomers by pyridium p-
toluenesulfonate catalyzed hydrolysis.  
O
MOMO
CHO
H
OH
MOMO
a b-d
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147  
Scheme 19.  Reagents and conditions: a) LiCu((CH2)2CHCH3CH=CH2)2, Et2O, -48 °C -> 
-40 °C, 20 min (93 %); b) O3, CH2Cl2, -78 °C, 15 min, Me2S, -78 -> 25 °C, 20 min; c) 
K2CO3, MeOH, 23 °C, 3 h; d) PhSH, BF3⋅Et2O, CH2Cl2, -78 °C, 10 min (47 %); e) 
LiDBB, -78 °C, 10 min; then CH3CH2COCH=CHOCH3, THF, -78 °C, 10 min; f) p-
TsOH⋅pyr, CH2Cl2, -40 °C, 1 h (42 % over 2 steps). 
 
 
 
 
 
 
 
 
47 
 
The bicyclo[4.3.0]nonane fragment of indanomycin 72 was prepared from the chiral diol 
148 (Scheme 20).(30) Selective silylation of the primary hydroxyl group (31) followed 
by Claisen ortho ester rearrangement provided the unsaturated ester upon treatment of the 
monoprotected diol with trimethyl orthoacetate in hot xylenes in the presence of 
propionic acid. The crude ester was reduced with DIBAL-H to E-alcohol 149 in high 
overall yield (87 %). Tosylation of alcohol 149 and substitution of the tosyl group by 
cyanide group afforded nitrile intermediate 150. Unsaturated aldehyde 151 was obtained 
by desilylation and oxidation. E,E-Diene phosphorane intermediate 153 was elaborated 
by alkylation and phosphorylation with concomitant rearrangement in high yield (87 %). 
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Scheme 20. Reagents and conditions: a) TBDMSCl, Et3N, DMAP, CH2Cl2, 23 °C, 10 h; 
b) CH3C(OCH3)3, CH3CH2CO2H, xylenes, rfx, 19 h; c) DIBAL-H, THF, -70 -> 23 °C, 
1.5 h (87 % over 3 steps); d) p-TsCl, pyr, CH2Cl2, 23 °C, 10 h; e) KCN, Me2SO, 55 °C, 5 
h (88 % over 2 steps); f) n-BuNF, THF, 0 °C, 20 min; g) PDC, CH2Cl2, 23 °C, 12 h (67 
% over 2 steps); h) CH2=CHMgBr, THF, -78 -> 23 °C, 30 min; i) Ph3P-HBr, CH2Cl2, 23 
°C, 10 min (87 % over 2 steps). 
 
Boeckman (30) continued the synthesis of indanomycin 72 by a Wittig coupling of the 
E:Z-mixture (3:1) of aldehyde 147 and phosphonium salt 153 (Scheme 21). The prepared 
tetraene mixture was isomerized to E,E,E,E-tetraene 154 by treatment with a catalytic 
amount of I2 in the presence of potassium carbonate and cesium carbonate. DIBAL-H 
reduction of the nitrile to aldehyde and Wittig coupling of the resulting aldehyde with 
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pyrryl phosphorane ylide 89  gave a pentaene intermediate, which was immediately 
subjected directly to thermal IMDA conditions to afford the cycloadduct 155 in moderate 
yield (53 %). Indanomycin 72 was finally elaborated by removing the MOM protecting 
group and oxidizing the resulting alcohol under Jones conditions. 
O
H
H
H
H
EtH
O
HN
O
MOMO
NC
a,b
MOMO
H
N
O
(Ph)3P
c,d e,f
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154
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155
72
 
Scheme 21. Reagents and conditions: a) t-BuOK, DMF, -23, 1 h, 0 °C, 35 min; b) I2, 
hexanes, Cs2CO3, K2CO3, 23 °C, 20 min (79 %); c) DIBAL-H, -78 °C, 6 min, -> 0 °C, 25 
min (83 %); d) phosphorane 89, ClCH2CH2Cl, BHT, SrCO3, Cs2CO3, 45 °C, 96 h, then 
65 °C, 48 h (53 %); e) Me3SiI, CHCl3, -78 -> -60 °C, 10 min; f) CrO3, acetone, -23 °C, 1 
h (79 %). 
   
2.2.2.1.5 Burke 
 
Burke et al. (32) based their synthesis of indanomycin 72 on RHDA cycloaddition, 
Ireland-Claisen rearrangement and Stille coupling. Ireland-Claisen [3,3] rearrangement of 
the silyl enolate of lactone 156 afforded the unsaturated pyran derivative 157 (Scheme 
22). Vinylsilane methodology was utilized to prepare vinyliodide 160 for Stille coupling 
(33).  
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O O
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O
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Scheme 22. Reagents and conditions: a) LiHMDS, Me3SiCl, Et3N, THF, -78 –> 23 °C, 
40 min, PhMe, rfx, 4 h, 5 % HCl, Et2O; b) NHMe(OMe)⋅HCl, DCC, DMAP, CH2Cl2, (70 
% over 2 steps); c) Bu3SnCH2OBOM, n-BuLi, THF, -78 -> 0 °C (89 %); d) Pd(OH)2, H2, 
EtOH, 23 °C, 1.5 h; e) TBDMSCl, imidazole, DMAP, CH2Cl2, 23 °C (83 % over 2 
steps); f) Ph3P=CH2, THF, -78 -> 0 °C, TBAF⋅3H2O, 0 -> 23 °C (95 %); g) BaMnO4, 
CH2Cl2, 23 °C; h) (Me3Si)3Al⋅OEt2, PhMe, -90 °C; i) Ms2O, DMAP, Et3N, CH2Cl2, 0 °C; 
j) MeMgBr, CuCN, THF, -78 -> -40 °C (63 % E/Z (3.8:1) over 4 steps); k) NIS, THF, -
15 -> 23 °C; SiO2 (dark) (79 %); l) LiBF4, CH3CN, 80 °C, 1 h (88 %); m) Jones oxidation 
(92 %). 
 
The chiral lactone 163 was prepared from trans,anti-trisubstituted cyclopentane 161 
(Scheme 23). Palladium catalyzed acylation of vinylstannane 162 with the acid chloride 
of trisubstituted cyclopentane 161 afforded a ketene intermediate. Luche reduction of the 
ketene and ester hydrolysis gave the starting material for a DMAP catalyzed lactonization 
to afford lactone 163 as a mixture of C14 epimers (1.2:1). The lactone was converted to 
its silyl ketene acetal for RHDA cycloaddition. The cyclic acid 164 was activated as the 
thiopyridyl ester for pyrrole connection with pyrrolyl magnesium bromide. Finally 
 
 
 
 
 
 
 
50 
 
reductive alkyne desilylation gave the vinylstannane derivative 165 ready for Stille 
coupling. 
HO2C
t-BuO2C
Me3Si
SnBu3
a-c O
O
d
H
H
Me3Si
HO O
e-h H
H
O
Bu3Sn
NH
161
162
163
164 165
14
 
Scheme 23. Reagents and conditions: a) (COCl)2, C6H6, DMF; b) PhCH2PdCl(PPh3)2, 
vinylstannane 162, THF, 50 °C (76 %); c) NaBH4, CeCl3, MeOH, 23 °C, 10 min; aq. 
NaOH, MeOH, THF, 24 h, aq. HCl; DIC, DMAP, CH2Cl2, 23 °C (71 %, 1.2:1 epimer); d) 
LiHMDS, Me3SiCl, Et3N, -100 -> 23 °C, 40 min; remove THF, PhMe, rfx, 36 h; 5 % 
HCl, Et2O; e) Aldrithiol-2(2,2’-dipyridyl sulfide), PhMe, 23 °C (66 % over 2 steps); f) 
EtMgBr, pyrrole, PhMe, THF, 0 °C, then thioester, THF, 0 °C (93 %); g) TBAF⋅3H2O, 
THF, 0 °C (98 %); h) Bu3SnH, Pd(PPh3)4, C6H6, 23 °C (71 %). 
The synthesis of indanomycin 72 was completed by Stille coupling of vinyliodide 160 
and vinylstannane 165 in moderate yield (61 %) (Scheme 24). The reaction required the 
use of freshly prepared (Ph3P)4Pd in DMF to avoid reductive dimerization of 
vinylstannane 165. 
O
CO2H
H
H
O
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a
72
160 + 165
 
 
 
 
 
 
 
 
51 
 
Scheme 24. Reagents and conditions: a) (Ph3P)4Pd, DMF, 23 °C (61 %). 
2.2.2.2 Stawamycin 166 
 
Stawamycin 166 was isolated from Streptomyces in 1995 by Miao et al. (34). (Figure 11). 
Stawamycin 166 is an inhibitor against the Epstein-Barr virus (human herpes virus) 
BZLF1 transcription factor to DNA with an IC50 = 50 µM in a DNA binding assay (34). 
Stawamycin 166 has a trisubstituted trans-fused endo- bicyclo[4.3.0]nonane substructure. 
The only reported efforts towards the synthesis of stawamycin are concentrated on the 
preparation of bicyclo[4.3.0]nonane fragment. 
O
N
H
HO
OH
HO O
stawamycin (166)
16
11
21
 
Figure 11. Structure of stawamycin 166. 
 
Dias et al. (35) have recently reported a synthesis of the C11-C21 fragment of 
stawamycin 166 by a thermal IMDA cycloaddition (Scheme 25). They used the chirality 
of (R)-3-hydroxy-2-methylpropionate 167 for creating the chiral center C16. Stille 
coupling was utilized for elaborating the triene precursor 173 for IMDA cycloaddition. 
Stannane 172 was obtained from propargyl alcohol by TBS-protection and 
tributylstannylation.  Unfortunately, thermal IMDA cycloaddition of the Weinreb amide 
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derivatized triene 173 resulted in low diastereoselectivity (48:52, endo-174:exo). The 
desired endo-cycloadduct 174 was obtained as a mixture with exo-cycloadduct after flash 
chromatographic purification (endo:exo, 48:14) in moderate yield (60 %). 
O
MeO2C
OH
a,b
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N
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j
N
O
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k
N
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Scheme 25. Reagents and conditions: a) PMB, acetimidate, CSA, CH2Cl2, r.t. (94 %); b) 
DIBAL-H, PhMe, -78 °C; c) Ph3P=CHCO2Et, CH2Cl2, rfx (86 % over 2 steps); d) H2, 
Pd/C, MeOH, r.t. (91 %): e) DIBAL-H, PhMe, -78 °C; f) Ph3P=CHCONMeOMe, 
CH2Cl2, rfx (78 % over 2 steps); g) DDQ, CH2Cl2, H2O (91 %); h) (COCl)2, DMSO, 
Et3N, CH2Cl2, -78 °C; i) CHI3, CrCl2, THF, 0 °C (65 % over 2 steps); j) (MeCN)2PdCl2, 
DMF (77 %); k) PhMe, BHT, 150 °C (78 %).  
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2.2.3 Cochleamycin A 175 
 
In 1992-1996 the team of Shindo and Kawai (36) isolated and characterized antitumor 
antibiotics which they named cochleamycins. The structure of cochleamycin A 175 is 
shown in Figure 12. Cochleamycin A 175 incorporates a tetrasubstituted cis-fused 
bicyclo[4.3.0]nonane fragment. 
OAc
Cochleamycin A (175)
O
O O
H OH
  
 
Figure 12. Structure of cochleamycin A 175. 
 
Paquette and Chang (37) have recently reported synthetic studies towards total synthesis 
of cochleamycin A 175. The chirality of L-(-)-malic acid was employed to elaborate the 
vinyl iodide fragment 181 for Sonagashira coupling (38) (Scheme 26). After conversion 
of L-(-)-malic acid to hydroxy acetal 176, the alcohol group was protected with PMB-
group. Deacetalization, pivaloylation, mesylation and cyclization afforded epoxide 178 in 
high yield (72 % over 4 steps). The left hand side of the vinyl iodide fragment 181 was 
elaborated by ozonolysis of the terminal double bond, reducing the resulting aldehyde 
and pivaloyl protection. Chemoselective opening of the oxirane 179 with lithium 
trimethylsilyl acetylide and desilylation was followed by oxidative cyclization with DDQ 
to  afford the desired protected propargylic alcohol intermediate 180. Finally, the vinyl 
iodide fragment 181 was obtained by stannylation and iodine substitution.  
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Scheme 26. Reagents and conditions: a) PMBBr, NaH, DMF (100 %); b) CH3COOH, 
H2O, THF (1:1), 50-60 °C (92 %); c) PivCl, pyr, CH2Cl2 (91 %); d) CH3SO2Cl, DMAP, 
pyr, CH2Cl2 (97 %); e) K2CO3, MeOH (89 %); f) O3, EtOAc, -78 °C, then Ph3P; g) 
NaBH4, MeOH, 0 °C; h) PivCl, pyr, CH2Cl2 (77 % for 3 steps); i) HC≡CSiMe3, n-BuLi, 
BF3⋅OEt2, THF, -78 °C; j) (n-Bu)4NF, THF, 0 °C (95 % for 2 steps); k) DDQ, 4 Å MS, 
CH2Cl2 (85 %); l) (n-Bu)3SnH, AIBN, PhH, rfx (99 %); m) I2, CH2Cl2 (96 %). 
 
The chirality of alkyne 187 was induced from L-(-)-ascorbic acid. Butenolide 182 was 
first prepared from L-(-)-ascorbic acid using known methods. With butenolide 182 in 
hand, this was allowed to react with lithium dimethylcuprate to provide the trans-adduct 
(Scheme 27). After reduction to lactol, HWE reaction of the lactol and PMB-protection 
of the resulting hydroxyl group the α,β-unsaturated ester 183 was obtained. Further 
standard operations were employed to elaborate the terminal alkyne fragment 187. 
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OTBDPS
a-d MeO2C
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Scheme 27. Reagents and conditions: a) (CH3)2CuLi, ether, THF, -30 °C (89 %); b) 
DIBAL-H, CH2Cl2, -78 °C; c) Ph3P=CHCO2Me, C6H6, rfx (100 % for 2 steps); d) 
PMBC(=NH)CCl3, CSA, CH2Cl2; e) DIBAL-H, CH2Cl2, -78 °C (60 % for 2 steps); f) 
Ac2O, DMAP, pyr, CH2Cl2 (97 %); g) (n-Bu)4NF, THF, 0 °C (100 %); h) IBX, 
THF/DMSO (9:1) (90 %); i) CBr4, Ph3P, CH2Cl2, -78 °C (98 %); j) n-BuLi, THF, -78 °C 
(90 %). 
 
Sonagashira coupling of vinyl iodide 181 and the alkyne fragment 187 afforded the 
corresponding triene in high yield (82 %) (Scheme 28). Reduction of the alkyne to E,Z,E-
triene 188 and IBX-oxidation afforded the substrate for the thermal IMDA reaction. The 
IMDA reaction was immediately followed by reduction of the bicyclic aldehyde to give 
the cycloadduct 190 via endo-transition state. Only one of the two possible endo-
cycloadducts were obtained. Up to today, Chang and Paquette have not published the 
final steps, which would complete the synthesis of cochleamycin A 175.  
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Scheme 28. Reagents and conditions: a) Pd(PPh3)2Cl2, CuI, Et3N (82 %); b) H2, Lindlar 
catalyst, EtOAc/pyr/1-octene (10:1:1) (95 %); c) IBX, THF/DMSO (9:1) (85 %); d) 20 % 
BHT, PhMe, sealed tube, 195 °C, 26 h; e) NaBH4, MeOH, 0 °C (66 % for 2 steps). 
 
2.2.4 Ikarugamycin 191 
 
Ikarugamycin 191 (Figure 13) was isolated in 1972 from the culture broth of 
Streptomyces phaeochromognes var. ikaruganensis by Jomon et al. (39) and fully 
characterized by Ito and Hirata (40) in 1972. It has a strong specific antiprotozoal 
activity, in vitro antiamoebic activity, and activity against some Gram-positive bacteria 
(39). Ikarugamycin 191 has a macrocyclic structure including cis-fused 
bicyclo[4.3.0]nonane substructure (AB ring junction) and two amide groups. 
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Figure 13. Structure of ikarugamycin 191. 
 
Several research groups have reported total syntheses of ikarugamycin 191. Synthesis 
strategies of research groups of Boeckman, Kurth, Jones and Roush are based on 
thermodynamic IMDA-reaction. Whitesell et al. have used a photocyclization strategy to 
prepare the tricyclic ABC system of ikarugamycin 191. The shortest route to the ABC 
structure of ikarugamycin 191 has been developed by Paquette et al. They discovered that 
an oxy-Cope rearrangement of chiral bicyclo[2.2.1]heptene pentene alcohol affords the 
tricyclic fragment of ikarugamycin 191. The synthetic studies of ikarugamycin 191 are 
presented in the following chapters, which are divided according to research groups.  
 
2.2.4.1 Boeckman 
 
Boeckman et al. (41) began the synthesis of the A-ring of ikarugamycin 191 from the 
bicyclic lactone 192 (Scheme 29). Acid promoted ring opening of the lactone ring with 
concomitant decarboxylation afforded a bromomethyl cyclopentanone, which was 
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subjected to iodine substitution to give 193. Phosphoryl ylide 194 was prepared from 193 
by ketalization and phosphorylation. 
O
O O
H
H
a,b
O
H
I
c,d
H
PPh3
I
OO
192 193 194  
Scheme 29. Reagents and conditions: a) HBr, CH2Cl2, -78  °C → r.t., 12 h, then HOAc, 1 
h (83 %); b) NaI, acetone, r.t., 40 h (91 %); c) HOH2CC(CH3)2CH2OH, MeOH, p-TsOH, 
PhH, rfx, 9 h (88 %); d) PPh3, NaHCO3, MeCN, rfx, 96 h (84 %). 
 
The B- and C-rings were synthesized from chiral (S)-(-)-glyceraldehyde acetonide 195 
(Scheme 30) (41). Wittig reaction of aldehyde 195 with propenyl phosphorane lithium 
salt afforded the alkene with high Z-stereoselectivity. Hydrolysis of the acetonide, 
silylation of the primary alcohol and acylation gave the allylic ester 196 in good yield (63 
%). Ester enolate Claisen rearrangement and esterification with diazomethane afforded a 
mixture of diastereomeric esters 197 in a ratio (86:14). The ester 197 was reduced with 
DIBAL-H and the resulting alcohol was activated as a tosylate for nitrile substitution. 
Reduction of the nitrile to aldehyde 198 with DIBAL-H and subsequent HWE reaction 
with phosphonate 199 followed by desilylation and oxidation afforded ester aldehyde 200 
ready for Wittig coupling. 
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Scheme 30. Reagents and conditions: a) n-BuLi, n-PrPh3Br, THF, 0 °C, 1 h (67 %); b) 
EtOH, HCl, r.t., 12 h (83 %); c) TBDMSCl, Et3N, DMAP, CH2Cl2, 0 °C → r.t., 7 h; d) 
EtCOCl, pyr, CH2Cl2, 0 °C → r.t., 15 h (63 % over 2 steps); e) LDA, 23 % HMPA-THF, 
-78 °C, Me3SiCl, -78 °C → r.t., 20 h; H3O+; CH3N2 (74 %); f) DIBAL-H, THF, 0 °C, 1 h 
(92 %); g) TsCl, pyr, CH2Cl2, 0 °C → r.t., 40 h; h) KCN, DMSO, 80 °C, 5 h (61 % over 2 
steps); i) DIBAL-H, Et2O, -20 °C, 30 min; 5 % AcOH/NaOAc (aq. Buffer)-THF-MeOH 
(1:1:1), r.t., 3 h; j) NaH, phosphonate 199, -50 → 0 °C, 2 h (77 % over 2 steps); k) THF-
H2O-HOAc (1:1:1), r.t., 16 h, l) PDC, CH2Cl2, r.t., 12 h (84 % over 2 steps). 
 
Wittig reaction between the phosphorane ylide 194 and aldehyde 200 afforded the diene 
201 as a E,Z/E,E-mixture (2:1) (Scheme 31) (40). The E,Z-diene was isomerized to the 
E,E-isomer 201 with a catalytic amount of iodine. The resulting E,E,E-trienyl ester 201 
was subjected to thermal IMDA cycloaddition (140 °C, 70 h) to obtain the A- and B-rings 
of ikarugamycin 191. The major endo-cycloadduct was obtained in (>5:1) ratio. The C-
ring was elaborated by reducing the ester with DIBAL-H and hydrolyzing the ketal 
protection. Further conversion of the hydroxyl ketone to a crystalline tosylate afforded 
precursor 202 for cyclization. Tetracyclic ketone 203 was elaborated by intramolecular 
cyclization using potassium tert-butyl alcoholate. 
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Scheme 31. a) n-BuLi, THF-HMPA (10:1), -50 °C → r.t., 1 h; b) aldehyde 200, -50 → 0 
°C, 2 h; c) I2, hexane, r.t., 6 h (87 % over 3 steps); d) BHT, PhMe, 140 °C, 70 h (87 %); 
e) DIBAL-H, THF, 0 °C, 1.5 h (87 %); f) 0.5 M HCl-THF (1:1), r.t., 16 h (82 %); g) 
TsCl, pyr, CH2Cl2, 4 °C, 40 h (72 %); h) t-BuOK, t-BuOH-PhH (1:2), r.t., 20 h (92 %). 
 
Boeckman et al. (41) used a ketene-mediated cyclization to construct the 16-membered 
macrocyclic lactam ring 210. Preparation of ketene 209 for ring closure started with 
oxidation of the tetracyclic ketone 203 to tetracyclic acyloins (4:1, α:β) (Scheme 32). 
Oxidative cleavage and protection of the ensuing ester aldehyde afforded an ester acetal 
in high yield (90 %). Reduction of the ester and PCC oxidation of the resulting acetal 
alcohol provided acetal aldehyde, which epimerized to the more stable conformer 204 in 
the presence of DBU. Next, acetal aldehyde 204 was subjected to a HWE reaction with 
potassium salt of phosphonate 205 to produce the E-dioxinone 206 in moderate yield (65 
%). After hydrolysis of the acetal, Boeckman et al. used highly Z-selective (Z:E 19:1) 
Still and Gennari modification (42) of HWE reaction to prepare the Z-olefinic side chain 
of ikarugamycin 191. After deprotection of the allyl ester, the resulting acid 207 was 
activated as mesitylene sulphonic anhydride for amide formation with primary amine 
acetate 208. The resulting secondary amine 209 was deprotected for ketene intermediated 
macrocyclization. Boeckman completed the synthesis of ikarugamycin 191 by using a 
transannular Dieckmann cyclization and deprotection of the N-aryl protection. 
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Scheme 32. Reagents and conditions: a) PhI(OAc)2, KOH, MeOH, 25 °C, 8 h; then 
Amberlyst-15, THF-H2O (95:5), 25 °C, 24 h (68 %); b) Pb(OAc)4, MeOH-THF (1:1), 0 
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°C, 0.5 h; then Amberlyst-15, 3Å MS, MeOH, 25 °C, 16 h; c) DIBAL-H, THF, 0 °C, 2 h; 
d) PDC, 3Å MS, CH2Cl2, 25 °C, 0.5 h; then DBU, CH2Cl2, 0 °C, 72-150 h (62 % over 3 
steps); e) phosphonate 205, KHMDS, THF, 0 → 25 °C, 4 h (65 %); f) Amberlyst-15, 
MeCN-H2O (9:1), 25 °C, 12 h; g) (CF3CH2O)2(O)PCH2CO2CH2CH=CH2, K2CO3, 18-
crown-6, PhMe, -20 → 0 °C, 4 h; h) NH4OAc, Pd(PPh3)4, dioxane, 25 °C, 24 h (78 %); i) 
MesSO2Cl, Et3N, THF, 25 °C, 10 min; then ammonium salt 208, DMAP, THF, 25 °C, 4 
h (60-80 %); j) HOAc, Pd(PPh3)4, THF, 25 °C, 12 h (96 %); k) PhMe, 105 °C, 8-10 h (77 
%); l) t-BuOK, t-BuOH, 0 °C, 15 min (75 %); m) TFA, 72 °C, 5 min (55 %).    
 
2.2.4.2 Kurth 
 
Kurth et al. (43) synthesized ABC-ring system of ikarugamycin 191 by a thermal IMDA 
cycloaddition and sulfone ester cyclization. They used the chiral unsaturated pentenoic 
acid 211 as the starting material (Scheme 33). Pentenoic acid 211 was reduced with 
LiAlH4 to the corresponding alcohol and the alcohol was oxidized under Parikh-modified 
(44) Moffatt oxidation conditions. HWE olefination of the resulting aldehyde with 
phosphonocrotonate 212 afforded the (E,E)-diene ester. Second reduction with DIBAL-H 
furnished a trienol, which was converted to sulfone 213 by a one-pot tosylation - sulfinate 
displacement method. Regioselective hydroboration-oxidation with 9-BBN afforded the 
terminal sulfone alcohol. PCC oxidation and HWE reaction furnished the (E,E,E)-triene 
sulfone 215 precursor for the thermal IMDA cycloaddition. Diastereoselective IMDA 
cycloaddition resulted in the formation of the crystalline bicycloadduct 216 in moderate 
yield (70 %). The C-ring was elaborated by homologating the ester 216 with Arndt-
Eistert procedure.(45) In this procedure, ester 216 was saponified and the crude acid was 
converted to the acid chloride. The additional methyl-group was obtained from 
diazomethane. Finally, sulfone ester cyclization using NaH as the base furnished 
octahydro-as-indacenone 218. 
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Scheme 33. Reagents and conditions: a) LiAlH4, Et2O, 25 °C, 16 h (93 %); b) PyrSO3, 
Et3N, DMSO, 25 °C, 1.5 h (83 %); c) phosphonate 212, LDA, THF, -78 °C, 30 min; then 
aldehyde, THF, -40 → 0 °C, 1.5 h (67 %); d) DIBAL-H, CH2Cl2, -78 °C, 3 h (94 %); e) 
MeLi, Et2O-HMPA (3:1), 0 °C, 30 min; then TsCl, HMPA, 0 °C, 2.5 h; then 
MePhSO2Na⋅2H2O, DMF, 25 °C, 16 h (88 %); f) 9-BBN, THF, 25 °C, 2.5 h; then NaOH, 
H2O, H2O2, 25 °C, 2.5 h (81 %); g) PCC, CH2Cl2, 25 °C, 2.5 h (89 %); h) phosphonate 
214, KOH, THF, 25 °C, 15 min (71 %); i) m-xylene, 139 °C, 32 h (70 %); j) 6 M KOH-
EtOH (1:8), rfx, 2 h (95 %); k) SO2Cl, pyr, CH2Cl2, 25 °C, 4 h; then CH2N2, Et2O-THF 
(2:1), 0 °C, 30 min, 25 °C, 30 min; then Ag2O, MeOH, 64 °C, 2 h (75 %); l) NaH, THF, 
25 °C, 1 h (90 %). 
  
 
2.2.4.3 Jones 
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Jones et al. (46) chose a tetraene as the precursor for IMDA cycloaddition, which was 
used to form the AB-ring system of ikarugamycin 191. They compared the outcome of 
thermal and Lewis acid promoted IMDA cycloadditions for the tetraene substrate. Lewis 
acid promoted IMDA was observed to give slightly lower yield due to increased 
polymerization compared to thermal IMDA. The formation of the ring A fragment was 
initiated by a Michael addition of tert-butyl butyrate enolate 220 to but-2-enoate ester 
219 (Scheme 34). This resulted in the formation of a mixture of 2-ethyl-3-
methylglutarates 221 (erythro:threo (5:1)) in high yield (97 %). Chemoselective 
reduction of the ethyl ester 221 with LiBH4 was followed by THP-protection of the 
resulting alcohol. Reduction of the tert-butyl ester group with LiAlH4 and PCC oxidation 
afforded the THP-aldehyde 223 for suitable chain elongation. Reaction of aldehyde 223 
with Z-1-methoxy-but-1-en-3-yne furnished the corresponding hydroxydienal. HWE 
reaction of aldehyde 225 with trimethyl phosphonoacetate 226 afforded the triene ester. 
THP-removal and oxidation with PCC gave the E,E,E-triene aldehyde 227. Finally, the 
tetraene ketone precursor for IMDA-cycloaddition was obtained from the HWE reaction 
of the triene aldehyde 227 with β-ketophosphonate 228. Thermal IMDA-cycloaddition of 
triene ketone gave hexahydroindane cycloadduct in 51 % yield after one crystallization. 
The same IMDA cycloaddition catalyzed by Et2AlCl gave 43 % yield for 
hexahydroindane cycloadduct. The yields of IMDA cycloadditions were low, because the 
triene ketone was a 5:1 mixture of erythro- and threo-stereoisomers as obtained from the 
initial Michael addition. 
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Scheme 34. Reagents and conditions: a) LDA, THF-HMPA, -78 °C (97 %); b) LiBH4, 
MeOH-Et2O (83 %); c) DHP, PPTS (93 %); d) LiAlH4, Et2O, rfx (93 %); e) PCC, 
NaOAc (89 %); f) (Z)-MeOCH=CHC≡CLi, THF, -78 °C; g) EtOH; h) LiAlH4; i) 1 M 
HCl; j) p-TsOH, THF (58 % over 5 steps); k) phosphonate 226, K2CO3, H2O, 20 °C (82 
%); l) Amberlite 15, MeOH (98 %); m) PCC, NaOAc (93 %); n) phosphonate 228, 
K2CO3, H2O, 20 °C (82 %); o) PhMe, rfx, 24 h (51 %). 
 
2.2.4.4 Roush 
 
Roush et al. (47) synthesized the ABC-ring system of ikarugamycin 191 by a long route 
(19 steps), starting from meso-(η4-2,4-hexadien-1,6-dial)iron tricarbonyl 230. The 
synthesis route is reviewed in a short manner in this chapter. The first key step is the 
highly enantioselective (≥98 %ee) allylboration of meso-(η4-2,4-hexadien-1,6-dial)iron 
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tricarbonyl 230 with the chiral borane reagent 231 (Scheme 35). Condensation of the 
resulting dienyl aldehyde 232 with Meldrum’s acid gave the malonate derivative 232. 
The second key step was very face-selective (≥97:3) 1,4-addition of 
vinylmagnesiumbromide to malonate iron tricarbonyl derivative 233. Acylation of the 
alcohol, alkylation of allyl acetate, -Fe(CO)3 elimination, hydrolysis of malonate and 
esterification afforded tetraene ester 235. Hydroboration of the terminal double bonds 
was followed by lactonization and Swern oxidation to afford dienyl aldehyde 236. 
Furthermore, aldehyde end was subjected to HWE-reaction to obtain the trienyl ester. 
The lactone was opened and the resulting acid was esterified. After this, trienyl 
dialdehyde 237 was elaborated via oxidation, acetonide protection, reduction and 
oxidation sequence. The third key step was the thermal IMDA cycloaddition of trienyl 
aldehyde, which provided rings A and B of ikarugamycin 191 as a 12:1 mixture of 
cycloadducts. Diastereomerically pure ABC-ring adduct 238 was obtained by direct 
cyclization with the trifluoroacetic acid salt of dibenzylamine in high yield (88 %). 
Reduction of cyclic α,β-unsaturated aldehyde 238 with a copperhydride reagent in wet 
benzene provided as-indacene part of ikarugamycin 191. 
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Scheme 35. Reagents and conditions: a) (S,S)-borane 231, 4Å MS, PhMe, -78 °C (90 %); 
b) Meldrum’s acid, pyr (92 %); c) H2C=CHMgBr, THF, -78 → 0 °C (83-88 %); d) Ac2O, 
DMAP, pyr, CH2Cl2; e) Et3Al, CH2Cl2, -20 → 0 °C (69-75 % over 2 steps); f) FeCl3, 
CH3CN, -15 °C; g) H2O, 3-pentanone, rfx; then CH2N2 (70 % over 2 steps); h) 9-BBN, 
THF; i) H2O2, NaOAc; j) p-TsOH, PhMe, 80 °C; k) (COCl)2, DMSO, Et3N, -78 → 0 °C 
(57 % over 4 steps); l) phosphonate 226, LiCl, DBU; m) LiOH, then CH2N2; n) (COCl)2, 
DMSO, Et3N, -78 → 0 °C; o) (MeO)3CH, p-TsOH; p) DIBAL-H, -78 °C; q) Dess-Martin 
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oxidation (56 % over 6 steps); r) PhH, 85 °C; s) Bn2NH2OCOCF3, PhH, 50 °C (88 % 
over 2 steps); t) [(Ph3P)CuH]6, PhH, H2O (85 %). 
 
2.2.4.5 Whitesell 
 
Whitesell and Minton (48) have developed an alternative method for preparing the 
carbocyclic portion of ikarugamycin 191. Resolution of bicyclic enantiomeric esters 
240a,b and their separate elaboration and combination afforded precursor 247 for 
photocyclization (Scheme 36). A slightly diastereoselective (1.2:1) dihydroxylation of the 
R-enantiomer of bicyclo[3.3.0]octane 240a using Woodward oxidation was followed by 
oxidative cleavage, reduction and mesylation to provide the dimesylate ester 242. Zinc 
mediated reduction of dimesylate ester 242 proceeded in good yield (75 %). Finally, the 
phosphonium salt 244 was obtained via reduction, substitution with bromine and 
phosphorylation. The aldehyde fragment 246 was constructed from the (S)-enantiomer of 
the bicyclic ester 240b via Woodward oxidation, deprotection, ketalization, reduction and 
oxidation. 
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Scheme 36. Reagents and conditions: a) AgOAc, HOAc, H2O, r.t., 15 h, 70 °C, 2 h (95 
%); b) p-TsOH, MeOH, rfx, overnight (95 %); c) NaIO4 (95%); d) NaBH4 (95 %); e) 
MsCl, Et3N, CH2Cl2, 0 °C, 2 h (100 %); f) NaI, Zn, DME, rfx, overnight (75 %); g) 
DIBAL-H (100 %); h) PBr3, pyr (75 %); i) Ph3P (90 %); j) (i-Pr)2CO, p-TsOH, PhH, 4Å 
MS, rfx, 28 h (75 %); k) PDC (90 %). 
 
Wittig reaction of unsaturated aldehyde 246 with phosphorane 244 provided the 
tetracyclic triene 247 precursor for photocyclization (Scheme 37). Photocyclization of 
triene 247 gave a 4:1 mixture of pentacyclic cycloadducts 248. The desired cycloadduct 
was chemoselectively reduced by dissolved metal reduction in moderate yield (45 %). 
Transacetalization, hydroboration, oxidation and epimerization gave the correct 
diastereomer of the pentacyclic intermediate 250. The endocyclic double bond was 
obtained from ketone phosphorylation and Birch reduction in high overall yield (88 %). 
Ketal hydrolysis furnished tetracyclic diol intermediate 252 for ikarugamycin 191 
synthesis. 
 
 
 
 
 
 
 
70 
 
H
H
H
H
O CH(iPr)2
O
a b,c
H
H
H
H
OH
OH
d,e
H
H
H
H
O CH(Me)2
O
f-h
H
H
H
H
O CH(Me)2
O
O
HH
HH
H
H H
H H
i,j
H
H
H
H
O CH(Me)2
O
H
H H
H
k
H
H
H
H
OH
OH
H
H H
H
(Z:E 2:1)
247 248
249 250
251 252
244 + 246
 
 
Scheme 37. Reagents and conditions: a) phosphorane 244, Et2O, n-BuLi, 0 °C, aldehyde 
246, 0 → rfx, 1.5 h (79 %); b) hexane, hν, -75 °C, 24 h; c) MeOH-THF (4:1), 2 M HCl, 
r.t., overnight (50 % over 2 steps); d) Li, NH3, t-BuOH, Et2O, -78 °C, 4 h, → r.t., 
overnight; e) acetone, p-TsOH, THF (50 % over 2 steps); f) BH3⋅THF; H2O2, NaOH 
(77%); g) PDC (90 %); h) NaOMe, MeOH (95 %); i) LDA, HMPA, ((Me)2N)2P(O)Cl; j) 
Li, NH3, t-BuOH, THF (88 % over 2 steps); k) MeOH-THF (2:1), H2O, HCl, rfx, 1.5 h 
(83 %). 
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2.2.4.6 Paquette 
 
Paquette et al. (49) have developed a very short synthesis to the carbotricyclic part of 
ikarugamycin 191. They discovered that anionic oxy-Cope rearrangement of tricyclic 
diene 253 produces tricyclic ketone 254 as a  kinetic mixture of epimers (Scheme 38). 
The undesired epimer was easily epimerized to the correct isomer under basic conditions. 
Although the oxy-Cope rearrangement produced the wrong stereochemistry at carbon 
atoms that unite rings B and C at 254, the correct stereochemistry was achieved by 
isomerization of tricyclic ketone 255 and reduction of the resulting isomeric ketone. 
Formylation of ketone 256 provided the basis for the construction of the second side 
chain. The correct stereochemistry of the side chains in 261 was achieved using Koga’s 
asymmetric 1,4-conjugate addition (50) to aldimine 260. However, the 1,4-addition of 
vinylmagnesium bromide to aldimine 260 produced 261 in low yield (22 %). The ratio of 
diastereomers was 5:1 and the major side product was enal 258. Ketalization, 
hydroboration and oxidation furnished ketal aldehyde 262. Paquette et al. prepared the 
dibromo olefin 263 from the resulting ketal aldehyde 262 for carbonyl homologation and 
triple bond formation to obtain 264.  
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Scheme 38. Reagents and conditions: a) KH, THF, 0 °C, r.t., 2.5 h (64 %); b) DIBAL-H, 
CH2Cl2, -78 °C, 3 h; then 3 M HCl, Et2O, r.t., 12 h (95 %); c) K2CO3, MeOH, 60 °C, 2.5 
h (98 %); d) Li, NH3, THF, -78 °C, 45 min (83 %); e) imidazole, DMF, TBDMSOTf, 25 
°C, 1 h (95 %); f) KHMDS, THF, -78 °C, 1 h; then ethyl formate, 25 min, → r.t., 3 h; 
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then HMPA, 2-iodopropane, 0 °C → r.t., 11 h; g) DIBAL-H, CH2Cl2, -78 °C, 2 h; then 30 
% HCl, 0 °C → r.t., 3 h (48 % over 2 steps); h) amine 259, Et2O, MgSO4, HOAc, 25 °C, 
20 h; i) THF, -36 °C, CH2=CH2MgBr, 25 min; then 10 % citric acid, 0 °C → r.t., 3 h (22 
% over 2 steps); j) (MeO)3CH, p-TsOH, 25 °C, 30 min (99 %); k) Sia2BH, THF, 0 °C, 40 
min; NaOH, H2O2 → r.t., 10 h (74 %); l) PCC, NaOAc, CH2Cl2, 0 °C, 2 h, → r.t., 2 h (89 
%); m) CBr4, CH2Cl2, Ph3P, 0 °C, 15 min (100 %); n) n-BuLi, THF, -78 °C, 35 min, → 
25 °C, 20 min; ClCO2Me, -78 °C, 40 min, → 10 °C, 1 h (94 %). 
 
Paquette et al. (49) used an approach developed by Boeckmann et al. (41) to elaborate 
the tetramic acid system of ikarugamycin 191. The only actual difference compared to 
Boeckmann’s approach was the selective hydrogenation of the triple bond of derivative 
270 to Z-olefin by Lindlar catalyst employing 5 % palladium on barium sulfate (Scheme 
39). Desilylation with hydrogen fluoride was followed by dehydration of the hydroxyl 
group from the ring B using Burgess reagent (51). However, the yield of dehydration was 
low (36 %). Finally, ikarugamycin was obtained through cyclization and N-deprotection.  
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Scheme 39. Reagents and conditions: a) K2CO3, MeOH, 43 °C, 4 h; 2,4,6-(Me)3PhSO2Cl, 
THF, 25 °C,  50 min; DMAP, ammonium salt 267, 16 h (46 %); b) p-TsOH, acetone, 25 
°C, 3 h (92 %); c) phosphonate 205, THF, KHMDS, -78 → 0 °C, 25 min, aldehyde 268, 
37 min, → 25 °C, 8 h (88 %); d) HOAc, THF, (Ph3P)4Pd, Ph3P, 25 °C, 4 h (71 %); e) 
PhMe, rfx, 4 h (94 %); f) H2, Pd-BaSO4, 25 °C, 5 h (79 %); g) MeCN, HF, 25 °C, 13 min 
(85 %); h) MeOC(O)NSO2NEt3 , PhH, r.t. → 50 °C, 18.5 h (36 %); i) t-BuOK, t-BuOH, 
25 °C, 10 min (66 %); j) TFA, 62 °C, 10 min (20 %). 
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2.2.5 Lepicidin A 272 
 
Lepicidin A 272 is a member of tetracyclic macrolides. To date, nine analogues, differing 
in the degree of N, O, C methylation on the aglygon and sugar constituents, have been 
isolated. Lepicidin A 272 was isolated in 1990 from the fermentation broth of the soil 
microbe Saccharopolyspora spinosa by Eli Lilly and Company researchers (52) (Figure 
14). Lepicidin A 272 exhibits insecticidal activity, particularly against lepidoptera larvae. 
Lepicidin A 272 consist of a trans-fused trisubstituted endo- bicyclo[4.3.0]nonane 
skeleton. Interestingly, it also includes two sugar units. 2,3,4-Tri-O-methylrhamnose is α-
linked to bicyclo[4.3.0]nonane part and the acid-labile  aminosugar L-forosamine is β-
linked to macrocycle part. 
O
NMe2O
Me
O
Et
O
O
Me
H H
O
OMe
OMe
OMe
OMe
(+)-Lepicidin A (272)  
Figure 14. Structure of antibiotic (+)-lepicidin A 272. 
 
Total synthesis of (+)-lepicidin 272 has only been accomplished by the Evans group and 
their synthesis is reviewed in the next chapter. 
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2.2.5.1 Evans 
 
Evans et al. (53) has made an enormous work on synthesizing macrolide (+)-A83543A 
((+)-lepicidin A 272) by asymmetric methods. The macrocyclic fragment of (+)-lepicidin 
272 was prepared beginning with an asymmetric aldol reaction of chiral oxazolidinone 
273 (Scheme 40). Silylation, transamidation and reduction provided the chiral β-siloxy 
aldehyde 275. Lewis acid promoted aldol reaction of 275 with silylenolate 276 afforded 
the Felkin adduct 277 with high diastereoselectivity (>20:1). Lactonization was used to 
protect the hydroxyl and carboxyl groups and it was anticipated that the lactone ring of 
279 allowed better stereocontrol in the conjugate addition of vinylstannane 280. After 
addition, the lactone ring was opened and the resulting acid esterified. The liberated 
hydroxyl group was protected as triethylsilyl ether. Selective hydroboration was followed 
by oxidation to provide aldehyde 282. Asymmetric (+)-N,N-dibutylnorephedrine-
catalyzed diethylzinc addition furnished aldehyde 282 to inducing chirality at C21 in 283. 
Addition was followed by ester hydrolysis to enable macrolactonization. The 
macrolactonization was performed under modified Yamaguchi conditions (54) to afford 
stannane 284.   
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Scheme 40. Reagents and conditions: a) Bu2BOTf, Et3N, 4-pentenal, CH2Cl2, -70 °C, 1 h 
→ 0 °C, 1.5 h; H2O2 (90 %); b) MeONHMe⋅HCl, Me3Al, CH2Cl2, -20 °C → r.t.; c) i-
Pr3SiOTf, 2,6-lutidine, CH2Cl2, 0 °C; d) DIBAL-H, THF, -78 °C (98 % over 3 steps); e) 
TiCl2(Oi-Pr)2, CH2Cl2, -78 °C (95 %); f) Me4NBH(OAc)3, MeCN, HOAc, -40 °C; g) 
PPTS, PhH, rfx (97 % over 2 steps); h) MsCl, Et3N, CH2Cl2, r.t. (93 %); i) stannane 280, 
BF3, THF, -78 °C (97 %); j) LiOH, THF; CH2N2; k) Et3SiOTf, 2,6-lutidine, CH2Cl2, -78 
°C (90 % over 2 steps); l) Sia2BH, THF, 0 °C; H2O2, NaHCO3, THF, 0 °C; m) pyr⋅SO3, 
DMSO, i-Pr2NEt, CH2Cl2, 0 °C (80 % over 2 steps); n) Et2Zn, DBNE, hexane, 0 °C 
 
 
 
 
 
 
 
78 
 
(98%, 82 % de); o) LiOH, t-BuOH, 35 °C; p) 2,4,6-trichlorobenzoyl chloride, DIPEA, 
THF, r.t.; DMAP, PhMe, 110 °C (78 % over 2 steps). 
 
The diene fragment 289 of IMDA precursor was prepared from TBS-protected 3-hydroxy 
1,5-dicarboxylate anhydride 285 (Scheme 41) (53). Unsymmetrical enantioselective 
transesterification with chiral (S)-1-hydroxy-ethylnaphthalene differentiated the 
carboxylate groups of 285 with high enantioselectivity (94 %de). Borane reduction 
followed by Swern oxidation afforded aldehyde 286. Aldehyde 286 was reacted with 
iodoform and chromous chloride to elaborate vinyl iodide as a stereoisomeric mixture 
(E:Z, 9:1). Wittig reaction completed the preparation of dienyl vinyliodide fragment 289.  
  
OO O
OTBS
a-c OHC
O O
Np
OTBS
d,e
CHO
OTBS
I
N O
Bn
O
Br-Ph3P
+
O
f
OTBS
I
NO
OO
Bn
(E:Z) = 23 :1
(E:Z) = 9 :1
285 286
287
288
289  
 
Scheme 41. Reagents and conditions: a) DMAP, (S)-1-hydroxy-ethyl-naphthalene, 
CH2Cl2, -60 °C (89 %, 94 %de); b) BH3⋅Me2S, THF, r.t.; c) (COCl)2, DMSO, Et3N, 
CH2Cl2, -70 °C (84 % over 2 steps); d) CHI3, CrCl2, dioxane/THF, r.t. (80 %); e) DIBAL-
H, PhMe, -78 °C (78 %); f) DMAP, CHCl3, 25 → 60 °C (84 %). 
 
 
 
 
 
 
 
79 
 
 
Modified Stille coupling (33) was employed to combine vinyliodide oxazolidinone 289 
and macrolactonic stannane 284  to give triene 290 suitable for Lewis acid promoted 
IMDA cycloaddition (Scheme 42) (53). IMDA-cycloaddition with Me2AlCl gave the 
cycloadduct 291 with good diastereoselectivity (10:1). Interestingly, achiral 
oxazolidinone derivative gave intrinsic asymmetric induction favoring the opposite endo-
cycloadduct. Although the removal of hindered oxazolidinones is difficult by normal 
hydrolytic methods, Evans et al. overcame this problem using the method developed by 
Damon and Coppola (LiSEt, THF, room temperature) (55) to afford an easily modifiable 
thioester. Reduction of the thioester afforded aldehyde 292 ready for intramolecular aldol 
reaction in high yield. Intramolecular aldol reaction of 292 furnished the tricyclic 
fragment 293 of lepicidin A 272 with high diastereoselectivity (12:1). Finally, 
dehydration with Martin sulfurane (56) afforded differentially protected (+)-lepicidin A 
aglycon 294.  
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Scheme 42. Reagents and conditions: a) Pd2(dba)3⋅CHCl3, CdCl2, DIPEA, 1-methyl-2-
pyrrolidinone, 45 °C (69 %); b) Me2AlCl, CH2Cl2, 0 °C → r.t. (71 %); c) LiSEt, THF, r.t. 
(97 %); d) HOAc, THF-H2O, r.t.; e) TBSCl, imidazole, CH2Cl2, r.t.; f) (COCl)2, DMSO, 
Et3N, CH2Cl2, -78 °C (90 % over 3 steps); g) Et3SiH, 5 % Pd/CaCO3/PbO, acetone, r.t.; 
h) NaHMDS, THF, -78 °C; i) Ph2S(OC(CF3)2Ph)2, CH2Cl2, 0 °C (81 % over 3 steps). 
 
2,3,4-tri-O-methyl-D-rhamnose was connected to (+)-lepicidin A aglycon 294 after 
chemoselective desilylation of the TIPS-group.(53) This was followed by deprotection of 
the TBS-group and glycosidation with L-forosamine (Scheme 43). Finally, the synthesis 
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of (+)-lepicidin A 272 was completed by deprotection of 298 and dimethylation of the 
resulting free amine. 
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Scheme 43. a) HOAc-THF-H2O, r.t., 21 h (87 %); b) glycosyl acetate, Ph3CClO4, 
toluene, 0 °C → r.t., 1.5 h (87 %); c) HF, MeCN, r.t., 2.5 h (97 %); d) Fmoc-amine 297, 
Ag-zeolite, 4Å MS, CH2Cl2, r.t., 2 h (10 %); e) Et2NH, r.t., 9 h; f) NaOAc, HOAc, H2O, 
CH2O; MeOH, r.t., 10 min, NaCNBH3, 30 min. 
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2.2.6 Summary 
 
IMDA cycloaddition is undoubtedly the most universal approach to prepare 
bicyclo[4.3.0]nonane containing natural compounds. The research groups of Roush, 
Nicolaou, Boeckman, Ley, Kurth, Jones, Paquette, Hase and Dias have used thermal 
IMDA for the preparation of their target molecules. However, the triene precursor for 
IMDA has to be chiral itself, if racemic mixture is to be avoided without using chiral 
catalysts. In some syntheses Lewis acid and covalently bound chiral auxiliary is used to 
improve diastereo- and enantioselectivity of the IMDA cycloaddition. For example, 
Oppolzer, Takano, Roush and Evans have used different covalently bound auxiliaries in 
their natural product synthesis. Furthermore, Evans has used asymmetric copper catalysis 
in IMDA during the preparation of isopulo’upone. Burke has concentrated on using 
RHDA cycloreversion in the synthesis of natural compounds. Photocyclization affords 
also an elegant route to bicyclo[4.3.0]nonanes, however the preparation of the precursor 
can be laborious as in the synthesis of ikarugamycin (15 steps). The oxy-Cope 
rearrangement approach also provides a short route to bicyclo[4.3.0]nonanes, which has 
been demonstrated by Paquette group. 
 
3 Preparation of bicyclo[4.3.0]nonane derivatives 
 
In the previous chapter, natural compounds containing the bicyclo[4.3.0]nonane fragment 
were presented. In this chapter, the methods to create bicyclo[4.3.0]nonane substructure 
are surveyed. The compounds are defined so that only bicyclo[4.3.0]nonane derivatives 
having substituents at positions 1, 2, 3, 4 and 5 are presented. 
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Figure 15. Substituted bicyclo[4.3.0]nonane structure. 
The preparation methods of bicyclo[4.3.0]nonane structures can be divided roughly into 
thermal IMDA, Lewis acid promoted IMDA, chiral auxiliary induced IMDA and other 
cycloadditions. A selectivity issue that influences the applicability of all IMDA reactions 
in the synthesis is diastereoselectivity, if the substrate is chiral or the reaction is catalytic. 
IMDA reaction is inherently diastereoselective, if the chain linking the diene and 
dienophile or the other structure include one or more stereocenters. Chiral auxiliary based 
cycloadditions involve a removable asymmetric subunit. Asymmetric induction in 
catalytic IMDA are based on the chirality of catalyst ligand(s). 
Diels-Alder reaction is assumed to follow a concerted mechanism, however other 
mechanisms like a stepwise diradical or dipolar mechanism are reported (57). Houk and 
Brown (58) claimed that IMDA cycloaddition proceed via “twist asynchronity” model. 
This model assumes that the selectivity of the reaction is controlled by the timing of the 
bond formation in the transition state. Furthermore, the model assumes that the diene and 
the dienophile parts have to be on top each other, before the bond formation may occur 
(Figure 16). 
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R1
R2
asymmetric stretch
R1
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Figure 16. Bonding types and asynchronicity modes. 
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IMDA reactions may be divided into two categories based on the point of connection of 
the diene to the dienophile. In the type I reactions, the connecting chain is in the terminus 
of the diene (Figure 17). The IMDA of E-dienes may produce trans- and cis-fused 
cycloadducts. If the chain connecting the diene and dienophile is short (less than four 
carbons), a bridged product is not possible. The formation of bridged type I cycloadducts 
is possible with the connecting chains of 10 or more atoms (59).  Z-Dienes with three or 
four atoms in the connecting chain produce only cis-fused products. Type II IMDA 
includes a tethered dienophile connected to one of the internal diene positions (Figure 
18). Type II reaction may produce both syn- or anti-products. 
E-diene
H
H
R2
R1
R2
R1
trans-fused
endo product
H
R2
R1 H
cis-fused
exo product
R2 R1
TYPE I REACTIONS
highly strained
for trienes with short
connecting chains
R2 R1
bridged product
Z-diene
R2
R1
H
R2
R1 H
cis-fused product only for
trienes with three- or four-
atom connecting chains
and/or
 
 
Figure 17. Type I IMDA cycloadditions. 
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TYPE II REACTIONS
R2
R1
R2
H
R2
H
R1 R1
syn-product
and not
anti-product  
 
Figure 18. Type II IMDA cycloadditions. 
The molecular orbitals of IMDA reaction of type I are shown in Figure 19. The 
cycloaddition can be activated by lowering the energy of dienophile LUMO (60) by 
electron withdrawing groups (EWG) and/or by Lewis acids. The diene HOMO can be 
activated by raising the energy by electron releasing groups (ERG). Both of these 
activation methods lowers the reaction enthalpy of the reaction by lowering the energy 
difference (∆H) of LUMO and HOMO. 
ERG
EWG
LUMO (dienophile)
HOMO (diene)
∆H
 
Figure 19. Molecular orbitals of IMDA cycloaddition. 
Houk and Lin (61) have calculated that the cis-fused transition state of nonatriene is 
favored enthalpically by ca. 1 kcal/mol. Furthermore, the parent nonatriene transition 
states are assumed to be nearly symmetrical (58). The addition of an electron with-
drawing group (CO2Me) to the terminus of dienophiles results in favoring (0.3-0.5 
kcal/mol) the trans-fused product. This is due to polarization of the dienophilic double 
bond that causes the LUMO coefficient at the β-carbon to the carbonyl group to be larger 
than at the α-carbon. The internal bond formation is more advanced than peripheral bond 
formation in the transition state. Furthermore, steric or other nonbonding interactions are 
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developed at an early stage of the cycloaddition, and the transition state that has more 
trans-disubstituted cyclopentanoid character becomes the more stable one. This is 
resulting from ‘twist asynchronicity’, which is caused by the torque applied to the 
internal bond formation. In a similar fashion, if the diene terminus is substituted so that 
the HOMO coefficient increases, the trans-selectivity should increase in the 
cycloaddition. 
In the case of internally activated trienes (for example such as 323 and 324), 
stereoselectivity is somewhat different. The LUMO coefficient at the α-carbon of the 
carbonyl group is greater that at β-carbon. The formation of the peripheral bond is likely 
to be more advanced in the transition state. However, this form of ‘twist asynchronicity’ 
is assumed to be less significant than with the terminally substituted nonatrienes (for 
example such as 299).  
Stereoselectivity for the trans-cycloadducts increases with trans-dienophile trienes as the 
dienophile activating group is changed along the series CONR2<CO2Me<COMe<CHO. 
(62). Furthermore, the stereoselectivity increases, if the triene is activated with Lewis 
acids (62). 
Stereoselectivity of Z,E,E-nonatrienes are not greatly affected by changes of the 
dienophile activating group. However, increased dienophile activation steers the 
selectivity towards cis-fused cycloadduct. 
 
3.1 Thermal cycloadditions 
 
First thermal IMDA cycloaddition examples were reported as early as in 1953 by Alder 
and Schumaker (63). A few other examples were reported in 1960’s, until in mid-1970’s 
a rapid growth of interest occurred (64). Thermal IMDA cycloadditions are normally 
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performed in a sealed vial. The substrate is usually dissolved in a degassed solution of 
toluene, mesitylene or benzene and the resulting mixture is boiled in the presence radical 
inhibitor, usually BHT. House and Cronin (65) reported in 1965 that IMDA reaction of  
E,E,E-triene 299 produces an equal mixture of trans- 303a and cis-fused 303b 
cycloadducts (Scheme 44). In 1980 Roush et al. (66) repeated the same cyclization at 150 
oC. Lower temperature raised the yield to 65 % and the ratio trans- 303a to cis-fused 
303b product was found to be 60:40. A larger group (i-propyl) at the terminus of the 
diene in E,E,E-triene 300 slightly changed the selectivity of the thermal IMDA. If the 
diene terminus is substituted by diethylamino-group as in 302, the trans-selectivity is 
increased considerably (67). The resulting selectivity (85:15) corresponds to an energy 
difference of 1.1 kcal/mol between the trans- and cis-transition states. 
 Z,E,E-Isomer 308 produced a comparable mixture of trans- 311a and cis-fused 311b 
products (Scheme 45). However, the terminally substituted Z,E,E-triene 309 gave 
comparable results as the unsubstituted 308. If the α-carbon of the diene in the 
connecting chain is substituted as in the substrates 301 and 310, the thermal cycloaddition 
produces mixture of endo- and exo-isomers by favoring the endo-cycloadducts with 
E,E,E-trienes and exo-adducts with Z,E,E-trienes. Furthermore, the steric demand of the 
substituent in this position does not change the endo/exo-selectivity markedly (68). Roush 
et al. have also found that the trans-selectivity for cycloadducts is increased in thermal 
conditions, if the dienophile group is changed along the series 
CONR2<CO2Me<COMe<CHO. However, the aldehyde triene affords only a moderate 
yield in thermal IMDA presumably due to polymerization (62a). 
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CO2Me
MeO2C MeO2C
50 (60) : 50 (40)
299
CO2Me 72 : 28
R1 R1
303a,b R1,R2,R3 = H
304a,b R1 = i-Pr, R2,R3 = H
:
300
R2
R3
R2
R3
CO2Me
OCH2Ph
301
305a 30 (R1 
= i-Pr,R2 
=OBn,
R3 = H)
306a 53 (R1 
= i-Pr,R2 = H,
R3 =OBn)
305b 4 (R1 = 
i-Pr,R2 =OBn,
R3 = H)
306b 13 (R1 
= i-Pr,R2 = H,
R3 =OBn)
:
CO2MeEt2N
EtO2C
NEt2
EtO2C
NEt2
:
85 : 15
302
307a 307b
a
b
c
d
 
Scheme 44.  Reagents and conditions: a) 245 °C, 47 % (150 °C, 65 %); b) 150 °C, 40 h 
(72 %); c) 115 °C, 110 h; d) 60 °C (62 %). 
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CO2Me
CO2Me
65 : 35
67 : 33
MeO2C MeO2C
R1 R1
311a,b R1,R2,R3 = H
312a,b R1= i-Pr, R2,R3 = H
:
308
309
R2 R2
R3 R3
CO2MeOBn
310
313a 37
 (R1 = i-Pr,
R2 =OBn,
R3 = H)
313b 34 
(R1 = i-Pr,
R2 =OBn,
R3 = H)
:
314a 29 
(R1 = i-Pr,
R2 = H,
R3 =OBn)
a
b
c
 
Scheme 45. Reagents and conditions: a) 180 °C, 5 h (75 %); b) 180 °C, 5 h (75 %); c) 
115 °C, 44 h (92 %).  
In the total synthesis of dendrobine 315 (Figure 20), Roush and Gillis (69) examined the 
selectivity and yield of the Z,E,E-trienes 316 and 317, which were activated by electron 
releasing group in the chain connecting the diene and dienophile (Scheme 46). The ring 
size of the ketone protecting group in IMDA of substrates 316 and 317 had only a minor 
effect on endo/exo-selectivity, but the yield of IMDA cycloaddition for substrate 317 was 
lower.  
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N
H
H
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O
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Figure 20. Structure of dendrobine 315. 
 
CO2Me
MeO2C MeO2C
:
83 : 17
317 (R = -(CH2)2-)
O
R
O
O
RO
O
RO
318a,b (R = -(CH2)3-)
316 (R = -(CH2)3-)
319a,b (R = -(CH2)2-)
79 : 21
a
b
 
Scheme 46. Reagents and conditions: a) 180 °C, 0.5 h (87-93 %); b) 180 °C, 4 h (73 %). 
 
Craig et al. (70) have studied IMDA reactions of sulphonyl-substitued trienes 320,321 
(Scheme 47). IMDA reaction of E,E,E-triene 320 gave a 1:1 mixture of isomers 322a,b 
and Z,E,E-triene 321 produced more trans-fused cycloadduct 322b than cis-fused 322a.  
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PhO2S
H
H
H
PhO2S
H
1 : 1
1 : 7
cis-fused
exo-adduct
trans-fused
endo-adduct
PhO2S
SO2Ph
320
321
322a 322b
a
b
:
 
 
Scheme 47. Reagents and conditions: a) PhMe, 145 °C, 48 h (93 %); b) PhMe, 165 °C, 
60 h (63 %).  
 
Trost et al. (71) have studied IMDA reactions of tetraenes. They found out that thermal 
IMDA reaction of terminally activated diacetate dienophiles 323,324 produced trans-
fused tetrahydroindanes 325, 326 in moderate yields (Scheme 48). 
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CO2Me
CO2Me
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MeO2C
MeO2C
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MeO2C
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324
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a
b
 
 
Scheme 48.  Reagents and conditions: a) mesitylene, rfx (70 %); b) mesitylene, rfx (73 
%). 
 
Burke et al. (72) observed out that a rigid butenolide ring is an excellent dienophile for 
stereospecific IMDA reactions if the diene is substituted by silyloxy-group as in 
substrates 328, 329. (Scheme 49). Butenolide E,E-diene 328 gave only trans-fused 
cycloadduct 331 and butenolide Z,E-diene 329 gave the corresponding cis-fused product 
332. 
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Scheme 49. Reagents and conditions: a) 180 °C (79 %); b) 230 °C (81 %); c) 230 °C (86 
%). 
 
LeGoff and Williams (73) have reported that the reaction enthalpy of trienediones 334, 
335 is low. The reaction of both isomers 334, 335 are completed in 4 hours at 61 °C. 
However, the low energy reactions of unsubstituted trienediones are unselective and they 
provide a nearly 1:1 mixture of endo/exo-mixtures. (Scheme 50). 
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337a 337b
a
b
O O
O O
 
Scheme 50. Reagents and conditions: a) CDCl3, rfx (92 %); b) CDCl3, rfx (82 %). 
Kurth et al. (74) have studied the IMDA reactions of terminally substituted nitrotrienes 
338, 339 (Scheme 51). The nitro-group activated E,E,E-triene 338 gave predominantly 
the endo-adduct 340a. In contrast, E,E,Z-nitrotriene 339 gave nearly an equal mixture of 
trans- 341a and cis-fused 341b products. 
NO2
NO2
O2N
+
89 : 11
O2N
O2N
+
53 : 47
O2N
338
339
340a 340b
341a 341b
b
a
 
Scheme 51. Reagents and conditions: a) PhH, rfx, 30 h (64 %); b) CDCl3, r.t., 3.5 d (73 
%). 
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A mixture of E,Z-isomers of the tribenzyloxy triene 342 derived from D-xylose can be 
cyclized to a single cis-fused adduct 343 (Scheme 52) (75). Thermal isomerization of the 
internal double bond must occur before the cycloadduct formation or the IMDA 
cycloaddition of these type of substrates have a common transition state. 
OBn
OBn
OBn
H
OBn
BnO
BnO
342 343
a
 
Scheme 52. Reagents and conditions: a) PhMe, 160 °C, 2 h (83 %). 
 
IMDA reaction of methyl ester silyloxy E,Z,E-triene 344 give endo-adduct 345 as the 
sole product (Scheme 53) (76). The sterically demanding tert-butyldimethylsiloxy-group 
is effectively steering the transition state of the reaction to give the endo-adduct. 
However, the reaction for this type of substrate is very slow (4 days). 
 
OTBDMS
CO2Me
MeO2C
OTBDMS
344 345
a
 
 
Scheme 53.  Reagents and conditions: a) PhMe, 170 °C, 4 d (79 %). 
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3.2 Lewis acid promoted cycloadditions 
 
Lewis acids activate dienophiles in IMDA reactions (Figure 21). Lewis acid withdraws 
the electrons from the dienophile causing a polarization of the dienophile. The increased 
reactivity of the dienophile gives a higher reaction rate. This allows lower reaction 
temperatures, better diastereoselectivities and sometimes better yields.  
 
R1 R2
O
M L
electron density
n
 
 
Figure 21.  Dienophile polarization by Lewis acid. (n= typically 2-4 ligands) 
 
Polymerization of the triene substrate and alkylation of the dienophile carbonyl are the 
frequently encountered problems in Lewis acid promoted IMDA cycloadditions. 
Consequently relatively mild Lewis acids such as the alkylaluminum chlorides are used 
(77). Furthermore, if the diene is functionalized by an alkoxy substituent, it may lead to 
the formation of a pentadienyl carbonium ion in presence of Lewis acids (61b). In cases 
like this, it is recommended to use highly activated dienophile to favor IMDA reaction  
instead of the pentadienyl carbonium ion decomposition (78). 
 
In the presence of achiral Lewis acids E,E,E-trienes 299, 300 give only trans-fused 
cycloadducts 303a, 304a (Scheme 54) (77,62b). However, other triene isomers give 
similar endo/exo-product ratios as in the thermal conditions. In most cases, stoichiometric 
 
 
 
 
 
 
 
97 
 
quantities of Lewis acid were required for full conversion. Alkoxy- and alkylaluminum 
chlorides including menthyl-OAlCl2, EtAlCl2 and Et2AlCl are found to be highest 
yielding Lewis acids for triene esters compared to AlCl3, BF3·Et2O, TiCl4 and SnCl4.  
CO2Me MeO2C
CO2Me MeO2C
299
300
303a
304a
a
b
 
 
Scheme 54. Reagents and conditions: a) menthyl-OAlCl2, 23 °C, 48-60 h (72-79 %); b) 
menthyl-OAlCl2, 23 °C, 48 h (79-83 %). 
 
Stereoselectivity is not greatly effected by the dienophile substituent in Lewis-acid 
catalyzed IMDA reactions of nona-trienes (69b). Roush et al. have observed that 
epimerization occurs using triene aldehydes as the substrates, if the cycloaddition is 
performed at room temperature. However, this problem can be avoided by using low 
temperatures (69b). 
Intramolecularly substituted trienes, which are susceptible to pentadienyl carbonium ion 
formation (for example such as compounds 301, 310 or 316), cannot be cyclized by 
Lewis acids (62b). This is presumably due to decomposition of the substrates.  
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3.3 Asymmetric IMDA cycloadditions 
 
Chiral auxiliaries are employed in IMDA cycloadditions to maximize ∆∆G in the 
transition state of the cycloaddition. The chiral induction can be brought into the reaction 
either through a covalently bonded ligand or through a chiral catalyst. At first, the 
methods employing a covalently bound chiral auxiliary are presented. After these, the 
catalytic versions of producing bicyclo[4.3.0]nonanes by IMDA are presented. 
 
3.3.1 Chiral auxiliary induced IMDA 
 
Evans et al. (79) have reported several examples of IMDA reactions of chiral 
oxazolidinone derived trienes 346-349 (Scheme 55). (S)-Phenylalaninol derived 
oxazolidinone  347 provides higher diastereoselectivities compared to other 
oxazolidinone analogues 346-349. 
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347
348
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350a 350b
351a 351b
352a 352b
353a 353b
a
 
Scheme 55. Reagents and conditions: a) Me2AlCl, -30 °C, 5 h. 
 
Oppolzer et al. (80) have developed chiral auxiliaries from camphor sultam and they have 
reported that camphor sultam triene 354, in the presence of EtAlCl2 as a Lewis acid, 
affords endo 355a :exo 355b cycloadducts with ratio >97:3. The yield of recrystallized 
product is 75 % (>99 %de) from this reaction (Scheme 56). 
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X
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355a endo: 355b exo, >97:3
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a
 
Scheme 56. Reagents and conditions: a) EtAlCl2, -20 °C (82 %). 
 
Hoshino et al. (81) have studied IMDA reactions of dithiane substituted chiral trienes 
356-360 in the presence of Lewis acids (Scheme 57). Saigo’s chiral oxazolidinone 
auxiliary derived triene 359 (82) gave the best enantioselectivity (96 %ee) compared to 
other chiral trienes 356-360 investigated. In some cases, the reactions were not complete 
even after 4 days of stirring at –25 °C. 
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Scheme 57. Reagents and conditions: a) Me2AlCl, -25 °C, 4 d. 
 
Craig  et al. (83) have studied asymmetric thermal IMDA reactions of sulfoximine 
substituted trienes (Scheme 58). Triflyl sulfoximine triene 366 derivatives were found to 
give slightly better endo/exo selectivities and diastereoselectivities compared to 4-
tolylsulfonyl and 2,4,6-triisopropylphenylsulfonyl sulfoximines when the diene terminus 
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was substituted with a methyl group. Without the terminal methyl group in the diene, the 
selectivities were similar with all above mentioned sulfoximine triene derivatives.  
S
NTf
O
Ph
S
NTf
O Ph S
NTf
O Ph
90 : 10
366 367a 367b
a
+
 
Scheme 58. Reagents and conditions: a) PhMe, 125 °C, 45 h (53 %). 
3.3.2 Catalytic asymmetric IMDA cycloadditions  
 
Evans et al. (84) have reported that chiral bis(oxazoline) copper complexes catalyze the 
IMDA-reaction of triene oxazolidinone in a highly selective manner (Scheme 59). This 
catalyst requires two carbonyl groups in the substrate for effective coordination.  
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Scheme 59. Reagents and conditions: a) 5 mol-% 368, CH2Cl2, 25 °C, 5 h (86 %); b) 10 
mol-% 368, CH2Cl2, 25 °C, 24 h (89 %). 
 
Yamamoto et al. (85) have reported that the boron catalyst 375 prepared from (S)-
mono(2,6-dimethoxybenzoyl)tartaric acid and borane facilitates IMDA cycloaddition of 
triene aldehyde 373 (Scheme 60). The yield of cycloaddition is good (74 %) at –20 °C 
with an endo:exo ratio 99:1. The enantiomeric excess in this reaction was only 46 %ee. 
Yamamoto et al. (86) have developed Brønsted acid-assisted chiral boron catalysts and 
the binaphthyl derivative 376 catalyses the IMDA reaction of triene aldehyde 373 in high 
yield (95 %). The cyclization afforded only the endo-adduct with 80 %ee (Scheme 60). 
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Scheme 60. Reagents and conditions: a) 10 mol-% 375, CH2Cl2, -20 °C (74 %); b) 30 
mol-% 376, CH2Cl2, -40 °C (95 %).  
 
Narasaka et al. (87) have developed titanium based catalysts for asymmetric IMDA 
cycloadditions. High levels of asymmetric induction were achieved with the titanium 
catalyst 379 prepared in situ from TiCl2(i-PrO)2 and chiral diol derived from (R)-tartaric 
acid. Molecular sieves (4Å MS) were required to keep the reaction catalytic in titanium 
reagent. IMDA cycloaddition of trienyl oxazolidinone 377 and corresponding 1,3-
dithiane derivative 378 catalyzed by 379 provided cycloadducts 380, 381 with high 
enantioselectivities (Scheme 61). 
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Scheme 61. Reagents and conditions: a) 30 mol-% 379, mesitylene, 4Å MS, 161 h, r.t. 
(87 %); b) 10 mol-% 379, mesitylene, 4Å MS, 68 h, r.t. (62 %). 
 
 
3.4 Other methods 
 
Little et al. (88) have reported that the trans-diester 382 can be cyclized predominantly to 
the trans-fused enone 383 (Scheme 62). 
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CO2Me
CO2Me
O
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Scheme 62. Reagents and conditions: a) Na, Me3SiCl, PhMe, rfx; then THF-CH3COOH-
H2O (58 %). 
 
Bauld and Harirchian (89) have prepared bicyclo[4,3,0]nonane derivatives by IMDA 
reaction induced by cation radicals (Scheme 63). They used tris(4-bromophenyl)aminium 
hexachlorostibnate as the catalyst and 2,6-di-tert-butyl-pyridine as a base to prevent 
Brønsted acid-catalyzed reactions (90). The cycloaddition of anisyl triene 384 gave high 
stereoselectivity favoring the trans-fused product 385. The product distribution was 
similar for E,E,E- and E,E,Z-trienes. This was proposed to be due to rapid isomerization 
of the E,E,Z-triene to the corresponding E,E,E-triene. The product 385 was a racemic 
mixture of cycloadducts. 
OMe MeO
trans:cis-fused
(98:2)
384 385
a
 
Scheme 63.  Reagents and conditions: a) 2,6-di-tert-butylpyridine, (p-BrPh)3+SbCl6-, 0 
°C, 10 min (83 %). 
Roush et al. (91) have investigated hydrofluoric acid catalyzed IMDA reactions of 
substituted 2-hydroxyethyl ester trienes (Scheme 64). Although the reaction of triene 386 
took 72 hours to complete at room temperature, the reaction afforded the cycloadduct in 
good yield (78 %) and the endo:exo ratio was high ≤98:2. The cycloadduct was reduced 
to the corresponding alcohol 387 with lithium aluminum hydride for analytical purposes. 
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O
O
OTBS
HO
386 387
a
endo:exo <98:2  
Scheme 64. Reagents and conditions: a) HF, CH3CN-CH2Cl2, 72 h, r.t.; then LiAlH4 (78 
%). 
 
Gorman et al. (92) reported in 1995 that tetraene 388 produces bicyclo[4.3.0]nonane 389 
in an IMDA catalyzed by triflic acid (Scheme 65).   
388
389
a
 
  
Scheme 65.  Reagents and conditions: a) 5 mol-% CF3SO3H, CH2Cl2, 23 °C, 2 min (86 
%). 
 
Tori et al. (93) formed hydrindene 392 in the synthesis of conocephalenol 390 by 
dehydration of the bicyclic alcohol 391 (Scheme 66). 
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Scheme 66. Reagents and conditions: a) pyr, POCl3 (91 %). 
 
Roush et al. (94) have developed a method to produce trans-anti-cis-decahydro-as-
indacene ring system 394 via a transannular IMDA reaction of a functionalized E,E,E-
cyclododeca-1,6,8-triene 393 (Scheme 67). 
O
O
HO2C
393 394
a
 
 
Scheme 67. Reagents and conditions: a) KHMDS, TBSOTf, THF-HMPA, 4 Å MS, -78 
→ 65 °C; then aq. HCl (35 %). 
 
Rokach et al. (95) have synthesized the hydrindene derivative 398 by a thermal Diels-
Alder reaction of chiral cyclopentenone 395 and 1,3-dimethoxy-1,3-butadiene 396 
(Scheme 68). After the formation of the bicyclo[4,3,0]nonane ring 397, allylic 
rearrangement afforded the dimethoxy derivative 398. 
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Scheme 68.  Reagents and conditions: a) xylene, 140 °C, BHT (63 %); b) (MeO)3C, 
MeOH, PPTS (98 %). 
 
Dauben et al. (96) have prepared the hydrindene derivative 400 by a thermal 
rearrangement of cyclic cis,cis,trans-triene 399 (Scheme 69). 
H
H
H
H
399 400
a
 
Scheme 69. Reagents and conditions: a) PhH-d6, 125 °C, 1 h (100 %). 
Trost et al. (97) have synthesized bicyclo[4.3.0]nonane phenylsulfone esters by an 
intramolecular cyclization of phenylsulfonyl anion catalyzed by palladium(0) catalyst 
(Scheme 70). The cyclization of 401 provided a diastereomeric mixture of phenylsulfone 
esters 402. 
OAc
CO2MePhO2S
PhO2S
CO2Me
401 402
a
 
Scheme 70. Reagents and conditions: a) NaH, (Ph3P)4Pd, THF, rfx (75 %). 
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Fukumoto et al. (98) have investigated the stereoselective asymmetric preparation of cis-
hydrindene derivatives (Scheme 71). Cycloadduct 407 was obtained by a palladium(II) 
catalyzed Heck reaction of the triflate derivative 403 in high yield (85 %). 
Cycloisomerization of 404 and 405 provided the cycloadducts 408 and 409 in high yields 
(81 and 98 %, respectively). Cycloalkenylation of 406 catalyzed by palladium acetate 
afforded 410 in good yield (78 %). 
OBn
OTf
OBn
OBn OBn
OBn
HO
TMS
OBn
HO
TMS
OBn
TMSO
OBn
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403
404
405
406
407
408
409
410
a
b
c
d
 
Scheme 71. Reagents and conditions: a) Pd(OAc)2, PPh3, Ag3PO4, CaCO3, MeCN, 60 °C 
(85 %); b) (Ph3P)2Pd(OAc)2, Ph3P, C6H6, 60 °C (81 %); c) Pd(OAc)2, BBEDA, 
CH2ClCH2Cl, 60 °C (98 %); d) Pd(OAc)2, MeCN, CH2Cl2, 45 °C (78 %). 
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Livinghouse et al. (99) have reported that low valent rhodium complexes catalyse IMDA 
cycloaddition between an unactivated dienophile and a diene (Scheme 72). The IMDA 
cycloaddition of E,E,E-triene 411 give exclusively the cis-fused product 412.  
OTBDMSOTBDMS
a
411 412  
Scheme 72. Reagents and conditions: a) THF, [(i-C3HF4O)3P]2RhCl, 55 °C, 18 h (61 %). 
3.5 Summary of preparation of bicyclo[4.3.0]nonane derivatives  
 
It is not surprising that several methods for preparing bicyclo[4.3.0]nonane derivatives 
have been developed. This is thanks to the wide variety of interesting compounds, which 
include the bicyclo[4.3.0]nonane substructure or can be derived from a 
bicyclo[4.3.0]nonane derivative. The major difference between the preparation methods 
is the product distribution. Some methods favor endo-adducts instead of exo-adduct and 
vice versa. In some cases, asymmetric induction has also been achieved. Although achiral 
methods sometimes facilitate short routes to bicyclo[4.3.0]nonanes, the separation of 
stereoisomers may be difficult and laborious. In the asymmetric methods, the isolation of 
the desired stereoisomer is usually easier and can usually be done by a single 
recrystallization step. The chiral auxiliary mediated IMDA cycloadditions (relayed 
asymmetric induction) usually demand more reaction steps for introducing and removing 
the auxiliary. This can be avoided using asymmetric catalytic processes (external 
asymmetric induction) developed especially in the laboratories of Evans, Narasaka or 
Yamamoto. The catalytic IMDA cycloadditions provide high asymmetric induction and 
allow flexibility for the substrates. However, the catalysts developed by Evans and 
Yamamoto require oxazolidinone derived dienophiles to provide high levels of 
asymmetric induction. Other methods using intermolecular Diels-Alder, Heck, 
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cycloisomerization or cycloalkenylation reactions are also asymmetric methods and 
provide useful synthons for organic chemists. 
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4 Total synthesis of amaminol A (1) 
 
4.1 Introduction 
 
I chose Amaminol A 1 as the target compound since it is a recently isolated compound 
which is cytotoxic against P388 murine leukemia cells (1). However, the biological 
activity was not the only reason to synthesize amaminol A 1. I was introduced to the 
preparation of vicinal amino alcohol during my master’s thesis (100) and indeed 
amaminol A 1 includes an amino alcohol fragment in it’s structure. Furthermore, the 
group of professor Koskinen (101) has been studying nitrogen containing compounds 
derivable from amino acids. Although amaminol A 1 has only eighteen carbon atoms, it 
provides a challenging target for synthesis. The challenges arise from the facts that the 
carbons C2, C3, C6, C7, C11 and C14 are chiral and they had to be synthesized by 
asymmetric means. Previous synthetic efforts toward amaminol A 1 had not been 
reported and I have accomplished the first total synthesis of amaminol A 1. Although I 
obtained amaminol A 1 as a side product due to wrong stereochemistry of the IMDA 
cycloaddition catalyst, amaminol A 1 can probably be synthesized as the major product 
by changing the stereochemistry of the organocatalyst to the opposite one for the IMDA 
cycloaddition step. 
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4.2 Retrosynthetic analysis of amaminol A (1)  
 
Retrosynthetic analysis of amaminol A 1 reveals that the vicinal amino alcohol moiety 
C1-C3 is derivable from (S)-alanine 416 via steps a and b (Scheme 72). Furthermore, the 
bicyclo[4.3.0]nonane fragment 414 C5-C15 is derivable by a retro-IMDA step (step c). 
Precursor 415 for the retro-IMDA is derivable from crotylphosphonate 417 (route d) or 
sorbic acid 418 (route e).  
OH
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b
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1
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Scheme 72. Retrosynthetic analysis of amaminol A 1.  
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4.3 Synthesis of E,E,E-trienes for IMDA cycloadditions 
 
The bicyclo[4.3.0]nonane skeleton of amaminol A 1 was formed by two different 
methods. At first, the Evans oxazolidinone auxiliary (79) was used to give the 
asymmetric induction for IMDA cycloaddition. In the second approach, a novel 
organocatalytic (102) IMDA cycloaddition was used to form the desired 
bicyclo[4.3.0]nonane derivative. 
After analyzing the review chapters of this thesis, it can be summarized that E,E,E-trienes 
are usually formed via the following sequence: oxidation -> Wittig, HWE reaction or 
Stille coupling -> oxidation -> Wittig, HWE reaction or Stille coupling sequence. 
However, the resulting mixtures of E,Z-isomers are rather difficult to separate, and 
usually require liquid chromatography. If large scale preparation is desired, flash 
chromatographic purification is a laborious and rather expensive method.  
My first approach to elaborate the triene precursor for the IMDA cycloaddition was based 
on a HWE reaction between crotyl phosphonate 417 and protected aldehyde 423 (Scheme 
73). At first, allyl alcohol 421 was protected with tert-butyldimethylsilyl group. Then the 
prepared siloxy alkene 422 was ozonolyzed to elaborate the aldehyde 423. The 
ozonolysis of siloxy alkene alcohol 422 appeared to be low yielding (56 %), although 
several work up procedures (Ph3P, thiourea or DMS) were examined. Phosphonate 417 
was prepared by initial bromination of ethyl crotonate 419. The resulting bromoester 420 
was reacted with triethylphoshite in Arbusov reaction (103) to give 417. After this, the 
diene 424 was prepared by coupling the aldehyde 423 and the phosphonate 417. 
Unfortunately, it was found out that the formation of the E,E-diene 424 was difficult with 
this method. In other words, it gave low yield (40 %) for the E,E-product 424 which was 
also difficult to separate from the other isomers. The low yield was also probably due 
decomposition of the α-siloxy substituted aldehyde 423. The diene ester 424 was reduced 
with DIBAL-H to the corresponding alcohol. The alcohol was then acetylated and the 
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acetylated diene 425 was allowed to react with the Grignard reagent 28 in the presence of 
a catalytic amount of lithium tetrachlorocuprate (104). Attempts to remove the dioxolane 
protection of aldehyde 426 group by mild hydrolysis conditions using para-toluene 
sulphonic acid in acetone/water solvent mixture proved more difficult than anticipated. 
Surprisingly, even the mild hydrolytic conditions deprotected the silyl protecting group to 
yield diene dioxolane alcohol 427. 
CO2Et CO2EtBr (EtO)2P
O
HO TBDMSO
O
TBDMSO
CO2EtTBDMSO
OAc
TBDMSO
TBDMSO
OO
HO
OO
E,E : E,Z : Z,E
4    :    1    : 1
a b
c d
e f,g
h i
CO2Et
419 420 417
421 422 423
424 425
426 427
417
 
Scheme 73. Reagents and conditions: a) NBS, CCl4, Bz2O2 (70 %); b) (EtO)3P (55 %); c) 
TBDMSCl, imidazole, CH2Cl2 (92 %); d) O3, CH2Cl2, Ph3P (56 %); e) LDA, THF, 
aldehyde 423, -40 °C (40 % for E,E-424); f) DIBAL-H, CH2Cl2, -78 °C; g) Ac2O, pyr, r.t. 
(81 % over 2 steps); h) 28, Li2CuCl4, -20 °C (70 %); i) p-TsOH, acetone, H2O (74 %). 
After unsuccessful hydrolysis of acetal protection and sluggish diene formation, I decided 
to develop a new method for the preparation of E,E,E-trienes. The method developed 
herein avoids chromatographic separations during the first steps of the synthesis. The 
method starts from esterification of the inexpensive sorbic acid 418 by an acid catalysis 
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to methyl sorbate 428 with a best yield of 94 % (Scheme 74) (105). The product 428 was 
easily purified by distillation under reduced pressure. 
CO2H CO2Me
a
418 428  
Scheme 74. Reagents and conditions: a) cat. H2SO4, MeOH, rfx (94 %). 
The bromination of methyl sorbate 428 with N-bromosuccinimide appeared to be 
problematic. First of all, the yield (70 %) in the reference article (106) was calculated 
wrong and the true yield calculated from a mass weight was 55 %. However, this must be 
the crude yield, because the reported reaction procedure was followed carefully and the 
best yield obtained by this method was 33 % of pure methyl 6-bromosorbate 429 (Table 
1, Entry 2). Furthermore, the reported boiling range of methyl 6-bromosorbate 429 was 
quite wide (89-94 °C at 0.1 mmHg). I found out that the wide boiling range (74-79 °C at 
0.2 mmHg) corresponded a product mixture, which contained only 54 % of the desired 
methyl 6-bromosorbate 429. The purity was justified by purifying the distillation fraction 
of the product by flash chromatography. The main byproducts of bromination reaction 
was anti- 430 and syn-4,5-dibromination products 431. It was also noticed, that the 
reaction did not go to completion with equimolar halogenating agent (NBS). An excess 
NBS, a longer reaction time and a lower temperature resulted in better conversion, but 
slightly worse selectivity to methyl 6-bromosorbate 429 (Entry 3). It was decided that the 
best reaction conditions for producing methyl 6-bromosorbate 429 were a short reaction 
time, a slight excess of NBS and a low concentration. It was also observed that a high 
reaction temperature >130 °C leads to increased formation of  polymeric compounds, 
which lowered the total yield. The reaction was also tested in two different solvents, 
carbon tetrachloride (Entry 4) and chlorobenzene. It was observed that reaction produced 
more dibrominated products 430, 431 when carbon tetrachloride was used as the solvent. 
The ratio of 430 to 431 was constant regardless which solvent was employed (compare 
entries 2 and 4). In larger scales (Entries 6 and 7), the reactions were performed in more 
concentrated solutions to avoid high volumes of chlorobenzene due to it’s 
carcinogenicity. Increased amount of side products 430, 431 were obtained in more 
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concentrated solutions. The mixture of brominated products 429-431 were separated from 
the crude product mixture by distillation under reduced pressure. 
CO2Me CO2MeBr
a
CO2Me
+
Br
CO2Me
Br
428 429
430
431
Br
Br
 
Scheme 75. Reagents and conditions: a) PhCl or CCl4, NBS, 100-150 °C, init. Bz2O2. 
Wei and Taylor (107) have prepared bromo diene ester 433 via a Wittig reaction of 3-
bromo-2E-propenal 432 and phosphorane (Scheme 76). Wittig reaction of 432 produced 
a mixture (6.8:1) of E,E- and E,Z-diene isomers with an overall yield of 78 %. However, 
the separation of the isomers are laborious. 
 
CO2EtBr
a
433
Br
O
Br
CO2Et
434432
+
6.8:1  
 
Scheme 76. Reagents and conditions: a) CH2Cl2, Ph3P=CHCO2Et, r.t. (78 %). 
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Table 1. Results of bromination of methyl sorbate 428. 
Entry 428 
a 
NBS 
[mol
-%] 
C 
mol/l 
Solv. T  
[° C] 
Rxn 
Time 
[h] 
 
428b 
 
429 
 
430 
 
431 
1 0.03 104 1.19 PhCl 110-150 2.0 2.9 5.2 1.6 1 
2 0.35 104 1.17 PhCl 100-130 1.5 5.6 6.9 1.8 1 
3 0.35 120 1.17 PhCl 100-103 16 2.7 5.1 2.0 1 
4 0.3 100 3.0 CCl4 
100-
110 25 2.6 2.0 1.9 1 
5 0.04 105 2.5 PhCl 100-150 1.0 3.2 4.5 2.0 1 
6 1.7 103 2.5 PhCl 105-138 0.33 3.4 4.2 1.8 1 
7 1.7 104 2.6 PhCl 100-120 0.75 3.4 4.9 1.8 1 
a Mol of 428. bThe product ratios were determined by 1H NMR from the crude product 
mixture. 
Methyl 6-bromosorbate 429 was the converted to methyl 6-hydroxysorbate 435 by a mild 
hydrolysis with an yield of 85 % (Scheme 76) (108). The hydrolysis succeeded nicely 
also with an impure starting material, which was obtained from the brominated product 
429 by distillation. The hydrolysis product 435 was easily purified by solvent washing 
and crystallization. 
CO2MeBr a
429
CO2MeHO
435  
Scheme 76. Reagents and conditions: a) acetone, NaHCO3, rfx, 2 h (85 %). 
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The next step was to protect the alcohol of 435. At first, I chose TBDPS-group as the 
protecting group due to its relative stability under acidic conditions and due to its easy 
cleavage with fluoride ion (109). Also, I though that the size of TBDPS-group might be 
beneficial during the asymmetric IMDA reaction. However, the yield of the silylation 
was low when TBDPS-Cl was used (Scheme 77), although DMAP (39) was used to 
catalyze the reaction. Although TBDPS-triflate is more reactive than the corresponding 
chloride, because triflic acid is a far more better leaving group than hydrogen chloride, 
the silylates were not employed because they are expensive to use in large scale. Finally, 
I decided to use benzyl protection due to its moderate steric size and compatibility with 
different conditions and reagents (109). Closa et al. (108) have reported that the reaction 
of diene alcohol 435 with benzyl trichloroacetimidate give a poor yield (24 %) for the 
benzylated product 437. I initially attempted benzyl protection using sodium hydride as 
the base and benzyl bromide as the alkylating reagent. However, the desired reaction was 
not observed. Benzyl protection of methyl 6-hydroxysorbate 435 was achieved 
successfully with benzyl triflate as the alkylating reagent and using an organic base. The 
first benzylation of hydroxyl group using benzyl triflate and organic base has been 
reported by Lemieux and Kondo (110). Berry and Hall (111) have reported that N-
benzylation of the organic base employed can be reduced by using sterically demanding 
bases such as 2,6-di-tert-butylpyridine as the proton scavenger. 
CO2MeHO
CO2MeBnO
CO2MeTBDPSO
a
b
c
435 436
437  
 
Scheme 77. Reagents and conditions: a) NaH, BnBr, (Bu)4NI, THF; b) TBDPSCl, Et3N, 
DMAP, CH2Cl2, r.t., 39 h (<16 %); c) BnOTf, base, -78 → -15 °C (41-93 %). 
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I chose to evaluate 2,6-di-tert-butylpyridine, 2,6-dimethylpyridine and 2,4,6-
trimethylpyridine as the proton scavengers for the benzylation reaction of methyl 6-
hydroxysorbate 435 (Table 2). The highest yields were obtained with 2,6-
dimethylpyridine (Entries 3-5). It was surprising that efficient proton scavenger like 2,6-
di-tert-butylpyridine gave a lower yield (Entry 1) than sterically less demanding 2,6-
dimethylpyridine. Several molar ratios for the substrates were screened and the best yield 
was obtained when 536 mol-% of benzyl triflate and 2,6-dimethylpyridine were used 
(Entry 4). It was assumed that using excess benzyl triflate there was enough benzylating 
reagent available during the reaction. The major byproducts were identified to be 
dibenzylether and N-alkylated 2,6-dimethylpyridine, explaining the high benzyl triflate 
consumption.  
 
Table 2. Benzyl protection of methyl 6-hydroxysorbate 435.  
Entry Benzyl 
alcohola 
[mol-%] 
Base 
for 
triflic 
acida 
Triflic 
anhydridea 
Base for 
deprotonationa 
Baseb 
 
Reaction 
timec 
Yield 
435 
1 159 161 159 260 DTB 3 h 55 % 
2 159 161 159 260 TM 20 h 41 % 
3 159 161 159 260 DM 20 h 59 % 
4 536 536 536 404 DM 2 h 15 
min 
93 % 
5 300 300 300 200 DM 1 h 45 
min 
80 % 
a Mol-% compared to 435. b DTB = 2,6-di-tert-butylpyridine, TM = 2,4,6-
trimethylpyridine, DM = 2,6-dimethylpyridine. c The reactions were conducted at equal 
temperatures and concentrations. 
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In the next step, the protected diene ester 437 was reduced to alcohol 438 with 
diisobutylaluminum hydride in high yields (80-90 %). The alcohol 438 was then 
acetylated with acetic anhydride in pyridine. The acetylation also worked satisfactorily 
also with crude 438 directly from ester 437 reduction (Scheme 78). The chain elongation 
was done with Grignard reagent 28. Lithium tetrachlorocuprate was used in this reaction. 
An inseparable mixture of isomers 440, 441 were obtained. The ratio of products varied 
from 65-85:35-15 depending on the reaction temperature. At lower temperature, more 
open chain product 440 was obtained . However, the conversion of the reaction was low. 
The dioxolane protection of 440 was removed by hydrolysis with dilute aqueous HCl in 
acetone. This method afforded a better yield than hydrolysis in THF and acetic acid. The 
aldehyde 442 was then subjected to Wittig reaction affording an E,E,E:E,E,Z-mixture of 
trienes 443. The ratio of E,E,E-product to E,E,Z-product was 13:1. Ester 443 was 
hydrolyzed with NaOH in THF to give triene acid 444. 
CO2MeBnO OH
BnO
OAc
BnO
BnO
BnO BnO
BnO
OO
a
OO
+
O
BnO
CO2Me CO2H
b
c
d e f
437 438
439
440 441
442 443 444  
 
Scheme 78. Reagents and conditions: a) DIBAL-H, CH2Cl2, -78 °C (80 %); b) Ac2O, 
pyr, r.t. (91 %); c) 28, Li2CuCl4, -20 – 0 °C (80 %); d) 0.5 M HCl, acetone, r.t. (87 %); e) 
Ph3P=CHCO2Me, CH2Cl2, rfx (80 %); f) NaOH, THF, 0 °C (99 %). 
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It was initially anticipated that a toluenesulfonyl group would be a better leaving group in 
the ensuing allylic substitution reaction. Replacement of the acetyl group of acetyl diene 
439 was next attempted (Scheme 79). I tried tosylation of 438 using phase transfer 
conditions (112) and by DMAP catalyzed method.  Unfortunately, diene tosylate 445 was 
very sensitive to dimerization and polymerization, which resulted in no observed product 
in the crude product mixtures. 
BnO
OTs
445
a
b
438
 
Scheme 79. Reagents and conditions: a) TsCl, KOH, (Bu)4NHSO4, PhH, r.t.; b) TsCl, 
Et3N, DMAP, CH2Cl2, r.t. 
4.3.1 Chiral auxiliary promoted asymmetric IMDA 
 
 
The chiral auxiliary promoted IMDA approach was chosen based on the fact that 
oxazolidinone derived chiral auxiliaries developed by Evans usually provide asymmetric 
induction (Figure 22). The phenylalanine derived oxazolidinone 41 often offers high 
asymmetric induction in many different types of asymmetric reactions. These chiral 
oxazolidinones have also been used in Diels-Alder reactions and IMDA reactions for a 
wide variety of substrates (79). 
41
O
HN
O
 
Figure 22. Phenylalanine derived oxazolidinone auxiliary 41 developed by Evans group. 
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I wanted to prepare a new chiral auxiliary, which can be synthesized easily from an 
inexpensive and readily available starting material. Molecular modeling (Cerius 2, 
Macromodel 7.0) and previous studies (100) suggested the oxazolidinone 449 derived 
from 1,2-dihydronaphthalene 446. 
Optically pure oxazolidinone 449 was prepared from 1,2-dihydronaphthalene 446 via a 
one pot synthesis (113) (Scheme 80). The first step was oxyamination of 1,2-
dihydronaphthalene 446. The second step was the formation of oxazolidinone 449 in situ 
from the cis-1-amino-2-alcohol 447. The reaction was attempted with several catalyst and 
ligand loadings (Table 3). Urethane gave better yield, enantioselectivity and 
stereoselectivity compared to benzyl carbamate in this reaction (Table 3, entries 1 and 2). 
Urethane, NaOH,
t-BuOCl
1-PrOH/H2O,
(DHQD)2PHAL,
K2OsO2(OH)4
HN
OH
O
O
NaOH
HN
O
O
446
447 449
OH H
N
448
O
NH
O
450
O
O
 
Scheme 80. Reagents and conditions: a) Urethane, NaOH, t-BuOCl, 1-PrOH-H2O, 
(DHQD)2PHAL, K2OsO2(OH)4; b) NaOH. 
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Table 3. Optimization of catalyst and ligand loadings in oxyamination reaction of 1,2-
dihydronaphthalene 446. 
 
Test Carba- 
mate 
Ligand 
[mol%] 
Catalyst 
[mol%] 
Rxn 
time  
1 step 
Rxn 
time  
2 step 
NaOH 
[mol%] 
1 step 
Yield 
% 
449 / 
450 
% e.e. 
449 / 
450 
1 Ethyl- 5 4 2 h 4.5 h 305 54 37 79 79 
2 Benzyl- 5 4 3 h 18 h 305 39 31 25 63 
3 Ethyl- 1.25 1 8.5 h 12 h 305 38 26 50 50 
4 Ethyl- 2.5 1 4 h 18 h 155 45 29 61 76 
5 Ethyl- 2.5 1.25 21.5 h 3 h 305 46 33 60 69 
 
a Yields for the flash chromatographically purified products. 
 
It was interesting to note that sodium hydroxide loading did not dramatically change the 
yields or enantioselectivities (compare Entries 4 and 5). However, increased sodium 
hydroxide accelerated the formation of oxazolidinones 449/450 (compare Entries 4 and 
5). Furthermore, it was observed that the yield and the enantioselectivity are influenced 
by the ligand and catalyst loads (compare Entry 1 to 3,4 and 5). 
 
1,2-Dihydronaphthalene 446 derived oxazolidinone 449 forms a rigid pocket like 
structure (Figure 23), where the angle between the oxazolidinone and the naphthalene 
moiety is near 90 degrees. The stereopresentation of 449 is obtained from CS Chem3D 
ProTM. I considered these characters to make oxazolidinone 449 an excellent auxiliary for 
asymmetric IMDA cycloaddition. 
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Figure 23. 3D molecular stereorepresentation of oxazolidinone 449. 
 
The Evans ligand 41 was easily prepared by a one step method developed by Greene et 
al. (114) (Scheme 81). The oxazolidinone 41 was purified by crystallization and the yield 
was 61 % (>99 %ee). The yield of oxazolidinone 41 can be certainly higher if the 
reaction parameters and the purification procedure is more studied and developed. 
However, only minor rasemization of the product was noticed during the reaction as 
performed according to the procedure developed by Greene et al. 
 
NH2
OH
O
O
HN
O
451 41
a
 
 
Scheme 81. Reagents and conditions: a) LiAlH4, THF; 10% NaOH; triphosgene; 
recrystallization (61 %). 
 
The lithiated auxiliaries 449 and 41 were attached to the triene acid 444, which was 
activated in situ as the mixed anhydride 451 with pivaloyl chloride (Scheme 82). 
Anhydride activation has been widely used for introducing oxazolidinone ligands to 
carbonyl groups. For example, Martinelli (115) has used pivaloyl chloride for preparing 
an anhydride, which was reacted in situ with lithium salt of 4-(phenylmethyl)-2-
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oxazolidinone. The solubility of the lithium salt of oxazolidinone 449 in THF was lower 
than that of the oxazolidinone 41, which probably caused the lower yield for the amide 
452 formation. The cycloadducts 454 and 455 were prepared by IMDA reaction by using 
a mild Lewis acid (Et2AlCl) to catalyze the reaction. The naphthalene derivative 454 gave 
lower yield, but very high diastereoselectivity. Actually, the wrong diastereomer was not 
even observed. The low yield was obtained because the temperature was allowed to rise 
to r.t. This resulted in the formation of alkylated product, which formed from the reaction 
with the diethylaluminium chloride. Polymerization of the starting material was also 
observed. The Evans auxiliary derived triene 453 gave good yield for the cycloadduct 
455. High diastereoselectivity was also noticed in this reaction. The product 455 was 
crystallized from methanol and the crystal structure of the cycloadduct 455 is presented 
in Figure 24.  
BnO
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Scheme 82. Reagents and conditions: a) Et3N, PivCl, Et2O; b) LDA, 449, Et2O (71 %); c) 
LDA, 41, Et2O (85 %); d) Et2AlCl, 6 h,  <-10 °C (23 %); e) Et2AlCl, 53 h, <-10 °C (72 
%). 
Figure 24. The crystal structure of IMDA cycloadduct 455. 
 
The X-ray crystal structure proved the product to be the (S)-endo-adduct. Two different 
forms of endo-adducts were found in the crystal structure of 455. The structures differed 
mainly in the conformation of the side chains containing the benzyloxy and 
oxazolidinone moiety.  
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4.3.1.1 Removal of the chiral auxiliary 
 
After forming the cycloadduct 455 , I attempted to remove the chiral auxiliary by several 
methods (Scheme 83). The purpose of the auxiliary removal was to enable the formation 
of the aldehyde, which is required for olefination to connect the amine containing side 
chain. Although DIBAL-H reduction of α-methyl substituted 3-acyl 4-isopropyl-2-
oxazolidinone derivatives were reported to give the corresponding aldehydes (116), I 
obtained a product mixture containing oxazolidinone ring opened products, 
oxazolidinone cleavage products and other reduced products. Penning et al. (117) have 
reported that partially hydrolyzed lithium borohydride affords aldehyde products when 
reacted with α-tert-butyldiphenylsiloxy substituted acyloxazolidinone derivatives. 
However, the reaction of oxazolidinone derivative 455 with inactivated lithium 
borohydride gave the hydrolysis product 456 as the major product. Aluminum trichloride 
mixed with N,N-dimethylaniline provides debenzylated products with alkylbenzyloxy 
derivatives (118). When cycloadduct 455 was treated with this reagent mixture, no 
reaction occurred. The inactivity of this reagent mixture was probably due to decreased 
reactivity of the aluminum by coordination to the carbonyl oxygen. The cycloadduct 455 
was then subjected to transamidation conditions to remove the oxazolidinone (119), but 
surprisingly the Weinreb amide was formed in a reverse manner to afford 457. 
 
Since the cleavage of the oxazolidine moiety proved difficult, the next attempts were 
based on the intramolecular assistance of the neighboring hydroxy functionality. Benzyl 
ether cleavage can be obtained with methanesulphonic acid in chloroform with 
alkylbenzyloxy derivatives (120). When applied to 455, a mixture of ring opened 
products was obtained. Dimethylsulfide complex of borontrichloride in dichloromethane 
(121) cleaved the benzyl group of 455. Debenzylation resulted in the unavoidable 
formation of the lactone 458. It was possible to recycle the oxazolidinone auxiliary 41. It 
has also been reported that DDQ cleaves benzyl groups (122). Treatment of cycloadduct 
455 with DDQ in dichloromethane-water (20:1) mixture resulted in the cleavage of the 
benzyl group and instant formation of the lactone 458. The yield was low probably due to 
the small scale. Finally, basic hydrolysis of cycloadduct 455 with KOH in methanol 
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resulted hydrolytic opening of the oxazolidinone ring to afford an amide alcohol 456 in 
near quantitative yield.  
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Scheme 83. Reagents and conditions: a) DIBAL-H, PhMe, -78 °C; b) LiBH4, H2O, THF 
(62 %); c) AlCl3-N,N-dimethylaniline, CH2Cl2; d) MeONHMe·HCl, AlMe3, CH2Cl2, -10 
→ +50 °C (78 %); e) MeSO3H, CHCl3; f) BCl3·SMe2, CH2Cl2 (84 %) ligand recovery (74 
%); g) DDQ, H2O, CH2Cl2 (40 %); h) KOH, MeOH (>99 %). 
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After amide alcohol 456 in hand, debenzylation was attempted with different methods 
(Scheme 84). Diphosphorous pentasulfide gives debenzylation and lactonization when 
the carboxylic group is in δ-position to benzyloxy group (123). I assumed that the amide 
456 would behave similarly and form lactone 458 after debenzylation with 
diphosphorous pentasulfide, but only traces of the lactone 458 was found from the 
product mixture after 1.5 hours reaction time. The reaction was not further studied, 
because diphosphorous pentasulfide appeared to be rather nasty smelling reagent and 
more convenient methods were decided to study. Furthermore, acidic hydrolysis with 
dilute sulphuric acid in dioxane did not result lactonization. However, concentrated 
solution of hydrochloric acid (6 M HCl) in dioxane resulted in lactonization of the amide 
456. Surprisingly, double bond of amide 456 was also saturated probably through 
cationic rearrangement under highly acidic conditions. The inseparable mixture of 
lactones 458, 459 were reduced with DIBAL-H to the corresponding lactols 460, 461 as a 
mixture of diastereomers. It was clear according to results obtained that the acid 
protomed lactonization of the amide 456 was pH dependent reaction. 
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Scheme 84. Reagents and conditions: a) P4S10, CH2Cl2, r.t., 90 min (traces of 458); b) 
0.75 M H2SO4, 1,4-dioxane, 100-105°C, 2.5 h; c) 6 M HCl, 1,4-dioxane, 100-105°C, 18.5 
h  (82 %); d) DIBAL-H, PhMe, -78 °C (62 %). 
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4.3.1.2 Reactions of the five membered lactol 
 
After learning that debenzylation of cycloadduct 455 was followed by unavoidable 
lactonization, I decided to reduce lactone 458 to lactol 460 and considered that lactol 460 
would react with phosphonates or phosphoranes to allow the amino fragment connection. 
It is known that five membered lactols are commonly used as substrates in Wittig 
reactions (124). Although acyclic lactols are used as a substrates in HWE reactions (125), 
a condensation reaction of phosphonates with cyclic lactols are not reported. Lactone 458 
produced from the cycloadduct 455 with borontrichloride dimethylsulfide was reduced 
with DIBAL-H to afford lactols 460a,b as a 20:1 mixture of diastereomers. The mixture 
of lactols 460a,b was subjected to HWE reaction using conditions developed by 
Mikolajczyk and Balczewski (126). In this method potassium carbonate is partially 
dissolved in ethanol to avoid racemization of the amino group. β-Ketophosphonate 413 
was prepared from N-BOC-protected L-alanine using the procedure developed by Corey 
and Kwiatkowski (127). However, the lactols 460a,b appeared to be unreactive toward 
nucleophilic attack of the phosphonate anion generated from β-ketophosphonate 413.     
 
O
O
O
HO
458 460a
O
HO
460b
+
NHBOC
P(OMe)2
O O
a b 413
 
 
Scheme 85. Reagents and conditions: a) DIBAL-H, PhMe, -78 °C (72-81 %); b) 
phosphonate 413, K2CO3, 94 w-% EtOH, r.t. 
 
I decided to study Mikolajczyk and Balczewski modified HWE reaction more closely. 
The condensation reaction of isobutyraldehyde 462 and phosphonate 413 was chosen as 
the model reaction (Scheme 86). I found out that the reaction did not proceed in dry 
ethanol, which was previously distilled from magnesium ethoxide to crushed 3Å 
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molecular sieves. Interestingly, the reaction did proceed when a few drops of water was 
added into the slurry reaction mixture. The addition of water improved the solubility of 
potassium carbonate, which was required for the anion formation. Furthermore, 
racemization was avoided when just a few percent of water was added. This was 
probably due to the low concentration of potassium carbonate in the reaction mixture. 
After observing that water was essential the reaction, I used systematically 94 weight 
percent ethanol for the reactions and the results did not change noticeably. In comparison, 
I employed the conditions developed earlier in our group (128) for the same reaction 
between isobutyraldehyde 462 and phosphonate 413. I noticed that by using potassium 
carbonate in dry acetonitrile the reaction was not completed even after 5 days of stirring, 
which was probably reason for the lower yield (61 %). The slow reaction was also 
accompanied with racemization of the amino group, which was not observed in the 
reaction in ethanol. The racemization was determined from the crude product mixture by 
gas chromatography using chiral column (γ-dextrine).  
 
NHBOC
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O O
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O
462
NHBOC
O
463
a
b
 
 
Scheme 86. Reagents and conditions: a) K2CO3, 94 w-% EtOH (69-73 %, >99 % ee); b) 
K2CO3, CH3CN (61 %, 97 % ee). 
 
An amino acid derived phosphorane ylide 465 was prepared for Wittig reactions from N-
BOC-protected L-alanine 464 by using a modified method developed by Jarosz and Skóra 
(129) (Scheme 87). The procedure of Jarosz and Skóra were modified so that 
phenyllithium instead of n-butyllithium was employed as the base to avoid alkyl-aryl 
 
 
 
 
 
 
 
134 
 
exchange of the phosphorane 465. Miyano and Stealey (130) have reported that the use of 
phenyllithium instead of butyllithium is essential if higher yields of 
alkyltriphenylphosphoranes are desired. Acid 464 was activated as an acylimidazoline 
and reacted with methylenetriphenylphosphorane prepared in situ to afford the 
phosphorane ylide 465. The ylide 465 was reacted with isobutyraldehyde 462 and 
benzaldehyde to test the reactivity the phosphorane 465. Isobutyraldehyde 462 did not 
react with phosphorane ylide 465 at refluxing dichloromethane. However, benzaldehyde 
reacted nicely in refluxing benzene with phosphorane 465 to afford the condensation 
product 466 in good yield (76 %). Racemization of the product 466 was not observed. 
Unfortunately, phosphorane ylide 465 did not react with lactol 460a,b in refluxing 
dichloromethane or benzene. 
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Scheme 87. Reagents and conditions: a) CDI, PhH, r.t.; Ph3PCH2Br, PhLi, r.t.; 6 °C → 
r.t., 1 h (54 %); b) 462, CH2Cl2, rfx, 18 h; c) benzaldehyde, PhH, rfx, 45 h (76 %); d) 
lactol 460a,b, CH2Cl2, + 40 °C, 25 h; e) lactol 460a,b, PhH, rfx, 24 h.  
After these rather discouraging results, I started to look for other ways to open the lactol 
ring of 460. Yau and Coward have reported that five membered cyclic lactols can be 
opened using silylating conditions (TBDPSCl, imidazole, DMF, + 50 °C) to afford an O-
silylated aldehyde (131). I employed these conditions for the mixture of lactols 460a,b 
(Scheme 88). The reaction appeared to be sluggish and several portions of imidazole and 
TBDPSCl-reagent were required to drive the reaction to completion. The main product 
was the O-silylated lactol 467. The major side product was the diastereomer 468 of the 
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lactol 460. The five membered lactol ring appeared to be more favorable than the 
aldehyde formation under O-silylating conditions.    
O
HO
460a/b
O
TBDPSO
+
O
HO
467 468
a
1.5:1  
 
Scheme 88. Reagents and conditions: a) TBDPSCl, imidazole, DMF, +50 °C, 22 h (65 
%). 
 
 The chiral auxiliary 41 can be removed to yield hydroxyl sulfones by using sulfur anions 
(55). However, such a cleavage of auxiliaries leads to a longer synthesis route due to 
extra steps for the introduction and removal of the sulfur containing moiety. At this point, 
I decided to consider other methods to prepare bicyclo[4.3.0]nonane aldehydes and the 
results of these experiments are presented in the following chapter. 
  
4.3.2 Organocatalytic asymmetric IMDA 
 
Faced with the problems described above, we turned our attention to the possibility of 
utilizing the recently described organocatalysis in our problem (132). No solid phase 
bound IMDA organocatalysts had been previously described, and achievement of solid 
supported organocatalytic IMDA became our next goal (133).  
To my surprise, results of organocatalytic IMDA has not been reported prior to my work. 
However, MacMillan et al. mentioned in their patent text (134) that their catalysts can be 
used in IMDA cycloadditions, but no experimental details were reported. Therefore, 
different imidazolidinone catalysts were investigated for IMDA cycloaddition. At first, I 
prepared triene aldehyde 470 as a starting material for the IMDA cycloadditions (Scheme 
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89). In order to achieve this, triene ester 443 was reduced with DIBAL-H to triene 
alcohol 469, which was oxidized preferably without isolation to the corresponding 
aldehyde 470 with MnO2. Oxidation required excess of MnO2 to be completed. The triene 
aldehyde 470 was susceptible for polymerization and it was preferably stored in a freezer. 
The linear triene aldehyde 470 was accompanied with inseparable branched aldehyde 
471, which formed in the chain elongation step (see 439→440+441). The ratio of 470 to 
471 depended on the chain elongation step as stated before. 
a BnO OH
BnO O
BnO
CO2Me
b
469
470
443
BnO
O
+
471  
Scheme 89. Reagents and conditions: a) DIBAL-H, CH2Cl2, -78 °C; b) MnO2, CH2Cl2, 
r.t., 24 h (89 % over 2 steps). 
Imidazolidinone catalysts 474-476 (Scheme 90) were prepared according to published 
procedures (135). The stereochemistries of the catalysts 474-476 were confirmed by 
NOE-NMR measurements. The cyclization of the amide 473 produced a diastereomeric 
mixture  of imidazolidinones 474a/b (1:3.1). Unfortunately, the cyclization favored the 
trans-cycloadduct, which was lower in energy. The NOE-NMR showed coupling 
between the protons H2 and H5 in imidazolidinone ring of 474a. It was interesting to 
note that the cis-product 474a did not racemize notably during the long reaction time. 
However, the trans-product 474b was prone to racemization and cycloadduct 474b was 
found to be entirely racemic by chiral HPLC analysis.  
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Scheme 90. Reagents and conditions: a) NaHCO3, CHCl3; b) BnCHO, PTSA, MeOH, + 
75 °C, 4 days (44 %). 
 
I decided to replace the N-methyl group of the organocatalyst 475 with an N-benzyl 
group, because I though that it would make the catalyst more rigid. By rigidifying the 
catalyst structure, the catalyst should give better enantioselectivity by favoring the 
desired reaction path to the cycloadduct. 
2-Amino-3-phenyl-propionic acid methyl ester hydrochloride salt 477 was directly 
amidated with benzylamine in high yield (88 %). The cyclization of 478 produced 18 % 
of the correct diastereomer 479a. The stereochemistry of the catalyst 479a was confirmed 
by NOE-NMR measurement. Consequently, H2 and H5 protons of the imidazolidinone 
ring showed NOE between them. Notable racemization was not observed for the cis-
cycloadduct 479a, however, the trans-cycloadduct 479b was accompanied with 
racemization.  
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Scheme 91. Reagents and conditions: a) BnNH2, EtOH, r.t., 23 h (88 %); b) (Me)3CCHO, 
PTSA, MeOH, rfx, 46 h (56 %). 
 
The starting materials of IMDA cycloadditions were mixtures of linear triene aldehyde 
470 and the inseparable branched triene aldehyde 471 (Scheme 92). The linear triene 
aldehyde 470 was more inclined for polymerization and thus some of the experiments 
were performed with starting materials containing more of the branched triene aldehyde 
471. However, both aldehydes 470 and 471 are capable of forming the iminium ion with 
the amine catalyst. The catalyst loadings were calculated according to the total aldehyde 
amount. The cycloadduct aldehyde 480 was reduced to the corresponding alcohol 481 for 
analytical purposes. The branched triene aldehyde 471 was unable to cycloaddition and 
was thus easily separated from the cycloadduct 480 by flash chromatography. The 
endo/exo selectivities were determined by 1H NMR from the crude product mixtures. The 
chemical shifts of the carbonyl protons of the endo-and exo-cycloadduct aldehydes 480 
differed by about 0.08 ppm’s. 
BnO
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Scheme 92. Reagents and conditions: a) organocatalyst, solvent mixture, acid; b) NaBH4, 
EtOH, r.t. 
The results of the organocatalytic IMDA cycloadditions are presented in the Table 4. 
Catalyst 475 gave highest enantioselectivities (Entry 2, 74 %ee), yields (entry 3, 99 %) 
and endo-selectivities (entries 2, 3, 4 and 7, >99:1) compared to other organocatalysts 
474a, 476 and 474a. Trimethyl oxazolidinone 476, which was chiral only at the C5-
position was found to give low stereoselectivities (Entry 1), although oxazolidinone 476 
is an excellent catalyst for Diels-Alder cycloaddition (135a). The IMDA cycloaddition of 
triene aldehyde 470 was noticed to be solvent dependent. Acetonitrile appeared to be the 
best of the examined solvents for this cycloaddition. However, MeOH afforded 
somewhat higher enantioselectivity (Entries 2 and 3), but an extra step was required for 
acetal cleavage, which was formed from the aldehyde 480 during the reaction. Also, the 
yield of the cycloadduct 480 was lower in MeOH than in acetonitrile. The 
enantioselectivities did not improve significantly using lower temperature (Entries 9 and 
10). Furthermore, the low temperature (-20 °C) retarded the reaction significantly, so that 
the reaction was not complete even after several days of standing. Surprisingly, the 
enantioselectivity was decreased at lower temperature in the reaction catalyzed by 475 
(Entry 3 and 4). In comparison, the enantioselectivity increased slightly, but the endo:exo 
ratio became worse when the reaction was catalyzed by 479a at low temperature (-20 
°C). Although a direct comparison between the co-acids can not be made, because the 
solvent system was also changed, it can be inferred that p-toluene sulphonic acid in 
dichloromethane/iso-propanol afforded worse endo:exo selectivities and 
enantioselectivities than other solvent/acid systems examined (Entries 5 and 11).     
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Table 4. The conditions and results of IMDA reaction of the triene aldehyde 470 
catalyzed by the organocatalysts 474a, 475, 476 and 479a. 
 
Entry Catalysta Temperature Solvent Acid Endo:Exob Yieldc 
(%) 
%e.ed 
1 474a r.t. H2O/CH3CN 0.1 M 
HCl 
>99:1 59 10 
2 475 r.t. H2O/MeOH 0.4 M 
HCl 
>99:1 54 74 
3 475 r.t. H2O/CH3CN 0.1 M 
HCl 
>99:1 99e 72 
4 475 -20 → +6 °C H2O/CH3CN 0.1 M 
HCl 
>99:1 54 66 
5 475 -20 → +6 °C CH2Cl2/i-
PrOH 
PTSA 25:1 45 41 
6 475 -20 → +6 °C H2O/THF TFA - - - 
7 475f r.t. H2O/CH3CN 0.1 M 
HCl 
>99:1 79 72 
8 476 0 °C → r.t. H2O/MeOH 0.4 M 
HCl 
3.3:1 28 - 
9 479a -20 → +6 °C H2O/CH3CN 0.1 M 
HCl 
17:1 40 56 
10 479a r.t. H2O/CH3CN 0.1 M 
HCl 
>99:1 54 47 
11 479a -20 → +6 °C CH2Cl2/i-
PrOH 
PTSA 14:1 38 12 
12 479a -20 → +6 °C H2O/THF TFA - - - 
 
a 20 mol-% of the catalyst was used compared to the calculated sum of total moles of 
aldehydes 470 and 471. b endo:exo ratios were determined by 1H NMR from the aldehyde 
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product mixture. c Yields of isolated pure aldehydes. The yields were correlated to the 
amount of linear aldehyde 470 in the beginning of the reaction. d For determination of the 
ee values, the aldehyde products were first reduced to alcohols with excess NaBH4 in 
EtOH, and the resulting alcohols were analyzed by HPLC using chiral Daicel OD 
column. Absolute and relative configurations were assigned by chemical correlation to 
compounds obtained by known methods for Diels-Alder reactions or by analogy. e The 
ratio of the linear triene aldehyde 470 to the branched triene aldehyde 471 was 1:3.76 in 
this reaction. f A 5.6 mol-% of the catalyst was used in this reaction. 
The proposed mechanism of the organocatalytic IMDA cycloaddition is shown in the 
Scheme 93. Condensation of triene aldehyde 470 with enantiopure amine 482 leads to the 
formation of an iminium ion 483. The iminium ion 483 is active enough to enable 
asymmetric IMDA cycloaddition with the diene part of the molecule. After the 
cycloadduct 484 has formed, the amine catalyst 482 is recovered by hydrolysis and the 
aldehyde cycloadduct 480 is produced. After this, a new catalytic cycle can begin.  
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Scheme 93. Mechanism of organocatalytic IMDA cycloaddition. The represented 
stereochemistry of the cycloadduct 480 is obtained with organocatalyst with (S,S)-
stereochemistry. 
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The different catalytic activity of the catalyst 476 in Diels-Alder reactions compared to 
intramolecular Diels-Alder reactions are propably due to steric hindrance between trans-
methyl group at position 2 of the imidazolidinone ring (see Scheme 90, methyl group at 
position 2 of 476) of the catalyst 476 and the aldehyde 470 -CH2- groups (see Scheme 93, 
carbons (4-6) of 470).  
 
4.4 Preparation of amino alcohol side chain 
 
The following chapters present the results and discussion of preparation of the amino 
alcohol side chain of amaminol A 1 which was prepared using two different origins of 
chirality. The first strategy was based on internal asymmetric induction from the existing 
chiral center of L-alanine 3. Second strategy was based on asymmetric oxyamination 
reaction.  
4.4.1 Chirality derived from L-alanine 
 
L-Alanine 3 was used as the starting material for two different coupling reagents. These 
reagents were phosphonate 413 and phosphorane ylide 465, which were prepared from L-
alanine in just a few steps. The general idea was to bring the chiral amino functionality  
as an α-amino ketone and then chemoselectively reduce the formed double enone to 
obtain the saturated side chain. The final amino alcohol moiety was considered to be 
formed by diastereoselective reduction using internal asymmetric induction of the amino 
group. 
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4.4.1.1 HWE based approach 
 The amino alcohol side chain of amaminol A 1 was connected using a HWE reaction 
between aldehyde 480 and β-keto phosphonate 413. At first, stereoselective reduction of 
485 to amino alcohols 486a,b was studied. Previously prepared α-amino ketone 463 was 
reduced by a method developed by Barrero et al. (136). They have reported that enones 
can be selectively 1,4-reduced with Raney nickel in THF. Raney nickel (type W2) 
reduction of 463 afforded the saturated α-amino ketone 485 in high yield (89 %) 
(Scheme 94). Significant racemization (>96 %ee) of the reduction product was not 
observed by chiral GLC or HPLC analyses. 
Reduction of α-amino ketone 485 to α-amino alcohol 486a,b was studied and several 
reduction systems were employed (Table 5). L-Selectride in THF gave low 1,2-
induction (syn:anti, 3.5:1) in the hydride addition to α-amino ketone 485 (Entry 1), 
although L-Selectride is reported to give high asymmetric induction favoring the 
formation of syn-product for N-(9-phenylfluoren-9-yl) protected 2-amino-1-phenyl-
propan-1-one.(137) The reason for the lower selectivity is probably the greater steric size 
of N-(9-phenylfluoren-9-yl) protection group compared to N-BOC group. The 
stereochemistry of amino alcohols 486a (J1,2 = 5.6-6.6 Hz) and 486b (J1,2 = 2.9-3.5 Hz) 
were established by 1H NMR analysis. The coupling constant J1,2 of 486a was similar to 
the coupling constant J1,2 obtained for syn-amino alcohol 487a. Deuterated methanol was 
found to be the best solvent for 1H NMR analysis of amino alcohols 486a,b and it 
allowed the calculation of the coupling constants. All tested methods favored formation 
of syn-amino alcohol 486a. The reductant prepared from LiAlH4 and axially 
dissymmetric (S)-bi-naphthol ((S)-BINAL-H) (138) was not active reductant for 485 
(Entry 2). Chiral proline based catalyst (139) (D-B-methyl-CBS) was only slightly syn-
selective (Entry 3). The chirality of the α-amino ketone 485 probably overcame the 
chirality of the D-B-methyl-CBS catalyst or the boron of CBS catalyst did not coordinate 
effectively to the carbonyl oxygen. Although titanium tetrachloride is an effective 
chelating agent in the reduction of chiral acyclic γ-amino β-keto ester (140) with borane-
pyridine complex, reduction of α-amino ketone 485 was not observed (Entry 4). Zinc 
bromide is reported to be a good chelating agent in reduction of γ-amino β-keto 
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sulfoxide.(141) Although it has been reported that the stereoselectivity in DIBAL-H 
reduction of γ-amino β-keto sulfoxide can be reversed by adding ZnBr2 as a chelating 
agent, in this case the addition of ZnBr2 to the reduction mixture improved syn-selectivity 
from 3.3:1 to 7.1:1 favoring the formation of amino alcohol 486a (Entries 5,6 and 8). 
Zinc bromide is not very soluble in organic solvents. Fortunately, ZnBr2 dissolves in 
dilute solutions of diethyl ether and THF. Diethyl ether was found to be better solvent 
than THF in the syn-selective reductions including ZnBr2 (Entries 5 and 6). This was 
probably due to lower coordinating ability of diethyl ether to ZnBr2 compared to THF. 
Thus, ZnBr2 was chelating more easily to the substrate. L-Selectride was also employed 
with ZnBr2 and it was noticed that the syn-selectivity was slightly improved even at a 
higher temperature (Entries 1 and 7). Luche conditions (142) afforded also syn-selective 
reduction (syn:anti, 5.3:1) of the α-amino ketone 485 (Entry 9). It was assumed that 
lanthanide salt (CeCl3) coordinated effectively to the substrate affording syn-selective 
reduction. All reaction products were not purified and only conversion of the substrate 
and diastereoselectivity were measured by gas chromatography. The products were 
solids, which enables purification of the syn-product by recrystallization. However, 
recrystallization of the products were not done, because the reactions were run in small 
scale (<0.1 mmol). 
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Scheme 94. Reagents and conditions: a) Raney Ni W2, THF, r.t. (89 %, >96 %ee); b) see 
table 5.  
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Table 5. Diastereoselective reduction of α-amino ketone 485. 
Entry Conditions 486a:486ba Yield (%)b 
1 L-Selectride, THF, -95 °C 3.5 : 1 99 
2 (S)-BINAL-H, THF, -78 °C -> r.t. - - 
3 (D)-B-Me-CBS, THF, -24 °C 1.4 : 1 100c 
4 TiCl4,BH3⋅pyr., THF, -78 °C - - 
5 ZnBr2, DIBAL-H, Et2O, -78 °C 7.1 : 1 77 
6 ZnBr2, DIBAL-H, THF, -78 °C 4.1:1 100c 
7 ZnBr2, THF, L-Selectride, -78 °C 3.8 : 1 95 
8 DIBAL-H, PhMe, -78 °C 3.3:1 99 
9 NaBH4, CeCl3⋅7H2O, MeOH, r.t. 5.3:1 100c 
a The syn:anti ratios were determined by GLC using Supelco γ-DEX 120 column. b 
Yields of isolated, purified amino alcohols 486a,b. c The products were not purified and 
the conversion of the substrate 485 was determined by GLC using Supelco γ-DEX 120 
column. 
It was clear from the results that if high syn-selectivity is desired in the reduction of α-
(N-BOC)-amino ketone 485, the reduction is preferably performed with ZnBr2/DIBAL-
H/diethyl ether combination. However, Luche conditions would probably afford even 
higher selectivities, if the reaction is conducted at lower temperature. 
The assumed Cram’s chelation model (143) of Lewis acid (ZnBr2 or CeCl3) is shown in 
Figure 25. In this model the metal of the Lewis acid (M) is chelated to two carbonyl 
oxygens. One of the chelating oxygens belongs to the target carbonyl and other one to the 
N-BOC carbonyl oxygen. After chelation, the reduction occurs from si-face of the ketone 
485 leading preferably to the formation of the syn-amino alcohol 486a. However, the 
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reduction was slightly syn-selective also without a chelating reagent due to the steric size 
of N-BOC, which blocks the re-face of the ketone 485. 
O NH
O
O
tBu
M
R
H
MeH
 
Figure 25. Chelation model of the reduction of α-amino ketone 485. Ligands of the 
Lewis acid are omitted for clarity. 
Corey et al. (144) has reported that enones can be reducted diastereoselectively with 
trialkylborohydrides if one of face of carbonyl group is blocked with sufficient steric 
bulk. By doing this, it is also possible to control the enone conformation as s-cis in order 
to direct the formation of the desired product. Furthermore, Koskinen group (101g,h) has 
reported that reductions of chiral N-BOC α-amino enones are very dependent on 
reductant and reaction conditions. Although, L-Selectride in THF is found to reduce N-
BOC α-amino enones by favoring the formation of syn product, reduction of unsaturated 
α-amino enone 463 with this system resulted very low diastereoselectivity (Scheme 95). 
The ratio of syn-487a to anti-product 487b was only 1.1:1. 
NHBOC
O
NHBOC
OH
463
a NHBOC
OH
+
1.1:1
487a 487b  
Scheme 95. Reagents and conditions: a) L-Selectride, Et2O, -78°C (92 %). 
 
Model reductions of the double bond of the amino alcohols 487a,b was performed to 
ensure that the allylic double bond can be selectively reduced in the presence of the other 
double bond. Palladium on calcium carbonate was chosen as the catalyst, because it has 
been reported that chemoselectivity is obtained in similar scenarios in synthesis of 
prostanoids (145). Cyclohexene was added to the reaction mixture to study if the reaction 
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was chemoselective towards the allylic double bond of 487a,b. Unfortunately, 
cyclohexene was reduced to cyclohexane and double bond of 487a,b (1.1:1) was reduced 
in high yield (86 %) (Scheme 96).  
NHBOC
OH
487a/b
Pd/CaCO3, H2, 1 atm NHBOC
OH
488a/b
86%
 
Scheme 96. Reagents and conditions: a) cyclohexene, Pd/CaCO3, H2, 1 amt, r.t. (86 %). 
 
HWE reaction of phosphonate 413 with 480 was attempted with three different reaction 
systems. At first, the same reaction system (K2CO3, 94 w-% EtOH) was used as in the 
model reactions with isobutyraldehyde 462 (see Scheme 86). Unfortunately, aldehyde 
480 epimerized during the long reaction period (Scheme 97). Thus the product was a 
mixture of diastereomers 489a,b (1.3:1). Similar epimerization of α-chiral aldehyde is 
also reported by Edmonds and Abell (146). To suppress the epimerization, the 
Masamune-Roush (i-Pr2NEt, LiCl, CH3CN) conditions (147) were examined. However, 
the reaction became so slow that very low conversion was obtained even after 5 days of 
stirring. The conversion of the substrate 480 was about 20 % by 1H NMR. However, the 
epimeric product was not observed in the crude product. HWE coupling between 
aldehyde 480 and phosphonate 413 was also tried by using sodium salt of 
hexamethyldisilazane at –78°C for deprotonation of the phosphonate 413. However, the 
no reaction was observed at –78 °C and the reaction temperature was gradually raised to 
+13 °C. The yield for the product mixture 489a,b was low very low (21 %). At this case, 
the ratio of 489a to 489b was not determined. 
Fortunately, it was possible to separate the diastereomers 489a and 489b by flash 
chromatography. Surprisingly, the product 489a showed double carbon peaks in 13C 
NMR. The reason for this was investigated by analyzing the adduct 489a by 2D NMR 
measurements including COSY, NOESY, HMBC and HSQC. However, a diastereomer 
of the product 489a was not found by these NMR methods. Careful examination of the 
1H NMR spectra of 489a showed two doublet of doublets peak patterns between 7.03-
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6.97 ppm. This corresponds to the proton H(5) as marked in the Scheme 97. The two dd 
patterns were assumed to be due to two different conformations of the acyclic double 
bond (Figure 26). Furthermore, the other product was not separable from 489a by chiral 
HPLC. It was assumed that the extra signals in the 13C NMR spectrum came from a 
conformer of the product 489a. The compound 489a was also analyzed by molecular 
modeling. (MM3 force field, Monte Carlo method, Macromodel 7.0) The energy 
difference between conformers 489a-1 and 489a-2 (Figure 26) was calculated to be 5.8 
kJ/mol, which theoretically means that the conformer 489a-2 should not be observed at 
room temperature, because the energy difference is so large. However, if both conformers 
formed during the HWE coupling reaction and if the energy barrier between conformer 
489a-1 and 489a-2 is so large that conformer 489a-2 does not convert to 489a-2 at room 
temperature, it is possible that the two conformers 489a-1 and 489a-2 exists as a mixture 
at room temperature. The product 489a was analyzed by 1H NMR at higher temperature 
(+50 °C) to see if the other conformer would disappear, but surprisingly this did not 
happen. The product 489a was not crystalline and thus crystal structure analysis was not 
achieved. The ketone 489a was derivatized with p-nitrophenylhydrazine, but no 
crystalline product was not obtained.  
OBn
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NHBOC
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Scheme 97. Reagents and conditions: a) K2CO3, 94 w-% EtOH, r.t., 47 h (79%). 
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Figure 26. Two different conformers obtained by computer-assisted molecular modeling. 
4.4.2 Wittig approach 
 
The amino alcohol fragment of amaminol A 1 was also attempted to be connected by 
Wittig reaction. The previously prepared phosphorane ylide 465 was reacted with cyclic 
aldehyde 480 in refluxing benzene. However, no reaction was observed even after 24 
hours of refluxing (Scheme 98). 
OBn
O
489
NHBOC
P(Ph)3
O
465
a
 
Scheme 98. Reagents and conditions: a) PhH, +90 °C, 24 h. 
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4.4.2.1 Crotonate oxyamination based approach 
 
Another approach to the side chain of amaminol A 1 was designed based on asymmetric 
oxyamination of crotonic acid ester derivatives (Scheme 99). Four different crotyl esters 
491-494 were subjected to Sharpless oxyamination (148). Janda et al. (149) have reported 
that tert-butyl crotonic ester 494 can be oxyaminated with high enantioselectivity in 
acetonitrile. I tried comparable reactions for 491-494 in 1-propanol/water solvent 
mixture, but lower yields for the products were obtained. This was assumed to be due to 
hydrolysis of the substrate and the product. Acetonitrile prevented these side reactions 
effectively and moderate yields for amino alcohol esters 495-498 were obtained. The 
methyl and ethyl ester products 495 and 496 were difficult to separate from the unreacted 
benzylcarbamate and thus yields for pure products are not reported. Isopropyl crotonate 
493 afforded amino alcohol 497 with higher enantioselectivity (91 %ee), but lower yield 
(46 %) compared to the corresponding reaction with t-butyl crotonate 494. Enantiopure 
amino alcohol 498 was obtained by single crystallization from ethyl acetate/hexane (1:4) 
with an overall yield of 39 %. 
O
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O
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O
O
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OH
Cbz
54 % (84 %ee)
O
O
<55% impure
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Scheme 99. Reagents and conditions: a) benzyl carbamate, (DHQ)2PHAL, 
K2OsO2(OH)4, CH3CN-H2O, 1,3-dichloromethylhydantoin, r.t., 30 – 60 min. 
 
The enantiopure amino alcohol 498 was converted to oxazolidine 499 with 2,2-
dimethoxypropane using p-toluenesulfonic acid as the catalyst (Scheme 100).(101f) The 
ester group was selectively reduced with lithium aluminum hydride to oxazolidine 
alcohol 500. The same reaction was also attempted with diisobutylaluminum hydride, but 
a mixture of several products were obtained. Next, the hydroxyl group of 500 was 
converted to a bromine 501 by using carbontetrabromide and triphenylphosphine. The 
bromo derivative 501 was subjected to Arbusov reaction (103) to prepare phosphonate 
reagent for HWE reaction, but unfortunately the bromo derivative 501 was not 
electrophilic enough for the phosphonate formation. Only polymeric compounds were 
obtained because of the high temperature required for the reaction. The alcohol 500 was 
also converted to the iodo derivative 502. The formation of the phosphorane ylide was 
unsuccessful from iodo oxazolidine 502. It was assumed that more a reactive phosphine 
such as tributylphosphine would form a phosphine coupling reagent. However, tributyl 
phosphine did not react with iodo oxazolidine 502.  
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Scheme 100. Reagents and conditions: a) (MeO)2CMe2, PTSA, rfx (83 %); b) DIBAL-H, 
PhMe, -78 °C; c) LiAlH4, THF, 0 °C; d) CBr4, DIPEA, Ph3P, THF, r.t. (75 % over 2 
steps); e) I2, imidazole, Ph3P, CH2Cl2, r.t. (76 %); f) (EtO)3P, 130-140 °C, 46 h; g) Ph3P, 
PhMe, 90 °C, 36 h; h) Bu3P, CH3CN, 0 → 65 °C, 24 h. 
A phenylsulfoxide derivative 504 was prepared by reacting the iodo oxazolidine 502 with 
an excess of sodium salt of phenylsulfoxide 503 in DMF. The phenylsulfoxide derivative 
504 was prepared for a Julia type coupling of the amino alcohol fragment to cyclic 
aldehyde 480.  
N O
I
Cbz
502
+
S
O
O
Na
503
N O
SO2
Cbz76%
DMF, + 50 oC
504  
Scheme 101. Reagents and conditions: a) DMF, 50 °C (76 %). 
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However, the Julia coupling of 480 and 504 was not attempted, because it was assumed 
that the hydroxyl group of the coupling product 505 would be too hindered to be reduced 
to the corresponding E-olefin 506 with sodium amalgam (Scheme 102). The hydroxyl 
group of 505 was assumed to be stabilized by the free electron pairs of oxygens of the 
oxazolidine ring (SE(1)) and benzyloxy chain (SE(2)). Also, a chemoselective reduction 
of allyl alcohol in the presence of disubstituted cis-double bond is not reported or it is 
difficult to achieve according the experiment that I had performed (see Scheme 96). 
O
O
Ph
SO2
Ph
N
O
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Cbz
SE(1)
SE(2)
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O
Cbz
OBn
504 + 480
a b
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506
 
Scheme 102. Reagents and conditions: a) base; b) Na/Hg. 
In order to prevent the interference of an intramolecularly hydrogen bonded hydroxyl 
group, an iodo derivative of alcohol 481 became my next goal (Scheme 103).  However, 
substitution of hydroxyl group of 481 by iodine appeared to be difficult and the reaction 
was not observed even at 85-90 °C. After this, I tried to prepare the mesylate from the 
alcohol 481 to activate the alcohol 481 for iodine substitution, but unfortunately 
mesylation of the alcohol 481 was not observed at room temperature. The alcohol 481 
was analyzed by IR in dry benzene and a weak peak was noticed in the region of 
intramolecular hydrogen-bonding. This provided evidence that the hydroxyl proton was 
indeed hydrogen bonded to the benzylic oxygen, which was assumed to be the reason for 
low reactivity of alcohol 481. The chelated hydroxyl proton was also observed in 1H 
NMR analysis and it appeared at δ 3.35 as an ABX pattern with coupling constants of 9.6 
and 1.7 Hz. These values were obtained in deuterated chloroform solution. 
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Scheme 103. Reagents and conditions: a) I2, imidazole, Ph3P, THF, r.t.; b) I2, imidazole, 
PhMe, 85-90 °C; c) CH3SO2Cl, Et3N, CH2Cl2, r.t. 
4.5 Preparation of the olefinic side chain 
 
I decided to prepare the olefinic side chain of amaminol A 1 by the Julia-Kocienski 
olefination (150). At first, propyl phenyl tetrazolyl sulfone 509 was prepared from 1-
phenyl-1H-tetrazole-5-thiol 507 (Scheme 104). Sulfonation of propanol using the 
Mitsunobu protocol (151) afforded propylsulfine phenyltetrazole 508 in high yield (87 
%). Finally, the coupling reagent 509 was obtained by m-CPBA oxidation of sulfide 508 
with a good yield (83 %). 
N
NN
N SH N
NN
N S N
NN
N S
O2
508507 509
a b
 
Scheme 104. Reagents and conditions: a) 1-PrOH, Ph3P, DEAD, 0 → r.t. (87 %); b) m-
CPBA, NaHCO3, CH2Cl2, r.t. (83 %). 
Model reactions were conducted by reacting phenyltetrazolyl sulfone 509 with 
cyclohexane carboxaldehyde 510 using two different bases. The reported procedure 
(150b) was followed precisely. Potassium hexamethyldisilazane gave a highly E-selective 
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olefination (E:Z, >99:1, measured by 1H NMR from the crude products). Sodium 
hexamethyldisilazane afforded also a very E-selective olefination (E:Z, >92:8) of 
carboxaldehyde 510. The outcome of the reactions differed widely, because the products 
511a,b were highly volatile and they were easily lost during concentration of the product.     
O
+
510
511a 511b
a
b
99 1
92 8  
Scheme 104. Reagents and conditions: a) 509, KHMDS, DME, -60 °C (48 %); b) 509, 
NaHMDS, DME, -60 °C (81 %). 
 
4.6 Elaboration of amaminol A (1) analog 
 
Synthesis towards amaminol A 1 and its analogues was continued by chemoselective 
reduction of the α-amino enone 489a with an excess of Raney nickel W2 (152) (Scheme 
105). The reaction was accompanied by isomerization of the cyclic double bond above 
temperatures of 0 °C. Consequently, the length of the reaction time was essential. After 
the reaction was complete according to TLC analysis, the reaction mixture was rapidly 
filtered through a pad of silica gel to avoid isomerization. Doubling of carbon signals 
were also  noticed in the 13C NMR spectra of 512 as with 489a and this phenomenon was 
observed with the rest of the products after the amino fragment was connected to 480. 
The 1H NMR and 13C NMR determinations of 512 and 513 were also performed at higher 
temperatures (50 °C), but no significant change was observed. After the enone 489a  was 
reduced to the α-amino ketone 512, the carbonyl group was reduced with the previously 
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developed method including diisobutyl aluminum hydride, zinc bromide and diethyl 
ether. The diastereoselectivity of the reduction was high, and the (S,R)-diastereomer was 
not observed by 1H NMR measurement from the crude product 513. The same reaction 
was also repeated with L-Selectride® in ether and a mixture of diastereomers were 
obtained. The crude product was analyzed by 1H NMR and it contained diastereomers 
S,S-513 and S,R in ratio of 2:1. Attempted protection of the hydroxyl group of 513 with 
tert-butyldiphenylsilylchloride and imidazole in DMF (153) solution at 0 → 50 °C 
proved unsuccessful. Silyltriflates (TIPSOTf and TBDMSOTf) reacted well with amino 
alcohol 513 in presence of 2,6-lutidine. However, an excess of silyltriflates also lead to 
reaction of the BOC-group. Sakaitani and Ohfune (154) have also reported that an N-
BOC group reacts to form N-silylcarbamates with 250 mol-% of TBDMSOTf and 100 
mol-% of 2,6-lutidine at room temperature. Thus, formation of the N-silylcarbamate 514 
occurred also at 0 °C, if 300 mol-% of TBDMSOTf and 350 mol-% of 2,6-lutidine were 
used.  
OBn
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Scheme 105. Reagents and conditions: a) Raney Ni W2, THF, 0 °C, 2 h, 0 °C → r.t., 15 
min (89 %); b) ZnBr2, Et2O, 550 mol-% DIBAL-H, -78 °C, 1 h (85 %); c) 300 mol-% 
TBDMSOTf, 350 mol-% 2,6-lutidine, CH2Cl2, 0 °C (97 %); d) 200 mol-% TBDMSOTf, 
250 mol-% 2,6-lutidine, CH2Cl2, 0 °C (80 %). 
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Cleavage of the benzyl group from 515 was attempted with borontrichloride 
dimethylsulfide (BCl3.SMe2) (121), but simultaneous deprotection of the silyl group was 
observed. Deprotection was also attempted with lithium 4,4’-di-tert-butylbiphenyl 
(LiDBBP) (155), but no reaction was observed. The unreactivity of LiDBBP may be also 
due to the small scale, because it was difficult to avoid moisture in the reaction mixture.  
Fortunately, the benzyl group of 515 was selectively removed using Birch reduction 
(156) (Na/NH3) (Scheme 106). The hydroxyl group of 516 was transformed to the 
corresponding aldehyde 517 by Swern oxidation (157). The aldehyde 517 was subjected 
to the Julia-Kocienski olefination (149) with 509 to form the protected olefinic amino 
alcohol 518. Simultaneous cleavage of N-BOC and O-TBDMS groups were obtained by 
hydrolysis with concentrated HCl in dioxane. Traces of amaminol A 1 was found from 
the crude product mixture 519. This observation was due to the formation of 
enantiomeric product of 480 in the organocatalytic IMDA cycloaddition.   
a
OH
OTBDMS
NHBOC
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b
OOTBDMS
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517
518
d
OH
NH2
519
+
OH
NH2
1traces of
515
 
Scheme 106. Reagents and conditions:  a) Na/NH3, THF, -78 °C (56 %); b) (COCl)2, 
DMSO, CH2Cl2, Et3N, -78 °C, 30 min (97 %); c) 509, KHMDS, DME, -55 → -35 → 0 
°C, 5 h (70 %); d) dioxane, 32 w-% HCl, r.t., 3.5 h (58 %).  
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5 Summary 
 
A new method was developed for the preparation of substituted trienes such as benzyloxy 
triene acid methyl ester 443. The new method developed employs inexpensive reagents 
and avoids chromatographic purifications during the first steps of the synthesis. 
The chiral auxiliary induced IMDA cycloaddition gave the correct diastereomer for 
amaminol A 1 synthesis. Difficulties were encountered in removal of the chiral 
oxazolidinone auxiliary from the cycloadduct 455. Debenzylation of 455 lead to 
unavoidable formation of the tricyclic lactone 458. It appeared to be difficult to activate 
the lactone 455 for the introduction of the side chains. The alcohol 481 was surprisingly 
unreactive, because of hydrogen bonding of the hydroxyl group to other side chain 
oxygens.  
A diastereomer 519 of amaminol A 1 can be synthesized using the novel organocatalytic 
IMDA cycloaddition to prepare the easily modifiable intermediate aldehyde 480. 
Unfortunately, the diastereomer 519 of amaminol A 1 was obtained as the final product, 
because the wrong enantiomer of the organocatalyst was used to prepare the aldehyde 
480. However, it may be possible to synthesize amaminol A 1 as the major product, if the 
IMDA cycloaddition step is catalyzed with the (R,R)-organocatalyst. 
 Diastereoselective reduction of α-amino ketone 485 to syn-amino alcohols 486a,b by 
chiral reductants were found to be ineffective. However, α-amino ketone 485 can be 
reduced to α-amino alcohol 486a with good diastereoselectivity using the novel reduction 
method employing achiral reductant (diisobutylaluminum hydride) in the presence of zinc 
dibromide as the coordinating agent in diethyl ether.  
Finally, the diastereomer 519 of amaminol A 1 was synthesized in total 17 steps starting 
from sorbic acid 418.  
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6 Experimental 
 
General: The solvents and starting materials were used as purchased from the 
suppliers unless otherwise noted. Tetrahydrofuran was distilled from sodium 
metal/benzophenone ketyl. Toluene was distilled from metallic sodium. 
Dichloromethane, benzene and chlorobenzene were distilled from calcium hydride. 
Methanol was distilled from Mg(OMe)2. Ethanol was distilled from Mg(OEt)2. Distilled 
water was filtered through Millipore filtration system. The glassware was oven-dried 
(>120 °C) or flame dried in an oil pump vacuum, when dry conditions were required. The 
reactions were performed under a positive atmosphere of argon when necessary. The 
NMR spectra were recorded with a Varian 400-spectrometer (1H NMR, 399.99 MHz, 13C 
NMR 100.58 MHz) and a Bruker Avance DPX400 spectrometer (1H NMR, 400.13 MHz, 
13C NMR 100.62  MHz). Thin layer chromatography was performed on silica mesh 60 
coated aluminium plates. For visualization UV light (254 nm) and ninhydrin, 
phosphomolybdenic acid, anisaldehyde and permanganate solutions was used.  The mass 
spectra were determined on a JEOL JMS-DX303 apparatus (Helsinki University of 
Technology) and LCT, Micromass (ES+) (University of Oulu, Department of Chemistry). 
Flash chromatography was performed with 60 mesh silica. FTIR spectra were measured 
with a Perkin Elmer Spectrum One instrument. The melting points were measured with 
Gallenkamp MFB-595 apparatus and are not corrected. GC was performed with a 
Hewlett-Packard 6810 instrument using Supelco gamma-dex 120 column, 30 m, 0.25 
mm, 0.25 µm film with He as the carrier gas. Gas velocity was 28 cm/sec. FID detector 
was used. For chiral HPLC, Daicel OD column was used (5 x 0.46 cm, 25 x 0.46 cm) 
with UV detection at l = 254 nm, and a flow rate 0.8 mL/min, unless otherwise noted. 
The eluent was a mixture of isopropanol and hexane. 
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6.1 Preparation of triene derivatives 
6.1.1 Acetic acid 6-(tert-butyl-dimethyl-silanyloxy)-hexa-2E,4E-dienyl ester (425) 
 
TBDMSO
OAc
TBDMSO
OH
425520  
 
 
Dry pyridine (8.70 g, 111 mmol, 1000 mol-%) was added into the reaction flask which 
contained 6-(tert-Butyldimethylsilanyloxy)-hexa-2,4-dien-1-ol 520 (2.53 g, 11.1 mmol, 
100 mol-%). Acetic anhydride (11.23 g, 111 mmol, 1000 mol-%) was added, which 
resulted in the formation of an orange solution. After stirring for 3 hours, excess pyridine 
and acetic anhydride (9.6 mL) were evaporated (15-17 mmHg/40-45 °C). The mixture 
was cooled and diluted with ether (100 mL) and washed twice with an ice cold solution 
of 0.5 M H3PO4 (50 mL). The water layer was back extracted with ether (20 mL). The 
combined organic layers were washed again with an ice cold solution of 0.5 M H3PO4 (50 
mL), twice with a 5 w-% solution of NaHCO3 (50 mL) and brine (20 mL). The combined 
water layers from NaHCO3 washes were extracted with ether (50 mL). The layers were 
separated and the organic layer was washed with brine (20 mL). The combined organic 
layers were dried with Na2SO4 and filtered. The solvents were evaporated to give 3.84 g 
of crude product. The crude product was purified by flash chromatography (5% 
EtOAc/C6) to give 425 (2.65 g, 88 %). Rf (15 % EtOAc/C6, E,E-2) = 0.49. 1H NMR 
(CDCl3, 399.99 MHz) δ 6.27 (m, 2H), 5.81 (dt, 1H, J = 14.4, 4.4 Hz), 5.73 (m, 1H), 4.59 
(d, 2H, J = 6.8 Hz), 4.23 (d, 2H, J = 4.2 Hz), 2.07 (s, 3H), 0.91 (m, 9H), 0.07 (m, 6H). 
13C NMR (CDCl3, 100.59 MHz) δ 171.4, 135.0, 134.6, 129.0, 126.5, 65.4, 63.9, 26.6, 
21.6, 19.1, -4.6. FT-IR (thin film) 2956, 2931, 2858, 1744, 1381, 1362, 1232, 1127, 1093, 
960, 837, 777 cm-1. HRMS (EI) calculated for [M-CH3COO] C12H23OSi: 211.1518, found 
211.1535.  
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6.1.2 2-(8-(tert-Butyldimethylsilanyloxy)-octa-4E,6E-diene))-1,3-dioxolane (426) 
 
TBDMSO O
O
TBDMSO
OAc
BrMg O
O
425 426
28
 
 
2-(2-Bromoethyl)-1,3-dioxolane (1.19 g, 6.58 mmol, 205 mol-%) was dissolved in dry 
THF (9.5 mL) and added in small portions into a flask equipped with a reflux condenser, 
which contained magnesium chips (0.26 g, 10.6 mmol, 330 mol-%). Heat generation was 
noticed during the addition and the mixture was stirred for 1 hour. In a separate 2-neck 
flask equipped with an argon balloon, 1-(tert-Butyldimethylsilanyloxy)-hexa-2E,4E-
diene-6-acetate 425 (0.87 g, 3.2 mmol, 100 mol-%) was dissolved in dry THF (4.5 mL).. 
A 0.1 M solution of Li2CuCl4 in THF (1.44 mL, 0.14 mmol, 4.5 mmol-%) was added and 
the resulting mixture was immersed in a cooling bath (acetone/ice) at –15 °C. The freshly 
prepared Grignard solution from above was added dropwise with a syringe into the 
orange reaction mixture. The colors of the reaction mixture changed during the addition 
in a following sequence: orange-brown-green-yellow/green-brown-purple red. The 
reaction was followed by TLC (20 % MTBE/hexane, PMA). After the addition, which 
took 45 minutes, the purple solution was immersed in an ice bath for 2.5 hours. At this 
time period, the reaction mixture turned yellowish. The reaction mixture was diluted with 
ether (25 mL) and washed with a saturated solution of NH4Cl (2 x 10 mL). pH of the 
NH4Cl solution was adjusted to 10 with NH4OH before washings. The layers were 
separated and the water layer was extracted three times with ether (30, 20, 10 mL). The 
organic layer was separated and dried with Na2SO4 overnight. The organic layer was 
filtered and the solvents were evaporated to give 1.09 g of yellow liquid. The crude 
product was purified by a gradient flash chromatography (5 %, 10 %, 100 % MTBE/ 
hexane) to give 426 (0.55 g, 55 %) as a clear oil. Rf (20 % MTBE/ hexane) = 0.28. 1H 
NMR (CDCl3/TMS, 399.99 MHz) δ 6.21-6.01 (m, 2 H), 5.68-5.61 (m, 2 H), 4.85 (t, 1 H, 
J = 4.8 Hz), 4.19 (d, 2 H, J = 5.2 Hz), 3.98-3.92 (m, 2 H), 3.89-3.83 (m, 2 H), 2.11 (q, 2 
H, J = 7.2 Hz), 1.70-1.64 (m, 2 H), 1.56-1.49 (m, 2 H), 0.92-0.88 (m, 9 H), 0.08 – 0.06 
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(m, 6 H). 13C NMR (CDCl3, 100.59 MHz) δ 134.4, 131.1, 130.9, 130.8, 105.2, 65.5, 64.3, 
34.0, 33.1, 26.7, 24.3, 19.1, -4.8. LRMS (EI) 312, 255, 211, 173, 137, 119, 93, 75, 73 
(100). HRMS (EI) calculated for C17H32O3Si : 312.2121, found 312.2029. 
6.1.3 2-(Octa-4E,6E-dien-8-ol)-1,3-dioxolane (427) 
 
HO O
O
TBDMSO O
O
426 427  
 
2-(8-(tert-Butyldimethylsilanyloxy)-octa-4E,6E-diene)-1,3-dioxolane 426 (0.13 g, 0.41 
mmol, 100 mol-%) was dissolved in acetone (7.5 mL). para-Toluenesulfonic acid 
monohydrate (12 mg, 0.06 mmol, 15 mol-%) and H2O (0.2 mL) were added to the 
mixture. The mixture was stirred at room temperature and followed by TLC (30 % 
MTBE/hexane, PMA). Stirring was continued for 35 minutes until the starting material 
had disappeared. An ice cold solution of NaHCO3 (5 mL) was added and stirring was 
continued for 5 minutes. The product was diluted with ether (35 mL). The layers were 
separated and the water layer was extracted with ether (3 x 15 mL). The combined 
organic layers were washed with water (5 mL) and brine (5 mL). The organic layer was 
dried with MgSO4 for 30 minutes and the solvents were evaporated to give 0.125 g of 
clear oil. The crude product was purified by flash chromatography (25 % EtOAc/hexane) 
to yield 427 (60 mg, 74%) as a clear oil. Rf (50% EtOAc/hexane) = 0.27. 1H NMR 
(CDCl3/TMS, 399.99 MHz) δ 6.22-6.05 (m, 2 H), 5.75-5.67 (m, 2 H), 4.86 (t, 1 H, J = 
4.7 Hz), 4.16 (d, 2 H, J = 5.3 Hz), 3.97-3.95 (m, 2 H), 3.86-3.83 (m, 2 H), 2.14 (q, 2 H, J 
= 7.0 Hz), 1.67-1.64 (m, 2 H), 1.57-1.49 (m, 2 H), 1.40 (s, 1 H). 13C NMR (CDCl3, 
100.59 MHz) δ 135.3, 132.3, 130.3, 130.1, 104.8, 65.3, 63.9, 33.7, 32.8, 23.9. LRMS (EI) 
198, 181, 167, 110, 99, 82, 73(100), 55. HRMS (EI) calculated for C11H18O3: 198.1256, 
found 198.1256.   
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6.1.4 Methyl 6-bromohexa-2E,4E-dienoate (429) 
 
O
O
O
O
Br
428 429  
 
Methyl sorbate 428 (3.16 g, 25 mmol, 100 mol-%) was dissolved in chlorobenzene (21 
mL) in an oven dried. flask. N-Bromosuccinimide (NBS) (4.63 g, 26 mmol, 104 mol-%) 
was added into the reaction mixture. The reaction flask was equipped with a reflux 
condenser and was warmed in an oil bath (110 °C) for 15 minutes and benzoyl peroxide 
(0.28 g, 1.2 mmol, 4.6 mol-%) was added in a small portions. The oil bath temperature 
was raised to 150 °C and the reaction mixture was stirred vigorously. The reaction was 
followed by TLC (60 % MTBE/hexane). At 135 °C, NBS dissolved totally into the 
yellow reaction mixture. After 1 hour at 150 °C (oil bath temperature), the reaction 
mixture had changed to brown. After 2 hours, the reaction mixture was allowed to cool to 
room temperature. The reaction was not complete by TLC. Chlorobenzene was 
evaporated (15 mmHg/45-50 °C). Some of the product had evaporated with 
chlorobenzene. Chlorobenzene, which contained some product was mixed with the rest of 
the product mixture. Ether (100 mL) was added and the mixture was washed with a 5 w-
% NaOH solution (10 x 20 mL). The organic phase was dried with MgSO4, filtered and 
concentrated by evaporation. Chlorobenzene was distilled from the crude product under 
reduced pressure (30-32 °C/12-14 mmHg). The crude product was analyzed by 1H NMR. 
The ratio of compounds (6-bromo 429: anti-dibromo 430:syn-dibromo 431:methyl 
sorbate 428) was (5.23 : 1.64 : 1 : 2.89). The impure product fractions were combined to 
give 2.85 g of yellow oil (70-100 °C/0.2 mmHg). Rf 429 (30% MTBE/C6) = 0.43. 1H 
NMR of 429 (CDCl3/TMS, 400.13 MHz) δ 7.27 (dd, 1 H, J = 15.6, 10.8 Hz), 6.43-6.36 
(m, 1 H), 6.28-6.22  (m, 1 H), 5.94 (d, 1 H, J = 15.5 Hz), 3.76 (s, 3 H). LRMS (EI) 205, 
173, 147, 125, 111, 93, 79, 66 (100). Ref: (108) 
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6.1.5 Methyl 6-hydroxyhexa-2E,4E-dienoate (435) 
 
O
O
Br
O
O
HO
429 435  
 
Impure methyl 6-bromohexa-2E,4E-dienoate 429 12 (0.92 g) was dissolved in acetone 
(12 mL) and a saturated solution of NaHCO3 (8 mL) was added. A yellowish slurry was 
formed. The reaction flask was equipped with a reflux condenser and a magnetic stirring 
bar. The reaction mixture was refluxed until TLC (30 % MTBE/hexane) showed the 
absence of the starting material. Refluxing was continued for 3 hours and 3 drops of 5 w-
% HCl solution was added to neutralize the mixture. Acetone was evaporated and 20 mL 
of EtOAc was added. The layers didn’t separate and thus H2O (5 mL) was added. The 
layers were separated and the water layer was extracted with EtOAc (3 x 20 mL). The 
combined organic layers were washed with brine (2 x 15 mL), dried overnight with 
Na2SO4, filtered and concentrated to give 0.45 g of yellow oil. The crude product was 
purified by a flash chromatography (25% EtOAc/hexane) to yield a white solid (0.27 g, 
42 %). Mp. = 56-58 °C. Rf (50% EtOAc/hexane) = 0.20. 1H NMR (CDCl3/TMS, 400.13 
MHz) δ 7.34-7.27 (m, 1 H), 6.46-6.39 (m, 1 H), 6.27-6.21  (m, 1 H), 5.90 (d, 1 H, J = 
16.0 Hz), 4.31 (d, 2 H, J = 4.0 Hz), 3.77 (s, 3 H), 1.7 (br s, 1H). 13C NMR (CDCl3, 
100.62 MHz) 168.1, 144.6, 141.8, 128.4, 121.6, 63.3, 52.3. LRMS (EI) 142, 113, 98, 
81(100), 55. Ref: (108) mp. = 52-54 °C. 
6.1.6 6-Benzyloxy-hexa-2E,4E-dienoic acid methyl ester (437) 
 
O
O
HO
O
O
BnO
435 437  
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Benzyl alcohol (0.649 g, 6.00 mmol, 536 mol-%) was dissolved in dry CH2Cl2 (5 mL) in 
a dry argon flushed flask and 2,6-dimethylpyridine (0.643 g, 6.00 mmol, 536 mol-%) was 
added. A second dry argon flushed flask was charged with methyl 6-hydroxyhexa-2E,4E-
dienoate 435 (0.160 g, 1.12 mmol, 100 mol-%), dry CH2Cl2 (9 mL) and 2,6-di-
methylpyridine (0.484 g, 4.52 mmol, 404 mol-%). A third dry argon flushed flask was 
charged with dry CH2Cl2 (15 mL) and trifluoromethanesulfonic anhydride (1.693 g, 6.00 
mmol, 536 mol-%). The third flask was cooled to –78 °C with a cooling bath 
(acetone/CO2(s)). After this, the contents of the first flask were transferred into the cooled 
flask dropwise. The addition took 10 minutes and the reaction was followed by TLC (50 
% EtOAc/hexane). Stirring was continued for 25 minutes and the reagents from the 
second  flask were transferred dropwise into the reaction mixture. The addition took 15 
minutes. Stirring was continued for 40 minutes at -78 °C and then the reaction mixture 
was immersed into a cooling bath at – 25 °C (ethylene glycol/CO2). After stirring for 1.5 
hours, pyridine (2 mL) was added followed by H2O (10 mL). The organic layer was 
washed with H2O (2 x 10 mL). The organic phase was stored in a refrigerator over 
weekend. The organic phase was dried with Na2SO4, filtered and concentrated to give 
2.62 g of yellow oil. The crude product was purified by flash chromatography (5 % 
EtOAc/hexane) to give 437 (0.244 g, 93%) as a clear oil. Rf (25% EtOAc/hexane) = 0.35. 
1H NMR (CDCl3/TMS, 400.13 MHz) δ 7.36 (m, 6 H), 6.46-6.39 (m, 1 H), 6.22-6.15  (m, 
1 H), 5.89 (dt, 1 H, J = 15.4, 0.7 Hz), 4.55 (s, 2 H), 4.14 (dd, 2 H, J = 5.2, 1.6 Hz), 3.75 
(s, 3 H). 13C NMR (CDCl3, 100.62 MHz) 168.1, 144.7, 139.4, 138.5, 129.8, 129.1, 128.5, 
128.4, 121.7, 73.3, 70.3, 52.2. Ref: (108). 
6.1.7 1-Benzyloxy-6-hydroxyhexa-2E,4E-diene (438) 
 
O
O
BnO
OH
BnO
437 438  
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Methyl 6-benzyloxyhexa-2E,4E-dienoate 437 (8.15 g, 35.1 mmol, 100 mol-%) was 
dissolved in dry toluene (250 mL) and the resulting mixture was cooled to –75 °C (ethyl 
acetate/N2). A 1 M solution of diisobutylaluminum hydride in toluene (110 mL, 110 
mmol, 314 mol-%) was added dropwise in portions (30 mL) to keep the inside 
temperature between –70 – 75 oC. After stirring for 10 minutes, acetone (6 mL) and 
MeOH (2 mL) were added to quench the reaction. The reaction mixture was poured into a 
beaker, which contained 1 M solution of HCl (300 mL) The mixture was stirred for 15 
minutes. The layers were separated and the water layer was extracted with ether (3 x 200 
mL). The combined organic layers were washed twice with brine (150, 100 mL), dried 
with Na2SO4 and filtered. The solvents were evaporated to give 7.7 g of clear oil. The 
crude product was purified by flash chromatography (20% EtOAc/hexane) to yield 438 
(0.80 g, 80%) as a clear oil. Rf (25% EtOAc/hexane) = 0.11. 1H NMR (CDCl3/TMS, 
400.13 MHz) δ 7.35 – 7.26 (m, 5 H), 6.32-6.23 (m, 2 H), 5.87-5.78  (m, 2 H), 4.52 (s, 2 
H), 4.18 (t, 2 H, J = 5.5 Hz), 4.06 (d, 2 H, J = 5.4 Hz). 13C NMR (CDCl3, 100.62 MHz) 
138.9, 133.1, 132.6, 131.2, 130.6, 129.1, 128.4, 128.3, 72.8, 70.9, 63.9. LRMS (EI) 204, 
186, 169, 160, 130, 107, 97, 83(100), 69, 55. HRMS (EI) calculated for C13H16O2: 
204.1150, found 204.1166. 
6.1.8 1-Acetoxy-6-benzyloxyhexa-2E,4E-diene (439) 
 
OH
BnO
OAc
BnO
438 439  
 
1-Benzyloxy-6-hydroxyhexa-2E,4E-diene 438 (0.71 g, 3.5 mmol, 100 mol-%) was 
dissolved in pyridine (2.75 g, 34.7 mmol, 1000 mol-%) and acetic anhydride (3.54 g, 34.7 
mmol, 1000 mol-%) was added. The orange reaction mixture was followed by TLC (50 
% EtOAc/hexane) and stirred for 2 hours. Excess pyridine and acetic anhydride was 
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distilled from the reaction mixture (24-40 °C/9-10 mmHg). The distillation residue was 
diluted with ether (30 mL) and washed with a 0.5 M solution of H3PO4 (15 mL). The 
layers were separated and the water layer was extracted with ether (10 mL). The 
combined organic layers were washed with brine (10 mL), dried with Na2SO4 and 
filtered. The evaporation of the solvents gave 1.0 g of yellow oil. The crude product was 
purified by flash chromatography (10% EtOAc/hexane) to give 439 (0.78 g, 91%) as a 
clear oil. Rf (50% EtOAc/hexane) = 0.57. 1H NMR (CDCl3/TMS, 400.13 MHz) δ 7.28-
7.26 (m, 5 H), 6.34-6.24 (m, 2 H), 5.88-5.73  (m, 2 H), 4.60 (d, 2 H, J = 6.2 Hz), 4.52 (s, 
2 H), 4.07 (d, 2 H, J = 5.5 Hz), 2.07 (s, 3 H). 13C NMR (CDCl3, 100.62 MHz) 171.4, 
138.9, 134.2, 132.0, 131.9, 129.1, 128.4, 128.3, 127.5, 72.9, 70.8, 65.3, 21.6. LRMS (EI) 
246, 235, 220, 202, 168, 155, 142, 130, 108, 91, 79, 67(100), 51. HRMS (EI) calculated 
for C15H18O3: 246.1256, found 246.1258. 
6.1.9 2-(8-Benzyloxyocta-4E,6E-diene)-1,3-dioxolane (440) 
 
OAc
BnO
BnO
BrMg O
O28
439
440
BnO
OOOO
+
441  
 
Grignard reagent 28 was prepared as follows. 2-(2-Bromoethyl)-1,3-dioxolane 28 (1.12 g, 
6.19 mmol, 205 mol-%) was diluted with dry THF (9 mL). This mixture was added into a 
flask equipped with a reflux condenser, which contained magnesium chips (0.24 g, 9.97 
mmol, 330 mol-%). The addition was done in portions to avoid over boiling of THF. 
Stirring was continued for 60 minutes. 1-Acetoxy-6-benzyloxyhexa-2E,4E-diene 439 
(0.74 g, 3.02 mmol, 100 mol-%) was dissolved in dry THF (4 mL) and a 0.1 M solution 
of Li2CuCl4 (1.4 mL, 0.14 mmol, 4.5 mol-%) in THF was added. This resulted formation 
of orange mixture. The Grignard reagent was added in portions into the reaction flask. 
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The color of the reaction mixture changed in the following order: orange-brown-green-
yellow-brown-purple. The addition took 35 minutes. The reaction was followed by TLC 
(50 % EtOAc/hexane). The reaction mixture was immersed in an ice bath. Stirring was 
continued for 1.5 hours and after this, the reaction mixture was allowed to warm to r.t. 
Stirring was continued for 14 hours and the reaction mixture was diluted with ether (25 
mL). The mixture was washed with a saturated solution of NH4Cl (2 x 10 mL), which 
was made basic (pH ≈ 8) with NH4OH before use. The combined water layers were 
extracted once with ether (20 mL). The combined organic layers were washed with brine 
(15 mL), dried with Na2SO4 and filtered to give 1.0 g of yellowish oil. The crude product 
was purified by flash chromatography (10 % MTBE/hexane) to yield 440/441 (0.57 g, 
65%) as a clear oil. The ratio of 440/441 was (84:16). The products 440/441 were 
inseparable by flash chromatography. Rf 440/441 (20% MTBE/hexane) = 0.25. 1H NMR 
440 (CDCl3/TMS, 400.13 MHz) δ 7.35-7.26 (m, 6 H), 6.23 (dd, 1 H, J = 14.8, 10.4  Hz), 
6.07 (dd, 1 H, J = 14.7, 10.2  Hz), 5.69 (dt, 2 H, J = 14.7, 7.0 Hz), 4.86 (t, 1 H, J = 4.6 
Hz), 4.51 (s, 2 H), 4.04 (d, 2 H, J = 6.6 Hz), 3.96-3.94 (m, 2 H), 3.86-3.83 (m, 2 H), 2.14 
(q, 2 H, J = 7.5 Hz), 1.70-1.64 (m, 2 H), 1.57-1.49 (m, 3 H). 13C NMR (CDCl3, 100.62 
MHz) 139.1, 135.5, 134.0, 130.7, 129.0, 128.5, 128.2, 127.9, 105.1, 72.6, 71.2, 65.5, 
34.0, 33.1, 24.2. LRMS (EI) 287, 197, 181, 153, 99, 91(100), 73, 65, 51. HMRS (EI+) 
calculated for C18 H24O3Na: 311.1628, found 311.1623.  
6.1.10 9-Benzyloxynona-5E,7E-dien-1-al (442) 
 
BnO O
O
BnO O
440 442  
 
2-(8-Benzyloxyocta-4E,6E-diene)-1,3-dioxolane mixture 440/441 (2.49 g, 8.64 mmol, 
100 mol-%) was dissolved in acetone (150 mL) and a 0.5 M solution of HCl (150 mL) 
was added. The reaction mixture was stirred for 17 hours at r.t. The reaction was 
followed by TLC (40 % MTBE/hexane, ninhydrin) and a small samples were worked up 
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and analyzed by 1H NMR during the reaction. The mixture was diluted with ether (200 
mL) and the layers were separated. The water phase was extracted with ether (100, 50 
mL). The combined organic phases were washed with brine (150 mL), dried with 
MgSO4, filtered and concentrated to give 2.7 g of  the product as an oil. The crude 
product was purified by flash chromatography (13 % MTBE/hexane) to yield 442 (1.84 
g, 87 %) as a clear oil. Rf (40 % MTBE/hexane) = 0.34. 1H NMR (CDCl3/TMS, 400.13 
MHz) δ 9.78 (s, 1 H), 7.35-7.33 (m, 5 H), 7.29-7.25 (m, 1 H), 6.95 (dt, 1 H, J = 15.7, 7.0  
Hz), 6.23 (dd, 1 H, J = 15.2, 10.4  Hz), 6.06 (dd, 1H, J = 15.0, 10.4 Hz), 5.82 (dt, 1 H, J = 
15.5, 1.6 Hz), 5.72-5.62 (m, 2 H), 4.51 (s, 2 H), 4.04 (d, 2 H, J = 6.3 Hz), 3.72 (s, 3 H), 
2.20 (qd, 2 H, J = 7.2, 1.5 Hz), 2.11 (q, 2 H, J = 7.0 Hz), 1.56 (q, 2 H, J = 7.4 Hz). 13C 
NMR (CDCl3, 100.62 MHz) 203.0, 139.0, 134.3, 133.5, 131.4, 129.1, 128.5, 128.4, 
128.3, 72.7, 71.1, 43.8, 32.5, 22.2. LRMS (EI+) 244, 200, 181, 170, 153, 135, 107, 91, 
81(100), 65. HRMS (EI+) calculated for C16H20O2: 244.1463, found 244.1468. 
6.1.11 11-Benzyloxyundeca-2E,7E,9E-triene methyl ester (443) 
 
BnO O BnO OMe
O
442 443  
 
9-Benzyloxynona-5E,7E-dien-1-al 442  (133 mg, 0.55 mmol, 100 mol-%) was dissolved 
in dry CH2Cl2 (2 mL) and methyl (tri-phenyl-phosphoranylidene) (195 mg, 0.58 mmol, 
105 mol-%) was added The reaction was followed by TLC (40 % MTBE/hexane, PMA). 
The reaction mixture was stirred for 21 hours at r.t. At this point, a second portion of 
methyl (tri-phenyl-phosphoranylidene) (18 mg, 0.055 mmol, 10 mol-%) was added. 
Stirring was continued for 2 hours and the mixture was diluted with CH2Cl2 (10 mL). The 
mixture was washed with brine (5 mL) and the layers were separated. The water layer 
was extracted once with EtOAc (5 mL) and the combined organics were dried with 
Na2SO4, filtered and the solvents were evaporated to give 161 mg of yellow oil. Hexane 
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(5 mL) was added and the mixture was stirred vigorously for 30 minutes. The white 
precipitate was filtered and washed with hexane (2 x 5 mL). The solvents were 
evaporated to give 161 mg of clear oil. The crude product was purified by flash 
chromatography (7 % MTBE/hexane) to yield 443 (33 mg, 80 %) as a clear oil. Rf (50 % 
MTBE/hexane) = 0.51. 1H NMR (CDCl3/TMS, 400.13 MHz) δ 7.34-7.26 (m, 5 H), 6.23 
(dd, 1 H, J = 15.2, 10.6  Hz), 6.07 (dd, 1 H, J = 15.0, 10.6  Hz), 5.66 (m, 2 H), 4.51 (s, 2 
H), 4.04 (d, 2 H, J = 6.2 Hz), 2.44 (td, 2 H, J = 7.4, 1.7 Hz), 2.14 (q, 2 H, J = 7.2 Hz), 
1.74 (q, 2 H, J = 7.3 Hz). 13C NMR (CDCl3, 100.62 MHz) 167.5, 149.5, 138.8, 134.5, 
133.4, 130.7, 128.8, 128.2, 121.6, 72.6, 71.0, 51.8, 32.3, 32.0, 28.3, 27.3, 23.1. LRMS 
(EI+) 299 (M-1), 209, 181, 165, 136, 105, 91(100), 81, 67, 55. HRMS (EI+) calculated 
for C19H24O3: 300.1726, found (M-1) 299.1733. The yield of 2Z,7E,9E-isomer of the 
product was 11 mg (6%). 
6.1.12 11-Benzyloxyundeca-2E,7E,9E-triene acid (444) 
 
BnO OMe
O
BnO OH
O
443 444  
 
11-Benzyloxyundeca-2E,7E,9E-triene methyl ester 443 (133 mg, 0.44 mmol, 100 mol-%) 
was dissolved in THF (2 mL) and a 1 M solution of NaOH (7 mL) was added. The 
reaction was followed by TLC (40% MTBE/hexane, PMA). The reaction mixture was 
stirred for 16 hours at r.t. After this, the reaction mixture was immersed in an oil bath to 
60-70 oC. Stirring was continued for 3 hours and the mixture was diluted with ether (10 
mL). The layers were separated and the water layer was extracted with ether (20 mL). 
The aqueous layer was acidified with 5 M HCl until the pH was 1-2. The aqueous was 
extracted with CH2Cl2 (2 x 10 mL). The combined organics were dried with Na2SO4. 
Na2SO4 was filtered and the solvents were evaporated to give 444 (97 mg, 77%) as a 
yellow oil. Rf (50% EtOAc/hexane) = 0.18. 1H NMR (CDCl3/TMS, 400.13 MHz) δ 7.35-
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7.26 (m, 5 H), 7.06 (dt, 1 H, J = 15.7, 6.8 Hz), 6.23 (dd, 1 H, J = 14.7, 10.4 Hz), 6.07 (dd, 
1 H, J = 15.0, 10.8 Hz), 5.83 (dt, 1 H, J = 15.7, 1.5 Hz), 5.74-5.62 (m, 2 H), 4.51 (s, 2 H), 
4.05 (dd, 2 H, J = 6.2, 0.9 Hz), 2.25 (qd, 2 H, J = 7.2, 1.6 Hz), 2.13 (q, 2 H, J = 7.2 Hz), 
1.58 (q, 2 H, J = 7.5 Hz). 13C NMR (CDCl3, 100.62 MHz) 172.4, 152.4, 134.7, 133.7, 
131.1, 129.0, 128.3, 121.6, 72.8, 71.1, 32.6, 32.3, 28.0. LRMS (EI+) 285 (M-1), 195, 
181, 165, 141, 119, 105, 91(100), 79, 67, 55. HRMS (EI+) calculated for C18H22O3: 
286.1569, found 286.1572.    
6.1.13 11-Benzyloxy-undeca-2E,7E,9E-trien-1-ol (469) 
 
BnO OHBnO OMe
O
443 469  
 
11-Benzyloxy-undeca-2,7,9-trienoic acid methyl ester 443 (0.352 g, 1.17 mmol, 100 mol-
%) was dissolved in dry CH2Cl2 (10 mL) and cooled to – 78 °C. DIBAL-H (3.6 mL, 3.60 
mmol, 308 mol-%) was added dropwise. Stirring was continued for 70 minutes and 
MeOH (1 mL) was added to quench the reaction. The mixture was allowed to warm to 0 
°C. After 10 minutes of stirring, a 1 M solution of HCl (10 mL) was added and stirring 
was continued at room temperature for 30 minutes. The layers were separated and the 
water layer was extracted with ether (3 x 10 mL). The combined organics were washed 
with brine (10 mL), dried with Na2SO4, filtered and concentrated to give 0.332 g of 469 
as a clear oil. The product was was pure enough for the next reaction. Rf (40 % MTBE in 
hexanes) = 0.16. 1H NMR (CDCl3, 400.132 MHz) δ 7.34 – 7.26 (m, 7 H), 6.23 (dd, 1 H, J 
= 15.0, 10.5 Hz), 6.06 (dd, 1 H, J = 15.1, 11.0 Hz), 5.72 – 5.65 (m, 4 H), 4.51 (s, 2 H), 
4.09 (br s, 2 H), 4.04 (d, 2 H, J = 6.3 Hz), 2.13 – 2.03 (m, 4 H), 1.52 – 1.45 (m, 2 H). 13C 
NMR (CDCl3, 100.62 MHz) δ 139.0, 135.6, 134.0, 133.5, 130.6, 130.0, 129.0, 128.4, 
128.2, 127.8, 72.7, 71.2, 64.4, 32.7, 32.3, 29.3. LRMS (EI+) 271 (M-1), 197, 181, 165, 
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129, 119, 105, 91(100), 79, 67, 55. HRMS (EI+) calculated for C18H24O2: 272.1776, 
found 272.1786.  
6.1.14 11-Benzyloxy-undeca-2E,7E,9E-trienal (470) 
 
BnO OBnO OH
469 470  
 
Crude 11-Benzyloxy-undeca-2,7,9-trien-1-ol 469 (0.313 g, 1.15 mmol, 100 mol-%) was 
dissolved in CH2Cl2 (20 mL) and MnO2 (0.600 g, 6.9 mmol, 600 mol-%) was added. 
Stirring was continued for 15 hours and a second portion of MnO2 (0.102 g, 1.17 mmol, 
102 mol-%) was added. Stirring was continued for 3.5 hours and a third portion of MnO2 
(0.298 g, 3.43 mmol, 298 mol-%) was added. Stirring was continued for 5 hours and the 
reaction mixture was filtered through a thin pad of Celite. The product was concentrated 
to give 0.461 g of yellowish oil. The crude product was purified by flash chromatography 
(14 % MTBE/hexane) to yield 470 (0.264 g, 89 % over 2 steps) as a clear oil. Rf (40 % 
MTBE in hexanes) = 0.22. 1H NMR (CDCl3, 400.132 MHz) δ) 9.51 (d, 1 H, J = 7.8 Hz), 
7.35 – 7.26 (m, 5 H), 6.83 (dt, 1 H, J = 15.6, 6.8 Hz), 6.24 (dd, 1 H, J = 14.8, 10.8 Hz), 
6.15 – 6.04 (m, 2 H), 5.75 – 5.61 (m, 2 H), 4.51 (s, 2 H), 4.05 (d, 2 H, J = 6.0 Hz), 2.34 
(qd, 2 H, J = 7.3, 1.4 Hz), 2.15 (q, 2 H, J = 7.3 Hz), 1.62 (q, 2 H, J = 7.3 Hz). 13C NMR 
(CDCl3, 100.62 MHz) δ 194.7, 158.9, 140.8, 139.0, 136.0, 134.4, 133.8, 133.5, 131.2, 
129.0, 128.3, 72.7, 71.1, 32.7, 32.6, 28.0. LRMS (EI+) 270, 180, 105, 91(100), 79, 65. 
HRMS (EI+) calculated for [M-43] 227.1435, found 227.1491. 
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6.2 Chiral auxiliary induced preparation of bicyclo[4.3.0]nonene 
derivatives and their reactions 
6.2.1 (3aR’,9bS’)-3a,4,5,9b-Tetrahydro-1H-naphtho[1,2-l]oxazol-2-one (449) 
 
HN
O
O
446 449
O
NH
O
+
450  
 
Urethane (0.552 g, 6.2 mmol, 310 mol-%) was dissolved in 1-PrOH (8 mL). NaOH 
(0.244 g, 6.1 mmol, 305 mol-%) in H2O (15 mL) was added, which was followed by t-
BuOCl (0.669 g, 6.1 mmol, 305 mol-%) and H2O (5 mL). After 5 minutes of stirring, the 
reaction mixture was immersed in an ice bath and (DHQD)2PHAL (83 mg, 0.1 mmol, 5 
mol-%) in 1-PrOH (7 mL) was added. The reaction mixture was homogeneous at this 
point. 1,2-Dihydronaphthalene 446 (0.262 g, 2.0 mmol, 100 mol-%) in 1-PrOH (5 mL) 
was added to the reaction mixture. This was followed by K2OsO2(OH)4 (31 mg, 0.08 
mmol, 4 mol-%). The reaction was followed by TLC (25 % EtOAc/hexane). At first, the 
reaction mixture was green. After 1.5 hours of stirring, the reaction mixture was taken to 
r.t. After 30 minutes of stirring, the color of the mixture turned to yellow and the 
complete formation of amino alcohols were noticed by TLC. After 2 hours and 15 
minutes of stirring, NaOH (0.318 g, 7.8 mmol, 390 mol-%) was added. This resulted in a 
slow formation of black/brown mixture. After 4.5 hours of stirring, the amino alcohols 
had disappeared and the reaction mixture was red. H2O (20 mL) was added and the 
mixture was extracted with EtOAc (3 x 20, 15 mL). The combined organic layers were 
washed with brine (50 mL), dried with MgSO4 and filtered. The solvents were evaporated 
to give 0.79 g of brown oil. The crude product was purified by flash chromatography (50 
% EtOAc/hexane) to yield 449 (0.205 g, 54%, 78 %ee) and  450 (0.134 g, 37%, 79 %ee). 
A part of the product 449 (76 mg) was recrystallized from boiling CH2Cl2 (3 mL) to yield 
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449 (41 mg, 54%, >99 %ee). Mp. 182-186 °C. [α]D20 = -217.9 (c 0.94 , CHCl3). The 
HPLC retention times were (449) = 21.2 min and it’s enantiomer was 28.0 min. The 
retention time of product 450 was 27.6 min and it’s enantiomer 31.9 min. Rf 449 (50% 
EtOAc/hexane) = 0.15. 1H NMR 449 (CDCl3/TMS, 400.13 MHz) δ 7.26-7.15 (m, 4 H), 
6.39 (s, 1 H), 5.16-5.12  (m, 1 H), 4.94 (d, 1 H, J = 8.3 Hz), 2.95-2.91 (m, 1 H), 2.64-2.60 
(m, 1 H), 2.32-2.27 (m, 1 H), 1.86-1.77 (m, 1 H). 13C NMR (CDCl3, 100.62 MHz) 159.9, 
138.0, 133.9, 129.3, 128.6, 127.6, 76.0, 53.6, 27.9, 24.3, 23.3. LRMS (EI) 189, 161, 146, 
128(100), 117, 104, 77, 51. HRMS (EI) calculated for C11H11NO2:  189.0790, found 
189.0789. Rf 450 (50% EtOAc/hexane) = 0.09. 1H NMR 450 (CDCl3/TMS, 400.13 MHz) 
δ 7.44-7.17 (m, 4 H), 5.90 (s, 1 H), 5.61  (d, 1 H, J = 8.0 Hz), 4.30-4.26 (m, 1 H), 2.91-
2.88 (m, 1 H), 2.64-2.59 (m, 1 H), 1.94-1.87 (m, 2 H). 13C NMR 450 (CDCl3, 100.62 
MHz) 160.0, 138.7, 131.0, 129.4, 128.8, 127.4, 122.0, 76.1, 52.0, 28.6, 25.3, 23.3. LRMS 
(EI) 189, 161, 145, 128(100), 115(100), 104, 91, 77, 65. HRMS (EI) calculated for 
C11H11NO2: 189.0790, found 189.0796. 
 
6.2.2 (3aR’, 9bS’)-1-(11-Benzyloxy-undeca-2E,7E,9E-trienoyl)-3a,4,5,9b-
tetrahydro-1H-naphtho[1,2-d]oxazol-2-one (452) 
 
BnO N
O
O
O
BnO
O
OH
444 452  
 
The triene acid 444 (0.327 g, 1.13 mmol, 110 mol-%) was dissolved in dry THF (3.2 
mL). Distilled triethyl amine (0.168 g, 1.66 mmol, 148 mol-%) was added. The resulting 
mixture was immersed in a cooling bath to – 45 oC (CH3CN/N2). Distilled pivaloyl 
chloride (0.14 mL, 1.13 mmol, 110 mol-%) was injected into the reaction flask in a 
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dropwise manner. The mixture was stirred at – 40 – 45 oC for 1.5 hours. During this 
period, oxazolidinone 449 was dissolved in dry THF (5 mL) with warming (+ 50 oC). The 
dissolved oxazolidinone solution was cooled to – 78 oC (acetone/CO2) and n-BuLi (2.104 
M in hexanes, 0.5 mL, 1.05 mmol, 103 mol-%) was added dropwise. A slurry formed and 
a 1 mL of dry THF was added to increase solubility. The mixture was immersed in an ice 
bath to increase the solubility. At this point, a brown homogeneous solution was 
obtained. The mixture was cooled again to – 78 oC. The lithiated oxazolidinone 449 was 
then transferred dropwise with a syringe into the reaction flask, which contained the acid. 
The lithiated oxazolidinone solution partially precipitated at – 78 oC during the addition. 
The addition resulted in the formation of a slurry. The reaction mixture was allowed to 
warm slowly. After 2.5 hours of stirring, the reaction mixture was immersed in an ice 
bath for 1.5 hours. After this, the reaction mixture was allowed to warm to r.t. for 1.5 
hours. A saturated solution of NH4Cl (8 mL) and EtOAc (10 mL) was added. The organic 
layer was separated and washed with a saturated solution of NaHCO3 (11 mL) and brine 
(20 mL). The organic phase was dried with Na2SO4, filtered and concentrated to give 
0.523 g of yellow oil. The crude product was purified by flash chromatography (20-23 % 
EtOAc/hexane) to yield 452 (0.272 g, 71 %) as a white solid. Rf (30 % MTBE/hexane) = 
0.16. [α]20D = + 99.7 (c 0.38, CHCl3). 1H NMR (CDCl3/TMS, 400.13 MHz) δ 7.79-7.76 
(m, 1 H), 7.34-7.11 (m, 9 H), 6.22 (dd, 1 H, J = 15.1, 10.4  Hz), 6.06 (dd, 1 H, J = 15.0, 
10.5  Hz), 5.81 (d, 1 H, J = 7.8 Hz), 5.72-5.59 (m, 2 H), 5.08-5.04 (m, 1 H), 4.50 (s, 2 H), 
4.04 (d, 2 H, J = 5.6 Hz), 2.99 (td, 1 H, J = 12.5, 3.8 Hz), 2.64 (dt, 1 H, J = 16.0, 3.2 Hz), 
2.41 (dq, 1 H, J = 14.5, 3.4 Hz), 2.25 (q, 2 H, J = 7.2 Hz), 2.11 (q, 2 H, J = 7.1 Hz), 1.86-
1.78 (m, 1 H), 1.57 (q, 2 H, J = 7.7 Hz). 13C NMR (CDCl3, 100.62 MHz) 166.2, 154.4, 
151.5, 139.0, 138.5, 134.8, 133.7, 132.8, 132.4, 131.0, 129.2, 129.0, 128.9, 128.4, 128.2, 
128.1, 127.6, 121.8, 74.7, 72.6, 71.1, 55.1, 32.6, 28.2, 27.6, 23.9. LRMS (EI+) 457, 336, 
268, 238, 190, 177, 160, 147, 130, 105, 91(100), 79. HRMS (EI+) calculated for 
C29H31NO4: 457.2253, found 457.2283.   
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6.2.3 [(3aS’,4R’, 5S’,7aR’), 3aR’, 9bS’]-1-(5-Benzyloxymethyl-2,3,3a,4,5,7a-
hexahydro-1H-indene-4-carbonyl)-3a,4,5,9b-tetrahydro-1H-naphtho[1,2-
d]oxazol-2-one (454) 
 
BnO N
O
O
O
N
OBn
O
O
O
452 454  
 
Triene oxazolidinone 452 (0.272 g, 0.59 mmol, 100 mol-%) was dissolved in dry CH2Cl2 
(12 mL) and cooled to – 45 oC. Diethylaluminum chloride in hexanes (1.0 M, 0.83 mL, 
0.83 mmol, 140 mol-%) was added dropwise in 20 minutes. Stirring was continued for 6 
hours between – 45 – 20 oC and then the reaction mixture was allowed to warm slowly to 
r.t. After 19 hours of stirring, the reaction mixture was cooled to – 45 oC and more DEAC 
(0.65 mL, 0.65 mmol, 110 mol-%) was added dropwise. The addition took 20 minutes 
and it resulted formation of white gas. Stirring was continued for 2 days and the reaction 
mixture was cannulated to ice cool solution of 1M HCl (10 mL). This resulted formation 
of white/yellow slurry. The layers were separated and the water layer was extracted with 
CH2Cl2 (5 mL). The combined organics were washed with 5 w-% NaHCO3 solution (10 
mL) and dried with Na2SO4. The filtration and concentration gave 0.278 g of orange oil. 
The crude product was purified by flash chromatography (5-15 % EtOAc/hexane) to 
yield 454 (62 mg, 23 %) as a white solid. Rf (30 % EtOAc/hexane) = 0.36. [α]20D = + 
182.2 (c 0.995, CHCl3). 1H NMR (CDCl3/TMS, 400.13 MHz) δ 7.86-7.84 (m, 1 H), 7.28-
7.09 (m, 9 H), 5.86 (d, 1 H, J = 9.9 Hz), 5.80 (d, 1 H, J = 8.3 Hz), 5.56 (ddd, 1 H, J = 9.9, 
3.6, 2.6 Hz), 5.81 (dtd, 1 H, J = 6.7, 3.9, 1.1 Hz), 3.81 (d, 2 H, J = 3.7 Hz), 3.07-2.94 (m, 
3 H), 2.83 (dd, 1 H, J = 8.6, 5.4 Hz), 2.63 (m, 1 H), 2.44 (dq, 1 H, J = 14.6, 2.9 Hz), 2.05 
(m, 1H), 1.95-1.65 (m, 6 H), 1.26-1.05 (m, 2 H). 13C NMR (CDCl3, 100.62 MHz) 174.6, 
153.9, 139.2, 138.9, 133.3, 132.0, 130.8, 128.9, 128.5, 128.4, 127.7, 127.6, 127.0, 74.3, 
72.6, 71.7, 55.5, 47.6, 45.0, 42.0, 38.8, 29.3, 28.8, 28.4, 23.9, 22.5. LRMS (EI+) 457, 
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349, 336, 268, 238, 220, 190, 177, 160, 147, 129, 105, 91(100), 79, 55. HRMS (EI+) 
calculated for C29H31NO4: 457.2253, found 457.2218.   
6.2.4 (4R)-4-Benzyl-3-(11-benzyloxy-undeca-2E,7E,9E-trienoyl)-oxazolidin-2-one 
(453) 
 
BnO
O
OH BnO N
O
O
O
444 453  
 
The triene acid 444 (0.286 g, 1.0 mmol, 105 mol-%) was dissolved in dry THF (5 mL) 
and triethylamine (0.152 g, 1.5 mmol, 150 mol-%) was added. The resulting mixture was 
cooled to – 40 °C (acetonitrile/N2). Pivaloyl chloride (0.121 g, 1.0 mmol, 105-%) was 
added dropwise in to reaction mixture. After the addition, the reaction mixture was 
immersed in a cooling bath to – 25 °C (ethylene glycol/CO2). Stirring was continued for 
40 minutes. During this period  (R)-4-benzyl-2-oxazolidinone (0.168 g, 0.95 mmol, 100 
mol-%) was dissolved in dry THF (4 mL) and the mixture was cooled to – 78 °C 
(acetone/CO2) and n-BuLi (492 µl, 0.98 mmol, 103 mol-%) was added dropwise. The 
addition resulted formation of orange solution. Stirring was continued for 30 minutes. 
Both reaction flasks were cooled to - 78°C and the lithiated oxazolidinone was slowly 
cannulated into the flask, which contained previously formed triene anhydride. The slurry 
was stirred for 1 hour and then the mixture was stirred for 20 minutes at – 30 °C. After 
this, the reaction mixture was warmed to 0 °C for 30 minutes and finally the reaction 
mixture was allowed to warm to r.t. A saturated solution of NH4Cl (4 mL) and EtOAc (5 
mL) was added. The layers were separated and the water layer was extracted with EtOAc 
(10 mL). The combined organics were washed with a saturated solution of NaHCO3 (10 
mL) and brine (10 mL). The organic phase was dried with Na2SO4, filtered and 
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concentrated to give 0.486 g of yellow oil. The crude product was purified by flash 
chromatography (15 % EtOAc/hexane) to yield 453 (0.358 g, 85 %) as a clear oil. Rf (20 
% EtOAc/hexane) = 0.14. [α]20D = - 41.5 (c 1.18, CHCl3). 1H NMR (CDCl3/TMS, 400.13 
MHz) δ 7.34-7.20 (m, 12 H), 6.24 (dd, 1 H, J = 15.4, 10.7 Hz), 6.08 (dd, 1 H, J = 15.0, 
10.4 Hz), 5.74-5.64 (m, 2 H), 4.74-4.68 (m, 1 H), 4.50 (s, 2 H), 4.20-4.13 (m, 2 H), 4.04 
(dd, 2 H, J = 6.3, 0.9 Hz), 3.32 (dd, 1 H, J = 13.3, 3.1 Hz), 2.79 (dd, 1 H, J = 13.5, 9.6 
Hz), 2.31 (q, 2 H, J = 7.3 Hz), 2.15 (q, 2 H, J = 7.2 Hz), 1.61 (q, 2 H, J = 7.3 Hz). 13C 
NMR (CDCl3, 100.62 MHz) 165.5, 153.8, 151.6, 138.8, 135.8, 134.6, 133.5, 130.8, 
129.9, 129.4, 128.8, 128.2, 128.0, 127.9, 127.7, 121.1, 72.4, 71.0, 66.5, 55.7, 38.3, 32.5, 
28.0. LRMS (EI+) 445, 354, 324, 268, 238, 204, 178, 160, 147(100), 133, 117, 105, 91, 
79, 53. HRMS (EI+) calculated for C28H31NO4: 445.2253, found 445.2169.   
6.2.5 [4R,(3aR’,4S’, 5R’,7aS’)]-4-Benzyl-3-(5-benzyloxymethyl-2,3,3a,4,5,7a -
hexahydro-1H-indene-4-carbonyl)-oxazolidin-2-one (455) 
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Triene oxazolidinone 453 (0.959 g, 2.15 mmol, 100 mol-%) was dissolved in dry CH2Cl2 
(35 mL) and cooled to – 41 oC (CH3CN/N2(l)). Diethylaluminum chloride in hexanes (1.0 
M, 3.12 mL, 3.12 mmol, 145 mol-%) was added dropwise. The addition resulted in the 
formation of a yellowish solution. The reaction mixture was allowed to warm slowly to –
10 – 18 °C in a cold room. After 53 hours of stirring, the reaction mixture was cannulated 
to ice cool solution of 1M HCl (30 mL). This resulted formation of a white slurry. 
Stirring was continued for 10 minutes and the layers were separated. The water layer was 
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extracted with CH2Cl2 (30, 2 x 20 mL). The combined organics were washed with 5 w-% 
NaHCO3 solution (2 x 30 mL). The water slurry was extracted with CH2Cl2 (2 x 30 mL). 
The combined organics were washed with brine (30 mL), dried with Na2SO4, filtered and 
concentrated to give 0.973 g of thick yellow oil. The crude product was purified by flash 
chromatography (6-15% EtOAc/hexane) to give 455 (0.686 g, 72%) as a white solid. The 
product was recrystallized from MeOH. mp. 92-93 °C. [α]20D = - 153.9 (c 1.00, CHCl3). 
Rf (50 % MTBE/hexane) = 0.52. 1H NMR (CDCl3/TMS, 400.13 MHz) δ 7.56-7.07 (m, 
10 H), 5.92 (d, 1 H, J = 9.8 Hz), 5.50 (ddd, 1 H, J = 9.8, 4.0, 2.6 Hz), 4.59-4.53 (m, 1H), 
4.41 (q, 2 H, J = 12.1 Hz), 4.07 (td, 1 H, J = 8.8, 0.8 Hz), 3.98 (dd, 1 H, J = 9.0, 2.5 Hz), 
3.73 (dd, 1 H, J = 11.3, 6.3 Hz), 3.54 (dd, 1 H, J = 9.7, 8.6 Hz), 3.42-3.37 (m, 1 H), 3.33-
3.27 (m, 2 H), 2.05 (dd, 1 H, J = 13.5, 11.0 Hz), 2.00-1.96 (m, 1 H), 1.90-1.69 (m, 5 H), 
1.27-1.19 (m, 1 H), 1.12-1.02 (m, 1 H). 13C NMR (CDCl3, 100.62 MHz) 174.2, 153.8, 
138.6, 136.7, 131.7, 129.8, 129.2, 128.7, 128.3, 127.9, 127.6, 127.4, 73.0, 71.2, 66.6, 
56.2, 47.3, 44.9, 42.1, 39.3, 37.7, 29.3, 22.5. LRMS (EI+) 445, 354, 324, 238, 178, 160, 
147, 117, 105, 91(100), 65, 55. HRMS (EI+) calculated for C28H31NO4: 445.2253, found 
445.2259.   
6.2.6 [2R,( 3aR’,4S’, 5R’,7aS’)]-N-Methoxy-N-methyl-carbamic acid 2-benzyl-3-
[(5-benzyloxymethyl-2,3,3a,4,5,7a-hexahydro-1H-indene-4-carbonyl)-
amino]-propyl ester (457) 
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MeONHMe⋅HCl (37 mg, 0.383 mmol, 240 mol-%) was treated with dry CH2Cl2 (2 mL). 
The mixture was cooled to – 10 – 12 °C (acetone/ice). Trimethyl aluminum in hexanes 
(0.18 mL, 0.359 mmol, 224 mol-%) was added dropwise, which resulted in the formation 
of white smoke. Stirring was continued for 10 minutes at – 10 °C and 30 minutes at room 
temperature. The reaction mixture was cooled to – 10 °C and adduct 455 (71 mg, 0.160 
mmol, 100 mol-%) in dry CH2Cl2 (2 mL) was added dropwise. Stirring was continued 20 
minutes and the reaction mixture was immersed in an ice bath for 1.5 hours. After this the 
reaction mixture was taken to r.t. for 16 hours. The reaction mixture was warmed with an 
oil bath (+ 50 °C) for 24 hours. A mixture of  0.5 M HCl (2 mL) and CH2Cl2 (1 mL) was 
added at 0 °C. Stirring was continued for 2.5 hours and  CH2Cl2 (3 mL) was added. The 
layers were separated and the water layer was extracted with CH2Cl2 (2 x 3 mL). The 
combined organics were washed with brine (3 mL), dried with Na2SO4, filtered and 
concentrated to give 457 (63 mg, 78 %) as a white solid. [α]20D = -119.2 (c 1.05, CHCl3). 
1H NMR (CDCl3/TMS, 400.13 MHz) δ 7.31-7.12 (m, 10 H), 6.02 (d, 1 H, J = 8.2 Hz), 
5.93 (d, 1 H, J = 9.9 Hz), 5.63 (ddd, 1 H, J = 9.9, 3.9, 2.8 Hz), 4.42 (s, 3 H), 4.11 (d, 2 H, 
J = 5.5 Hz), 3.69 (s, 3 H), 3.44 (dd, 2 H, J = 5.6, 1.9 Hz), 3.14 (s, 3 H), 2.81-2.65 (m, 3 
H), 2.42 (dd, 1 H, J = 11.4, 7.0 Hz), 1.82-1.61 (m, 7 H), 1.19-1.14 (m, 1H), 1.01-0.97 (m, 
1 H). 13C NMR (CDCl3, 100.62 MHz) 173.5, 157.8, 139.1, 137.8, 131.7, 130.0, 129.2, 
128.9, 128.3, 128.1, 127.3, 73.7, 72.4, 67.0, 62.3, 54.1, 50.9, 50.4, 45.6, 42.9, 40.3, 37.9, 
36.2, 29.5, 28.5, 22.8. IR (FT-IR) 3019, 2400, 1671, 1513, 1427, 1211, 1046, 929, 758, 
670. LRMS (EI+) 506, 476, 415, 310, 280, 237, 176, 147, 117, 105, 91, 65. HRMS (ES+) 
calculated for C30H38N2O5Na: 529.2678, found 529.2698.    
6.2.7 (3aR’,5aS’,8aR’,8bS’)-3,3a,5a,6,7,8,8a,8b-Octahydro-indeno[4,5-c]furan-1-
one (458) 
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Hexahydroindene oxazolidinone 455 (12 mg, 0.027 mmol, 100 mol-%) was dissolved in 
CH2Cl2 (0.5 mL) and H2O (0.025 mL). 2,3-Dichloro-5,6-dicyano-1,4-benzoquinone 
(DDQ) (10 mg, 0.044 mmol, 163 mol-%) was added. Stirring was continued for 3 days at 
r.t. and then the reaction mixture was warmed with a water bath (+30-35 °C). Stirring 
was continued for 1 day at this temperature and CH2Cl2 (2 mL) was added. The organics 
were washed with a saturated solution of NaHCO3 (2 mL). The water layer was extracted 
with CH2Cl2 (2 x 5 mL). The combined organics were dried with Na2SO4, filtered and 
concentrated to give 9.3 mg of yellow oil and brown precipitate. The crude product was 
purified by flash chromatography (10 % EtOAc/hexane) to give 458 (1.9 mg, 40%) as a 
white solid. Rf (50% EtOAc/hexane) = 0.33. 1H NMR (CDCl3/TMS, 400.13 MHz) δ 6.04 
(d, 1 H, J = 9.9 Hz), 5.55 (dt, 1 H, J = 9.9, 2.9 Hz), 4.52 (t, 1H, J = 8.7 Hz), 3.90 (dd, 1 
H, J = 10.7, 8.7 Hz), 3.21 (q, 1 H, J = 7.2 Hz), 2.55 (dd, 1 H, J = 12.1, 8.5 Hz), 2.02-1.93 
(m, 3 H), 1.79-1.75 (m, 2 H), 1.51-1.41 (m, 2 H), 1.26-1.20 (m, 2 H). 13C NMR (CDCl3, 
100.62 MHz) 179.0, 133.4, 124.4, 72.5, 44.6, 43.8, 42.1, 37.5, 28.9, 28.5, 22.4. LRMS 
(EI+) 178, 149, 133(100), 120, 105, 91, 79, 65, 51. HRMS (EI+) calculated for C11H14O2: 
178.0994. found 178.0994.    
6.2.8 (3aR’,5aS’,8aR’,8bS’)-3,3a,5a,6,7,8,8a,8b-Octahydro-indeno[4,5-c]furan-1-
one (458) 
 
IMDA adduct 455 (0.136 g, 0.305 mmol, 100 mol-%) was dissolved in dry CH2Cl2 (4 
mL). A 2.0 M solution of BCl3⋅SMe2 (1.06 mL, 2.120 mmol, 700 mol-%) was added 
 
 
 
 
 
 
 
182 
 
dropwise. Stirring was continued for 5 hours and a saturated solution of NaHCO3 (10 
mL) was added cautiously. A formation of CO2 was noticed. A 20 mL of sat. NaHCO3 
and CH2Cl2 (20 mL) was added. The layers were separated and the water layer was 
extracted with CH2Cl2 (3 x 20 mL). The combined organics were washed with a solution 
of 1M HCl (2 x 10 mL). The water phase was extracted with CH2Cl2 (3 x 15 mL). The 
combined organics were washed with brine (20 mL), dried with Na2SO4, filtered and 
concentrated to give 0.123 g of brown oil. The crude product was purified by flash 
chromatography (15 % to 85 % EtOAc in hexanes). to yield 458 (45 mg, 84%). 40 mg 
(74 %) of chiral auxiliary was recovered. Rf (25 % EtOAc/hexane) = 0.29. [α]20D= +54.4 
(c 1.00, CHCl3). 1H NMR (CDCl3/TMS, 400.13 MHz) δ 6.05 (d, 1 H, J = 9.7 Hz), 5.55 
(dt, 1 H, J = 9.9, 3.2 Hz), 4.52 (t, 1 H, J = 8.9 Hz), 3.90 (dd, 1 H, J = 10.8, 8.7 Hz), 3.23-
3.21 (m, 1 H), 2.55 (dd, 1 H, J = 12.1, 8.4 Hz), 2.05-1.20 (m, 8 H). 13C NMR (CDCl3, 
100.62 MHz) 179.1, 133.6, 124.6, 72.8, 44.8, 44.0, 42.3, 37.8, 29.1, 28.8, 22.6. HRMS 
see above. 
6.2.9 [3aR’,4S’, 5R’,7aS’,(1R)]-5-Benzyloxymethyl-2,3,3a,4,5,7a-hexahydro-1H-
indene-4-carboxylic acid (1-benzyl-2-hydroxy-ethyl)-amide (456) 
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Hexahydroindene oxazolidinone 455 (26 mg, 0.059 mmol, 100 mol-%) was dissolved in 
MeOH (5 mL) and KOH (31 mg, 0.556 mmol, 942 mol-%) was added. Stirring was 
continued for 1 hour at r.t. and then the reaction mixture was acidified with 2 M KHSO4 
(10 drops) until the pH was 4. MeOH was evaporated to give a white slurry. CH2Cl2 (10 
mL) was added ant the organic phase was washed with 2 M KHSO4 (3 mL). The layers 
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were separated and the water phase was diluted with water (10 mL). The water layer was 
extracted with CH2Cl2 (4 x 5 mL). The combined organics were washed with brine (5 
mL), dried with Na2SO4, filtered and concentrated to give 36 mg of white solid. The 
crude product was purified by recrystallization from 60 % hexane/CH2Cl2 to give 456 (9 
mg, 53 %) as a white solid. Rf (100% EtOAc) = 0.43. [α]20D = -120.1 (c 1.00, CH2Cl2). 
1H NMR (CDCl3/TMS, 400.13 MHz) δ 7.35-7.05 (m, 10 H), 5.93 (d, 1 H, J = 9.9 Hz), 
5.86 (d, 1 H, J = 6.6 Hz), 5.53 (ddd, 1 H, J = 9.9, 3.8, 2.7 Hz), 4.46 (q, 2 H, J = 12.0 Hz), 
4.09-4.02 (m, 1 H), 3.71-3.66 (m, 1 H), 3.58-3.49 (m, 4 H), 2.77-2.65 (m, 3 H), 2.44 (dd, 
1 H, J = 11.8, 7.0 Hz), 1.82-1.77 (m, 2 H), 1.62-1.58 (m, 4 H), 1.44-1.38 (m, 1 H), 1.19-
1.14 (m, 1H), 0.99-0.88 (m, 1 H). 13C NMR (CDCl3, 100.62 MHz) 175.2, 138.8, 138.3, 
132.0, 129.8, 129.3, 129.1, 128.7, 128.5, 128.4, 127.3, 73.8, 72.1, 65.7, 54.5, 51.2, 45.7, 
42.9, 40.3, 37.4, 29.5, 28.5, 22.9. HRMS (ES+) calculated for C27H33NO3Na: 442.2358, 
found 442.2363. 
6.2.10 [3aR’,4S’, 5R’,7aS’,(1R)]-5-Benzyloxymethyl-2,3,3a,4,5,7a-hexahydro-1H-
indene-4-carboxylic acid (1-benzyl-2-hydroxy-ethyl)-amide (456) 
 
IMDA adduct 455 (52 mg, 0.116 mmol, 100 mol-%) was dissolved in dry THF (3 mL). 
H2O (2.3 µl, 0.128 mmol, 110 mol-%) was added and the mixture was cooled to 0 °C. A 
2.0 M solution of LiBH4 in THF (64µl, 0.128 mmol, 110 mol-%) was added. Stirring was 
continued for 3.5 hours and a second portion of LiBH4 in THF (65µl, 0.130 mmol, 112 
mol-%) was added. The whitish cloudy reaction mixture was stirred 17 hours at room 
temperature. A 5 w-% solution of citric acid (5 mL) was added cautiously. The water 
layer was extracted with ether (4 x 10 mL). The combined organics were washed with 
brine (5 mL), filtered and concentrated to give 54 mg of white solid. The crude product 
was purified by flash chromatography (50-100% EtOAc in hexanes) to yield 456 (30 mg, 
62%). For analytical details, see 6.2.9. 
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6.2.11 (3aR’,5aS’,8aR’,8bS’)-3,3a,5a,6,7,8,8a,8b-Octahydro-indeno[4,5-c]furan-1-
one (458) 
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Amide 456 (32 mg, 0.076 mmol, 100 mol-%) was dissolved in dioxane (2 mL) and 6 M 
HCl (2 mL) was added, which resulted in precipitation. The reaction mixture was 
warmed in an oil bath (100-105 °C). Stirring was continued for 18.5 hours and the 
reaction mixture was cooled to r.t. The product was partitioned between H2O (10 mL) 
and CH2Cl2 (15 mL). The water layer was extracted with CH2Cl2 (6 x 5 mL). The organic 
layer was dried with Na2SO4, filtered and concentrated to give 22 mg of white solid. The 
crude product was purified by flash chromatography. The column was 2.5 g, 1 x 14 cm. 
The eluent was 13 % EtOAc in hexanes to 100 % EtOAc. The yield was 11 mg (82%) of 
lactone mixture 458 and 459. The ratio of 458 to 459 was 2.5:1 by 1H NMR. Rf 458/459 
(50 % EtOAc/hexane) = 0.56. 1H NMR 458 (CDCl3/TMS, 400.13 MHz) δ 6.05 (d, 1 H, J 
= 9.9 Hz), 5.55 (d, 1 H, J = 9.9 Hz), 4.52 (t, 1 H, J = 8.9 Hz), 3.90 (dd, 1 H, J = 10.8, 8.7 
Hz), 3.23-3.20 (m, 1 H), 2.55 (dd, 1 H, J = 12.1, 8.4 Hz), 2.52 (m, 1 H) 2.05-1.70 (m, 7 
H), 1.57-1.40 (m, 1H), 1.30-1.18 (m, 1 H). 13C NMR (CDCl3, 100.62 MHz) 179.2, 133.7, 
124.6, 72.8, 44.9, 44.1, 42.3, 37.8, 29.2, 28.8, 22.7. LRMS (EI+) 178, 149, 133, 119, 105, 
91(100), 79, 65, 51. For HRMS see chapter 6.2.7. 
6.2.12  [(3aR’,5aS’,8aR’,8bS’),1R/S]-3,3a,5a,6,7,8,8a,8b,-Octahydro-1H-
indeno[4,5-c]furan-1-ol (460a,b) 
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3,3a,5a,6,7,8,8a,8b-Octahydro-indeno[4,5-c]furan-1-one 458 (44 mg, 0.25 mmol, 100 
mol-%) was dissolved in dry toluene (4 mL). The resulting mixture was cooled to – 78 
°C. A 1.0 M solution of DIBAL-H (0.3 mL, 0.300 mmol, 120 mol-%) in toluene was 
added dropwise. Stirring was continued for 30 minutes and saturated solution of NH4Cl 
(5 mL) was added. The reaction mixture was allowed to warm to room temperature. A 
saturated solution of Rochelle’s salt was added (10 mL).  Stirring was continued for 15 
minutes and the water phase was extracted with ether (4 x 20 mL). The combined 
organics were washed with brine (20 mL), dried with Na2SO4, filtered and concentrated 
to give 43 mg of clear oil. The crude product was purified by flash chromatography (15 
% EtOAc/hexane) to yield 460a/460b (33 mg, 72 %) in ratio 20:1. Rf (50% 
EtOAc/hexane) = 0.28. [α]20D = +16.2 (c 1.06, CHCl3). 1H NMR (CDCl3, 400.132 MHz) 
δ 5.92 (d, 1 H, J = 9.7 Hz), 5.60 (dt, 1 H, J = 9.9, 3.0 Hz), 5.40 (d, 1 H, J = 2.9 Hz), 4.30 
(dd, 1 H, J = 9.5, 7.8 Hz), 3.58 (t, 1 H, J = 8.0 Hz), 3.12 (m, 1 H), 3.04 (d, 1 H, J = 3.1 
Hz), 2.16 (dd, 1 H, J = 12.1, 7.7 Hz), 1.87 (m, 3 H), 1.73 (m, 2 H), 1.21 (m, 3 H). 13C 
NMR (CDCl3, 100.61 MHz) δ 131.8, 127.5, 102.8, 73.6, 51.4, 43.6, 43.6, 38.4, 29.8, 
29.1, 22.9. LRMS (EI+) 180, 162, 150, 134, 119(100), 105, 91, 790, 67, 53. HRMS (EI+) 
calculated for C11H16O2: 180.1150, found 180.1140. 
6.2.13 [1S,(3aR’,5aS’,8aR’,8bS’)]-1-tert-Butyl-(3,3a,5a,6,7,8,8a,8b-octahydro-1H-
indeno[4,5-c]furan-1-yloxy)-diphenyl-silane (467) 
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Lactol 460a,b (16.1 mg, 0.089 mmol, 100 mol-%) was dissolved in dry DMF (1 mL) and 
imidazole (6.8 mg, 0.100 mmol, 112 mol-%) was added. tert-Butyldiphenylsilyl chloride 
(23 µl, 0.088 mmol, 99 mol-%) was added and stirring was continued at 50-55 °C (oil 
bath). After 45 minutes of stirring, a second portion of imidazole (7.2 mg, 0.106 mmol, 
118 mol-%) and tert-butyldiphenylsilyl chloride (24 µl, 0.092 mmol, 103 mol-%) was 
added. Stirring was continued for 90 minutes and a third portion of imidazole (6.6 mg, 
0.097 mmol, 109 mol-%) and tert-butyldiphenylsilyl chloride (24 µl, 0.092 mmol, 103 
mol-%) was added. Stirring was continued for 19 hours at 55 °C. The organic phase was 
diluted with ether (20 mL), washed with H2O (5 mL), brine (5 mL) and dried with 
MgSO4. The filtration and concentration gave 84 mg of clear oil. The crude product was 
purified by flash chromatography (2 - 10 % MTBE/hexane) to yield 467 (15 mg, 39 %). 
Rf (5 % MTBE in hexanes) = 0.38. [α]20D = +38.1 (c 1.30, CHCl3). 1H NMR (CDCl3, 
400.132 MHz) δ 7.75-7.35 (m, 10 H), 5.88 (d, 1 H, J = 9.6 Hz), 5.64 (dt, 1 H, J = 9.7, 3.0 
Hz), 5.36 (s, 1H), 4.31 (dd, 1 H, J = 9.7, 7.7 Hz), 3.55 (t, 1 H, J = 7.9 Hz), 3.25-3.20 (m, 
1H), 2.19 (dd, 1 H, J = 11.8, 7.4 Hz), 1.90 – 1.50 (m, 5 H), 1.07 (s, 9H), 1.00-0.80 (m, 
3H). 13C NMR (CDCl3, 100.62 MHz) δ 136.4, 136.3, 135.9, 134.8, 134.5, 133.2, 131.5, 
130.9, 130.3, 130.3, 128.6, 128.3, 128.3, 128.1, 103.2, 73.6, 53.3, 43.6, 38.3, 29.8, 28.9, 
27.5, 27.2, 22.9, 19.9. LRMS (EI+) 418, 362, 332, 283, 274, 253, 239, 217(100), 199, 
181, 163, 145, 135, 117, 105, 91, 77, 63, 57, 51. HRMS (EI+) (M-(t-Bu)) calculated 
361.1624, found 361.1640.  
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6.3 Organocatalytic preparation of bicyclo[4.3.0]nonane derivatives 
6.3.1 (2S,5S)-5-Benzyl-3-methyl-2-phenyl-imidazolidin-4-one (474a) 
 
NH3Cl
NHO
N
H
NO
472 474  
 
A HCl salt of amine 472 (2.37 g, 11.1 mmol, 100 mol-%) was treated with a saturated 
solution of NaHCO3 (45 mL). The free amine was extracted with CHCl3 (3 x 50 mL). 
The organics were dried with Na2SO4, filtered and concentrated to give 2.05 g of 
yellowish oil. Methanol (20 mL), benzaldehyde (1.29 g, 12.2 mmol, 110 mol-%) and 
para-toluenesulphonic acid monohydrate (0.21 g, 1.1 mmol, 10 mol-%) was added and 
the reaction mixture was warmed with an oil bath to +75 °C. Stirring was continued for 3 
days and the reaction mixture was allowed to cool to r.t. The solvents were evaporated to 
give 3.26 g of orange oil. The crude product was purified by flash chromatography (50-
100 % EtOAc/hexane) to yield 474 (0.31 g, 11 %) as a yellowish oil. The ratio of 
(S,S):(S,R/R,S)-products were 1:3.1 by 1H NMR. Rf (S,S)-474 (75% EtOAc in hexanes) = 
0.16. [α]20D = -46.5 (c 1.12, CHCl3). Rf (S,R/R,S) (75 % EtOAc in hexanes) = 0.33. The 
product was analyzed by chiral HPLC (10 % i-PrOH in hexane, flow rate 1.0 mL/min) 
The retention times were (S,S) 13.59 min and (S,R) 11.8 min. RT (R,S) 9.4 min. 1H NMR 
474 (CDCl3, 400.132 MHz) δ 7.32-7.24 (m, 8H), 6.85-6.83 (m, 2H), 5.14 (d, 1H, J = 1.5 
Hz), 3.88 (t, 1H, J = 0.5 Hz), 3.28-3.16 (m, 2H), 2.56 (s, 3H). 13C NMR (CDCl3, 100.62 
MHz) δ 174.4, 138.4, 136.7, 129.8, 129.5, 129.0, 128.8, 127.1, 126.9, 77.6, 60.4, 36.8, 
27.3. HRMS (ES+) calculated for [M+1] C17H19N2O: 267.1497, found 267.1484.      
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6.3.2 (2S,5S)-3,5-Dibenzyl-2-tert-butyl-imidazolidin-4-one (479a) 
 
NH2
NHO
N
H
NO
478 479a  
 
Free amine 478 (2.22 g, 8.73 mmol, 100 mol-%) was dissolved in MeOH (15 mL). 
Trimethylacetaldehyde (0.83 g, 9.60 mmol, 110 mol-%) and para-toluenesulphonic acid 
monohydrate (0.17 g, 0.87 mmol, 10 mol-%) was added. The resulting mixture was 
warmed with an oil bath to + 75 °C. Stirring was continued under reflux for 2 days and 
the reaction mixture was allowed to cool to r.t. The solvents were evaporated to give 2.72 
g of yellow oil. The crude product was purified by flash chromatography (32 % 
EtOAc/hexane) to yield 479a (0.52 g, 18 %) as a clear oil. The ratio of (S,S) to (S,R/R,S) 
was 1:2 by 1H NMR. Rf (S,S)-479a (70% EtOAc/hexane) = 0.49. [α]20D = -128.0 (c 1.11, 
CHCl3).  Rf (S,R/R,S) (70% EtOAc/hexane) = 0.65. 1H NMR (CDCl3, 400.132 MHz) δ 
7.32-7.13 (m, 10H), 5.06 (d, 1H, J = 15.7), 4.25 (d, 1H, J = 15.7 Hz), 4.13 (s, 1H), 3.85 
(ddd, 1H, J = 7.5, 4.1, 1.4 Hz), 3.22 (dd, 1H, J = 13.7, 4.1 Hz), 3.04 (dd, 1H, J = 13.7, 7.5 
Hz), 0.76 (s, 9H). 13C NMR (CDCl3, 100.62 MHz) δ 174.4, 138.4, 136.7, 129.8, 129.5, 
129.0, 128.8, 127.1, 126.9, 77.6, 60.4, 36.8, 27.3. (S,S)-Configuration was confirmed by 
COSYGPGF (coupling between 4.13 and 3.85 was noticed). HRMS (EI) calculated for 
C21H26N2O: 322.2045, found [M-1] 321.1994. 
6.3.3 (3aS’,4R’,5S’,7aR’)-5-Benzyloxymethyl-2,3,3a,4,5,7a-hexahydro-1H-indene-
4-carbaldehyde (38)  
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(2S,5S)-5-Benzyl-2-tert-butyl-3-methyl-imidazolidin-4-one 475 (128 mg, 0.52 mmol, 6 
mol-%) was dissolved in CH3CN (20 mL) and a 0.1 M aqueous solution of HCl (5.2 mL) 
was added. The resulting mixture was stirred for 5 minutes and a 65 w-% triene aldehyde 
470 (2.50 g, 9.25 mmol, 100 mol-%) in CH3CN (32 mL) was added. The reaction mixture 
was stirred for 20 hours and the reaction mixture was diluted with ether (200 mL) and 
washed with H2O (50 mL) and brine (50 mL) mixture. The organic phase was dried with 
MgSO4, filtered and concentrated to give 2.8 g of yellow oil. The crude product was 
purified by flash chromatography (5 % EtOAc/hexane) to give 480 (1.23 g, 79 %, 72 
%ee) as a clear oil. The branched triene aldehyde 471 was easily separated by flash 
chromatography. The enantiomeric excess was determined by chiral HPLC from the 
corresponding alcohol. Rf (20 % MTBE in hexanes) = 0.34. 1H NMR (CDCl3, 400.132 
MHz) δ 9.77 (d, 1H, J = 2.8 Hz), 7.34-7.27 (m, 5H), 5.96 (d, 1H, J = 9.9 Hz), 5.47 (ddd, 
1H, J = 9.9, 3.9, 2.6 Hz), 4.41 (d, 1H, J = 11.6 Hz), 4.33 (d, 1H, J = 11.6 Hz), 3.44 (dd, 
1H, J = 9.9, 3.6 Hz), 3.37 (t, 1H, J = 9.4 Hz), 3.09 (m, 1H), 2.61 (ddd, 1H, J = 11.6, 6.5, 
2.7 Hz), 2.06 (m, 1H), 1.84-1.61 (m, 5H), 1.17-1.04 (m, 2H). 13C NMR (CDCl3, 100.62 
MHz) δ 203.2, 137.7, 132.3, 128.4, 127.8, 127.7, 126.2, 72.8, 70.7, 55.3, 45.0, 39.8, 39.6, 
28.4, 27.6, 22.4. LRMS (EI+) 270, 180, 105, 91(100), 79, 65.  HRMS (EI) calculated for 
C18H22O2: 270.1620, found 270.1624. 
6.3.4 (3aS’,4R’,5S’,7aR’)-5-Benzyloxymethyl-2,3,3a,4,5,7a-hexahydro-1H-indene-
4-carbaldehyde (480) 
 
 
 
 
 
 
 
 
190 
 
(2S,5S)-5-Benzyl-2-tert-butyl-3-methyl-imidazolidin-4-one 475 (10 mg, 0.04 mmol, 20 
mol-%) was treated with a 0.4 M solution of HCl (0.1 mL). A 73 w-% 11-benzyloxy-
undeca-2E,7E,9E-trienal 470 (54 mg, 0.20 mmol, 100 mol-%) was dissolved in MeOH 
(1.9 mL) and added into the reaction flask. After 2 minutes of stirring, the reaction 
mixture was yellowish solution. The reaction mixture was stirred for 5 hours and the 
reaction mixture was diluted with ether and the combined organics were washed with 
brine (10 mL). The water layer was extracted once with ether (5 mL) and the combined 
organics were dried with Na2SO4. The filtration and concentration of the organics gave 
0.182 g of yellow emulsion. The dimethyl acetal product was hydrolyzed by treating the 
product with TFA:H2O:CHCl3 (1:1:2) (4 mL). Stirring was continued for 2 hours and the 
reaction mixture was neutralized by adding a saturated solution of NaHCO3 (12 mL). The 
layers were separated and the water layer was extracted with ether (3 x 20 mL). The 
combined organics were dried with Na2SO4, filtered and concentrated to give 0.140 g of 
clear oil. The crude product was purified by flash chromatography (5 – 20 % EtOAc in 
hexanes) to yield 480 (21 mg, 54 %). The enantiomeric excess was determined by HPLC 
(1.6 % i-PrOH in hexanes, flow rate 0.7 mL/min, λ = 230 nm). Only the endo-
cycloadduct was observed by 1H NMR. The enantiomeric excess was determined to be 74 
%. For analytical details, see 6.3.3. 
6.3.5 (3aS’,4R’,5S’,7aR’)-5-Benzyloxymethyl-2,3,3a,4,5,7a-hexahydro-1H-indene-
4-carbaldehyde (480) 
 
A 68 w-% 11-benzyloxy-undeca-2E,7E,9E-trienal 470 (56 mg, 0.21 mmol, 100 mol-%) 
was dissolved in MeOH (1.9 mL) and (5S)-5-benzyl-2,2,3-trimethyl-imidazolidin-4-one 
476 (9 mg, 0.04 mmol, 20 mol-%) was added. The mixture was cooled to 0 °C. After this, 
a 0.4 M solution of HCl (0.1 mL) was added. The reaction mixture was stirred for 4 hours 
and the reaction mixture was allowed to warm to room temperature. Stirring was 
continued for 44 hours and the reaction mixture diluted with ether (20 mL) and the 
combined organics were washed with brine (10 mL). The water layer was extracted once 
with ether (5 mL) and the combined organics were dried with Na2SO4. The crude product 
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was filtered and concentrated to give yellow emulsion. The dimethyl acetal product was 
hydrolyzed by treating the product with TFA:H2O:CHCl3 (1:1:2) (4 mL). Stirring was 
continued for 2 hours and the reaction mixture was neutralized by adding a saturated 
solution of NaHCO3 (15 mL). The layers were separated and the water layer was 
extracted with ether (3 x 20 mL). The combined organics were dried with Na2SO4, 
filtered and concentrated to give 93 mg of clear oil. The crude product was purified by 
flash chromatography (5 % EtOAc in hexanes) to yield 480 (11 mg, 28%). The endo/exo 
ratio was determined by 1H NMR to be 3.3:1. The enantiomeric excess was not 
determined.  
6.3.6 (3aS’,4R’,5S’,7aR’)-5-Benzyloxymethyl-2,3,3a,4,5,7a-hexahydro-1H-indene-
4-carbaldehyde (480) 
 
(2S,5S)-5-Benzyl-3-methyl-2-phenyl-imidazolidin-4-one 474a (6 mg, 0.023 mmol, 20 
mol-%) was dissolved in CH3CN (1 mL) and treated with a 0.1 M solution of HCl (0.23 
mL). Because linear triene 470 polymerized more rapidly than the branched triene 471, 
only the ratio of branched triene was higher. It was not possible to separate the trienes 
470 and 471 by flash chromatography, although several eluent mixtures were tested. A 21 
w-% 11-benzyloxy-undeca-2,7,9-trienal 470 (31 mg, 0.111 mmol, 100 mol-%) was 
dissolved in CH3CN (1 mL) and added into the reaction flask. After 30 minutes of 
stirring, the reaction mixture was yellowish solution. The reaction mixture was stirred for 
44 hours and the reaction mixture was diluted with ether (5 mL) and the combined 
organics were washed with brine (3 mL), dried with MgSO4, filtered and concentrated to 
give 40 mg of yellow oil. The crude product was purified by flash chromatography (5  % 
EtOAc in hexanes) to yield 480 (3.6 mg, 59 %). The enantiomeric excess was determined 
from the corresponding alcohol by chiral HPLC (5 % i-PrOH in hexanes). The 
enantiomeric excess was 10 %. Only endo-adduct was observed by 1H NMR. 
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6.3.7 (3aS’,4R’,5S’,7aR’)-5-Benzyloxymethyl-2,3,3a,4,5,7a-hexahydro-1H-indene-
4-carbaldehyde (480) 
 
(2S,5S)-5-Benzyl-2-tert-butyl-3-methyl-imidazolidin-4-one 475 (6 mg, 0.025 mmol, 20 
mol-%) was dissolved in CH3CN (1 mL) and treated with a 0.1 M solution of HCl (0.25 
mL). A 21 w-% 11-benzyloxy-undeca-2,7,9-trienal 470 (33 mg, 0.124 mmol, 100 mol-%) 
was dissolved in CH3CN (1.5 mL) and added into the reaction flask. After 30 minutes of 
stirring, the reaction mixture was yellowish solution. The reaction mixture was stirred for 
17 hours and diluted with ether (5 mL). The combined organics were washed with brine 
(3 mL). The combined organics were dried with MgSO4, filtered and concentrated to give 
44 mg of yellow oil. The crude product was purified by flash chromatography (5 - 25  % 
EtOAc in hexanes) to yield 480 (7 mg, 99 %) as a clear oil. The enantiomeric excess was 
determined from the corresponding alcohol by chiral HPLC (5% i-PrOH in hexanes). The 
enantiomeric excess was 72 %. [α]20D = +23.3 (c 1.33, CDCl3).  Only endo-adduct was 
observed by 1H NMR. 
6.3.8 (3aS’,4R’,5S’,7aR’)-5-Benzyloxymethyl-2,3,3a,4,5,7a-hexahydro-1H-indene-
4-carbaldehyde (480) 
 
(2S,5S)-5-Benzyl-2-tert-butyl-3-methyl-imidazolidin-4-one 475 (6.0 mg, 0.024 mmol, 20 
mol-%) was dissolved in CH3CN (1 mL) and a 0.1 M solution of HCl (0.25 mL) was 
added. A 65 w-% 11-benzyloxy-undeca-2,7,9-trienal 470 (32.6 mg, 0.121 mmol, 100 
mol-%) was dissolved in CH3CN (1.5 mL) and added into the reaction flask. The reaction 
mixture was stored in a freezer at –20 °C for 25.5 hours. After this, the mixture was 
allowed to stand for 44 hours at 6 °C (cold room). The reaction mixture was diluted with 
ether (5 mL) and the combined organics were washed with brine (3 mL). The water layer 
was extracted once with ether (3 mL) and the combined organics were dried with MgSO4. 
The filtration and concentration of the organics gave 38 mg of clear oil. The crude 
product was purified by flash chromatography (5 % EtOAc in hexanes) to yield 480 (7 
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mg, 54 %) as a clear oil. The enantiomeric excess was determined from the 
corresponding alcohol by chiral HPLC (5 % i-PrOH in hexanes). The enantiomeric 
excess was 66 %. Only endo-adduct was observed by 1H NMR. 
6.3.9 (3aS’,4R’,5S’,7aR’)-5-Benzyloxymethyl-2,3,3a,4,5,7a-hexahydro-1H-indene-
4-carbaldehyde (480) 
 
(2S,5S)-5-Benzyl-2-tert-butyl-3-methyl-imidazolidin-4-one 475 (5.9 mg, 0.024 mmol, 18 
mol-%) was dissolved in CH2Cl2 (1.5 mL) and i-PrOH (0.25 mL) was added. p-
Toluenesulfonic acid monohydrate (4.6 mg, 0.024 mmol, 18 mol-%) was added. A 65 w-
% 11-benzyloxy-undeca-2,7,9-trienal 470 (35.2 mg, 0.130 mmol, 100 mol-%) was 
dissolved in CH2Cl2 (1.0 mL) and added into the reaction flask. The reaction mixture was 
stored in a freezer at –20 °C for 25.5 hours. After this, the reaction mixture was allowed 
to stand for 67 hours at 6 °C (cold room). The reaction mixture was diluted with ether (5 
mL) and the combined organics were washed with brine (3 mL). The water layer was 
extracted once with ether (3 mL) and the combined organics were dried with MgSO4. The 
filtration and concentration of the organics gave 41 mg of clear oil. The crude product 
was purified by flash chromatography (5 % EtOAc in hexanes) to yield 480 (10.2 mg ,45 
%). The enantiomeric excess was determined from the corresponding alcohol by chiral 
HPLC (5% i-PrOH in hexanes). The enantiomeric excess was 41 %. Endo/exo ratio was 
determined by 1H NMR to be 25:1. 
 
6.3.10 (3aS’,4R’,5S’,7aR’)-5-Benzyloxymethyl-2,3,3a,4,5,7a-hexahydro-1H-indene-
4-carbaldehyde (480) 
 
(2S,5S)-3,5-Dibenzyl-2-tert-butyl-imidazolidin-4-one 479a (8.3 mg, 0.026 mmol, 20 
mol-%) was dissolved in CH3CN (1 mL) and a 0.1 M solution of HCl (0.25 mL) was 
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added. A 65 w-% 11-benzyloxy-undeca-2,7,9-trienal 470 (35.6 mg, 0.132 mmol, 100 
mol-%) was dissolved in CH3CN (1.5 mL) and added into the reaction flask. The reaction 
mixture was stored in a freezer at –20 °C for 25.5 hours. After this, the reaction mixture 
was allowed to stand for 68 hours at 6 °C (cold room). The reaction mixture was diluted 
with ether (5 mL) and the combined organics were washed with brine (3 mL). The water 
layer was extracted once with ether (2 mL) and the combined organics were dried with 
MgSO4. Filtration and concentration of the organics gave 60 mg of yellow oil. The crude 
product was purified by flash chromatography (5 % EtOAc in hexanes) to yield 480 (9.3 
mg, 40%). The enantiomeric excess was determined from the corresponding alcohol by 
chiral HPLC (5% i-PrOH in hexanes). The enantiomeric excess was 56 %. Endo/exo ratio 
was determined by 1H NMR to be 17:1. 
6.3.11 (3aS’,4R’,5S’,7aR’)-5-Benzyloxymethyl-2,3,3a,4,5,7a-hexahydro-1H-indene-
4-carbaldehyde (480) 
 
(2S,5S)-3,5-Dibenzyl-2-tert-butyl-imidazolidin-4-one 479a (8.3 mg, 0.026 mmol, 19 
mol-%) was dissolved in CH2Cl2 (1.5 mL) and i-PrOH (0.25 mL) was added. p-
Toluenesulfonic acid monohydrate (4.9 mg, 0.026 mmol, 19 mol-%) was added. A 65 w-
% 11-benzyloxy-undeca-2,7,9-trienal 470 (37.3 mg, 0.138 mmol, 100 mol-%) was 
dissolved in CH2Cl2 (1.0 mL) and added into the reaction flask. The reaction mixture was 
stored in a freezer at –20 °C for 25.5 hours. After this, the reaction mixture was allowed 
to stand for 68 hours at 6 °C (cold room). The reaction mixture was diluted with ether (5 
mL) and the combined organics were washed with brine (3 mL). The water layer was 
extracted once with ether (2 mL) and the combined organics were dried with MgSO4. The 
filtration and concentration of the organics gave 48 mg of clear oil. The crude product 
was purified by flash chromatography (5 % EtOAc in hexanes) to yield 480 (9.1 mg, 38 
%). The enantiomeric excess was determined from the corresponding alcohol by chiral 
HPLC (5 % i-PrOH in hexanes). The enantiomeric excess was 12 %. Endo/exo ratio was 
determined by 1H NMR to be 14:1. 
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6.3.12 (3aS’,4R’,5S’,7aR’)-5-Benzyloxymethyl-2,3,3a,4,5,7a-hexahydro-1H-indene-
4-carbaldehyde (480) 
 
(2S,5S)-3,5-Dibenzyl-2-tert-butyl-imidazolidin-4-one 479a (8.3 mg, 0.026 mmol, 19 
mol-%) was dissolved in CH3CN (1 mL) and a 0.1 M solution of HCl (0.25 mL) was 
added. A 65 w-% 11-benzyloxy-undeca-2,7,9-trienal 470 (36.9 mg, 0.136 mmol, 100 
mol-%) was dissolved in CH3CN (1.5 mL) and added into the reaction flask. The reaction 
mixture was stirred for 72 hours. The reaction mixture was diluted with ether (5 mL) and 
the combined organics were washed with brine (3 mL). The water layer was extracted 
once with ether (2 mL) and the combined organics were dried with MgSO4. The filtration 
and concentration of the organics gave 45 mg of yellow oil. The crude product was 
purified by flash chromatography (5 % EtOAc in hexanes) to yield 480 (13.0 mg, 54 %). 
The enantiomeric excess was determined from the corresponding alcohol by chiral HPLC 
(5 % i-PrOH in hexanes). The enantiomeric excess was 47 %. Only endo-cycloadduct 
was observed by 1H NMR.  
 
6.3.13 (3aS’,4R’,5S’,7aR’)-(5-Benzyloxymethyl-2,3,3a,4,5,7a-hexahydro-1H-inden-
4-yl)-methanol (481) 
 
OBn
O
OBn
HO
480 481  
 
The cyclic aldehyde 480 (9 mg, 0.033 mmol, 100 mol-%) was dissolved in EtOH (1 mL) 
and NaBH4 (excess) was added at r.t. The reaction mixture was stirred for 1 hour and 
quenched with 5 w-% aqueous solution of citric acid (1 mL). The product was extracted 
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with ether (3 x 2 mL) and washed with brine (2 mL). The organic phase was dried with 
Na2SO4, filtered and concentrated to give 9.3 mg of 481 as a clear oil. Rf (40 % MTBE in 
hexanes) = 0.35. UV(max) = 239 nm. HPLC (5 % i-PrOH in hexanes). RT (minor 
diastereomer) = 11.4 min, RT (major diastereomer) = 13.7 min. The enantiomeric excess 
was 72 %. [α]20D = +92.5 (c 0.32, MeOH). 1H NMR (CDCl3, 400.132 MHz) δ 7.33 (m, 
5H), 5.90 (d, 1H, J = 9.8 Hz), 5.45 (ddd, 1H, J = 9.6, 4.3, 2.4 Hz), 4.52 (s, 2H), 3.67-3.51 
(m, 4H), 3.35 (dd, 1H, J = 9.6, 1.7 Hz), 2.84 (m, 1H), 2.02 (m, 1H), 1.80-1.68 (m, 6H), 
1.22-1.08 (m, 2H). 13C NMR (CDCl3, 100.62 MHz) δ 137.2, 132.2, 128.6, 128.1, 128.0, 
127.4, 73.6, 71.2, 63.2, 46.1, 44.5, 41.7, 38.7, 28.7, 27.1, 22.5. HRMS (EI) calculated for 
C18H24O2: 272.1776, found 272.1786. 
6.4 Preparation of amino alcohol side chain by oxyamination  
6.4.1 (2R,3S)-Isopropyl 3-(benzyloxycarbonylamino)-2-hydroxybutanoate (497) 
 
NH
OH
O
O
Cbz
O
O
493 497  
 
Benzyl carbamate (0.470 g, 3.10 mmol, 310 mol-%) was dissolved in CH3CN (4 mL). 
NaOH (0.122 g, 3.05 mmol, 305 mol-%) in H2O (7.5 mL) was added. After 5 minutes of 
stirring, 1,3-dichloro-5,5-dimethyl hydantoin  (0.300 g, 1.52 mmol, 152 mol-%) was 
added. After 15 minutes of stirring, (DHQD)2PHAL (40 mg, 0.05 mmol, 5 mol-%) and 
trans-isopropyl crotonate 493 (0.129 g, 1.00 mmol, 100 mol-%) was dissolved in CH3CN  
(3.5 mL) and added to the reaction mixture. This was followed by K2OsO2(OH)4 (15 mg, 
0.04 mmol, 4 mol-%). The reaction was followed by TLC (50 % EtOAc/hexane). The 
starting material consumption was followed by coloring the TLC plates with 
permanganate solution. The reaction mixture was brown at start. After 1 hour of stirring, 
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Na2SO3 (1 g) was added to the yellow reaction mixture to quench the reaction. After 30 
minutes of stirring, the product was extracted with EtOAc (4 x 10 mL). The combined 
organic layers were washed with brine (10 mL) and dried with Na2SO4 and filtered. The 
solvents were evaporated and the product was concentrated to give 0.791 g of yellowish 
solid. The crude product was purified by flash chromatography (25 % EtOAc/hexane) to 
give 497 (0.137 g, 46 %) as a white solid. Chlorinated ethyl carbamate was the main 
byproduct. Rf (50 % EtOAc in hexanes) = 0.40. HPLC (0.9 mL/min, 10 % i-PrOH in 
hexanes) RT (major) 10.94 min, (minor) 12.41 min. The enantiomeric excess was 91 %. 
[α]20D = -1.0 (c 1.06, CHCl3). 1H NMR (CDCl3, 400.132 MHz) δ 7.36 – 7.30 (m, 5 H), 
5.08 – 5.02 (m, 3 H), 4.97 (d, 1 H, J = 9.4 Hz), 4.26 (qv, 1 H, J = 7.2 Hz), 4.07 (dd, 1 H, 
J = 4.1, 2.2 Hz), 3.12 (d, 1 H, J =  4.1 Hz), 1.60 (s, 1 H), 1.27 (d, 6 H, J = 6.8 Hz), 1.21 
(d, 3 H, J = 6.2 Hz). 13C NMR (CDCl3, 100.62 MHz) δ 172.8, 155.5, 136.5, 128.5, 128.1, 
128.0, 73.2, 70.5, 66.7, 49.0, 21.7, 21.4, 18.2. LRMS (EI+) 295, 236, 208, 178, 149, 134 
(100), 121, 107, 91, 79, 65, 57. HRMS (EI+) calculated for C15H21NO5: 295.1420, found 
295.1416.  
6.4.2 (4R,5S)-Benzyl 4-(tert-butoxycarbonyl)-2,2,4-trimethyl-3-
oxazolidinecarboxylate (498) 
 
NH
OH
O
O
Cbz
N
O
O
OCbz
494 498  
 
Benzene was dried by passing it through a pad of active alumina. tert-Butyl (2R,3S)-3-
(benzyloxycarbonylamino)-2-hydroxybutanoate 494 (90 mg, 0.29 mmol, 100 mol-%) 
was dissolved in previously dried benzene (2 mL). 2,2-Dimethoxypropane (68 mg, 0.64 
mmol, 221 mol-%) and para-toluenesulfonic acid monohydrate (1 mg, 0.005 mmol, 2 
mol-%) was added and the resulting mixture was refluxed. The oil bath temperature was 
80-88 °C. The reaction was followed by TLC (50 % EtOAc/hexane). After 2 hours of 
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refluxing, the reaction mixture was treated with H2O (2 mL) and the product was 
extracted with EtOAc (3 x 5 mL). The combined organic layers were washed with brine 
(5 mL). The organic layer was dried with Na2SO4 and filtered. The solvents were 
evaporated to give 0.1 g of yellow oil. The crude product was purified by flash 
chromatography (15 % EtOAc/hexane) to give 498 (85 mg, 83 %) as a white solid. M.p. 
64-66 °C. Rf (50 % EtOAc/hexane) = 0.53. [α]20D = -10.9 (c 1.63, CHCl3). 1H NMR 
(CDCl3/TMS, 400.13 MHz) δ 7.37-7.33 (m, 5 H), 5.16 (t, 2 H, J = 12.4  Hz), 4.26 (m, 1 
H), 4.16 (d, 1 H, J = 4.1 Hz), 1.64 (s, 3 H), 1.58 (s, 3 H), 1.48 (s, 9 H), 1.42 (s, 3 H). 13C 
NMR (CDCl3, 100.62 MHz) 129.2, 128.7, 128.6, 83.0, 28.6. IR (CHCl3) 3020, 1746, 
1700, 1410, 1353, 1221, 1217, 1213, 1210, 1087, 759. LRMS (EI) 349, 334, 292, 278, 
258, 248, 234, 204, 181, 158, 114, 91, 84, 77, 65(100). HRMS (EI) calculated for 
C19H27NO5: 349.1889, found 349.1824. 
6.4.3 (4R,5S)-5-Hydroxymethyl-2,2,4-trimethyl-oxazolidine-3-carboxylic acid 
benzyl ester (500) 
 
N
O
O-tBuCbz N
O
OHCbz
O
498 500  
 
tert-Butyl oxazolidine derivative 498 (1.76 g, 5.03 mmol, 100 mol-%) in dry THF (50 
mL) was cooled to 0 °C and LiAlH4 (0.57 g, 19.13 mmol, 380 mol-%) was added in 
portions. The resulting mixture was stirred for 1.5 hours and the reaction was quenched 
with H2O (0.6 mL). This was followed by NaOH (0.6 mL, 15 w-%) and H2O (1.7 mL). 
The resulting mixture was stirred for 20 minutes and dried with Na2SO4. The mixture was 
filtered and treated with diethyl ether (20 mL). The mixture was filtered through a Celite 
pad and the pad was washed with ether (200 mL). The filtrate was dried with Na2SO4, 
filtered, concentrated and purified by flash chromatography (20 % EtOAc in hexanes) to 
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give 500 (1.22 g, 87 %) as a colorless oil. Rf (50 % EtOAc in hexanes) = 0.27. [α]D20 = + 
9.05 (c 1.00, CHCl3).  IR (CHCl3) ν 3684, 3608, 3019, 2400, 1698, 1410, 1352, 1222, 
1076, 757, 669 cm-1. 1H NMR (CDCl3, 400 MHz) δ 7.34 (m, 5H), 5.15 (m, 2H), 3.84 (m, 
2H), 3.75 (m, 1H), 3.62 (m, 1H), 2.04 (s, 1H), 1.65 (s, 3H), 1.54 (s, 3H), 1.33 (s, 3H). 13C 
NMR (CDCl3, 100 MHz) δ 153.3, 137.1, 129.2, 128.8, 128.7, 101.2, 82.7, 67.4, 63.1, 
54.4, 27.6, 26.9, 20.3, 14.9. LRMS (EI) m/z [M+1] 278, 264, 220, 105, 91(100), 84, 65, 
59. HRMS (EI) calculated for C15H21NO4: 279.1471, found 279.1385. 
6.4.4 (4R,5S)-Benzyl 5-bromomethane-2,2,4-trimethyl-3-oxazolidine (501) 
 
N
O
OHCbz N
O
BrCbz
500 501  
 
Crude benzyl (4S,5R)-4-hydroxymethyl-2,2,4-trimethyl-3-oxazolidine 500 (≈0.53 mmol, 
100 mol-%) from the reaction above was dissolved in dry THF (10 mL). 
Triphenylphosphine (0.324 g, 1.24 mmol, 200 mol-%), carbon tetrabromide (0.408 g, 
1.23 mmol, 200 mol-%) and diisopropylethylamine (0.158 g, 1.22 mmol, 200 mol-%) 
was added. The resulting mixture was stirred for 1 hour and the mixture was diluted with 
ether (50 mL). The organics were washed with 0.5 M H3PO4 (2 x 25 mL). The combined 
water layers were extracted with ether (25 mL). The organics were washed with a 
saturated solution of NaHCO3. The water layer was extracted with ether (25 mL). The 
combined organics were washed with brine (25 mL), filtered and concentrated to give 
0.577 g of brown oil. The crude product was purified by flash chromatography (6 % 
EtOAc/C6) to give 501 (0.136 g, 75 % from 498) as a clear oil. Rf 501 (50 % 
EtOAc/hexane) = 0.55. [α]20D = +9.5 (c 1.59, CHCl3). 1H NMR (CDCl3/TMS, 400.13 
MHz) δ 7.38-7.31 (m, 5 H), 5.20 (m, 2 H), 4.01 (m, 2 H), 3.42 (d, 2 H, J = 6.0 Hz), 3.21 
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(q, 1 H, J = 7.2 Hz), 1.65 (s, 3 H), 1.56 (s, 3 H), 1.36 (s, 3 H). 13C NMR (CDCl3, 100.62 
MHz) 153.0, 137.0, 129.2, 128.8, 128.7, 96.3, 82.3, 67.4, 57.4, 33.7, 28.4, 27.7, 21.1. 
LRMS (EI+) 341, 326, 282, 248, 236, 204, 164, 135, 107, 92(100), 77, 65, 51. HRMS 
(EI) calculated for C15H20BrNO3: 341.0627, found [M-1] 340.0578.  
6.4.5 (4R,5S)-5-Iodomethyl-2,2,4-trimethyl-oxazolidine-3-carboxylic acid benzyl 
ester (502) 
 
N
O
ICbzN
O
OHCbz
500 502  
 
Triphenyl phosphine (1.56 g, 5.94 mmol, 150 mol-%) and imidazole (0.40 g, 5.94 mmol, 
150 mol-%) was added into a solution of alcohol 500 (1.11 g, 5.03 mmol, 100 mol-%) in 
dry CH2Cl2 (40 mL). Iodine (1.51 g, 5.94 mmol, 150 mol.%) was added into the mixture 
and the reaction mixture was stirred for 5 hours. The reaction mixture was diluted with 
diethyl ether (100 mL) and washed with 0.5 M H3PO4 (50 mL). The product was 
extracted with diethyl ether (3 x 50 mL) and washed with a saturated solution of NaHCO3 
(50 mL) and brine (50 mL). The organics were dried with Na2SO4, filtered and 
concentrated to give white solid. The crude product was purified by flash 
chromatography (10 % EtOAc in hexanes) to give 502 (1.16 g, 76 %) as a clear oil. Rf 
502 (50 % EtOAc in hexanes) = 0.62. [α]D20 = + 6.9 (c 1.00, CHCl3). IR (CHCl3) ν 3682, 
3492, 3017, 2401, 1698, 1409, 1353, 1211, 1093, 770, 668 cm-1. 1H NMR (CDCl3, 
400.132 MHz) δ 7.34 (m, 5H), 5.11 (m, 2H), 3.92 (m, 2H), 3.25 (m, 2H), 1.67 (s, 3H), 
1.55 (s, 3H), 1.35 (s, 3H). 13C NMR (CDCl3, 100.62 MHz) δ 153.0, 137.0, 129.2, 128.8, 
128.7, 96.4, 82.5, 67.4, 58.5, 28.5, 27.9, 21.1, 8.3. LRMS (EI) m/z [M+1] 390, 374(100), 
330, 282, 224, 181, 148, 107, 91, 84, 77, 65, 59, 51. HRMS (EI) calculated for 
C15H20NIO4: 389.0488, found 389.0465. 
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6.4.6 (4R,5S)-Benzyl 5-sulfonylphenylmethane-2,2,4-trimethyl-3-oxazolidine 
(504) 
 
N O
I
Cbz +
S
O
O
Na
N O
SO2
Cbz
502 503 504  
 
Benzyl (4S,5R)-4-iodomethane-2,2,4-trimethyl-3-oxazolidine 502 (45 mg, 0.12 mmol, 
100 mol-%) was dissolved in dry DMF (2 mL) and sodium phenylsulfone 503 (57 mg, 
0.35 mmol, 292 mol-%) was added at r.t. and stirring was continued for 30 minutes. After 
this, the reaction mixture was warmed with an oil bath to + 50 °C. Stirring was continued 
for 13 hours. A second portion of sodium phenylsulfone (30 mg, 0.02 mmol, 17 mol-%) 
was added and stirring was continued for 7 hours. The third portion of sodium 
phenylsulfone (27 mg, 0.02 mmol, 17 mol-%) was added and stirring was continued for 
16 hours. The reaction mixture was cooled to r.t. and the product was partitioned between 
H2O (10 mL) and ether (10 mL). The layers were separated and the water phase was 
extracted with ether (3 x 10 mL). The combined organics were washed with brine (10 
mL), dried with MgSO4, filtered and concentrated to give 46 mg of clear oil. The product 
was purified by flash chromatography (40 % MTBE in hexanes) to give 504 (35 mg, 76 
%) as a clear oil. Rf (40 % MTBE/hexane) = 0.15. [α]20D = - 22.2 (c 0.99, CH2Cl2). 1H 
NMR (CDCl3, 400.132 MHz) δ 7.93 – 7.34 (m, 10H), 5.17 – 5.09 (m, 2H), 4.25 (dt, 1H, 
J = 4.1, 6.1 Hz), 3.90 (s, 1H), 3.37 (qd, 2H, J = 14.3, 6.1 Hz), 1.47 (s, 3H), 1.40 (s, 3H), 
1.33 (s, 3H). 13C NMR (CDCl3, 100.613 MHz) δ 152.8, 140.2, 136.9, 134.6, 129.9, 129.2, 
129.0, 128.8, 128.7, 96.0, 67.5, 60.9, 58.5, 28.0, 27.5, 20.3. LRMS (EI+) 403, 388, 344, 
312, 268, 204, 181, 160, 141, 126, 112, 91, 77(100), 65, 51. HRMS (EI+) calculated for 
[M+1] C21H26NO5S: 404.1533, found 404.1541. 
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6.5 Preparation of amino alcohol side chain by HWE and Wittig 
approaches   
6.5.1 (1S)-(1,5-Dimethyl-2-oxo-hex-3-enyl)-carbamic acid tert-butyl ester (463) 
 
NHBOC
P
O O
OMe
OMe
NHBOC
O
413 463  
 
Ethanol was distilled from Mg(OEt)2 to 3 Å molecular sieve powder. (3S)-(3-tert-
Butoxycarbonylamino-2-oxo-butyl)-phosphonic acid dimethyl ester 413 (63 mg, 0.21 
mmol, 100 mol-%) was dissolved in dry EtOH (2 mL) and K2CO3 (30 mg, 0.22 mmol, 
102 mol-%) was added. Stirring was continued for 15 minutes and isobutyraldehyde (17 
mg, 0.24 mmol, 111 mol-%) in dry EtOH (2 mL) was added. The reaction mixture was 
stirred for 40 minutes and reaction was not noticed. A drop of water was added. A slow 
reaction was noticed. Stirring was continued for 2 hours and 2 drops of water was added. 
Stirring was continued for 25.5 hours and the reaction mixture was filtered. The reaction 
mixture was concentrated and EtOAc (5 mL) was added. The organics were washed with 
a 10 w-% aqueous solution of citric acid (5 mL). The water phase was extracted with 
EtOAc (2 x 5 mL). The combined organics were washed with brine (10 mL), dried with 
Na2SO4, filtered and concentrated to give 86 mg of white precipitate. The crude product 
was purified by flash chromatography (10 % EtOAc in hexanes) to give 463 (36 mg, 69 
%) as a white solid. M.p. 49-51 °C. [α]20D = +10.5 (c 1.0, CHCl3). Rf (15 % EtOAc in 
hexane) = 0.22. The product was analyzed by chiral HPLC (flow rate 0.6 mL/min, 5 % i-
PrOH in hexanes). The retention times with HPLC were (463) 10.44 min, (enantiomer) 
13.96 min. GLC (Supelco γ-dex) (inj. 240 °C, vel. 28 cm/sec, 100-220 °C, 8 °C/min, det. 
270 °C. The retention times with GLC were (463) 14.85 min, (enantiomer) 15.49 min. 
The enantiomeric excess was >99 %ee. 1H NMR (CDCl3, 400.132 MHz) δ 6.97 (dd, 1 H, 
 
 
 
 
 
 
 
203 
 
J = 15.8, 6.7 Hz), 6.13 (d, 1 H, J = 15.9 Hz), 5.40 (s, 1H), 4.58 (t, 1 H, J = 7.2 Hz), 2.49 
(m, 1H), 1.44 (s, 9 H), 1.33 (d, 3 H, J = 7.0 Hz), 1.08 (d, 6 H, J = 6.8 Hz). 13C NMR 
(CDCl3, 100.62 MHz) δ 199.1, 156.2, 155.5, 124.0, 79.9, 53.6, 31.7, 28.7, 21.5, 21.5, 
19.2. LRMS (EI+) 242 (M+1), 168, 144, 125, 97, 88, 57(100). HRMS (EI+) calculated 
for [M+1] C13H24NO3: 242.1758, found 242.1704. 
6.5.2 (1S)-(1,5-Dimethyl-2-oxo-hex-3-enyl)-carbamic acid tert-butyl ester (463) 
 
(3S)-(3-tert-Butoxycarbonylamino-2-oxo-butyl)-phosphonic acid dimethyl ester 413 (151 
mg, 0.51 mmol, 100 mol-%) was dissolved in CH3CN (5 mL) and K2CO3 (141 mg, 1.02 
mmol, 200 mol-%) was added. The reaction mixture was stirred for 2 minutes and 
isobutyraldehyde (55 mg, 0.75 mmol, 150 mol-%) was added. Stirring was continued in 
an argon atmosphere for 5 days and the reaction mixture was neutralized by adding a 10 
w-% aqueous solution of citric acid. The product was extracted with EtOAc (3 x 10 mL). 
The combined organics were washed with brine (10 mL), dried with Na2SO4, filtered and 
concentrated to give 0.236 g of yellow oil. The crude product was purified by flash 
chromatography (10 % EtOAc in hexanes) to give 463 (75 mg, 61 %) as a white solid. 
The enantiopurity was determined by GLC. The temperature program was 240 °C (inj.), 
oven 100-220 °C/8 °C/min, 28 cm (vel.), 240 °C (det.). The retention times with GLC 
were (463) 14.8 min, (enantiomer) 15.4 min. The enantiomeric excess was 97 %. See 
chapter 6.5.1. for analytical details. 
 
6.5.3 (1S)-(1,5-Dimethyl-2-oxo-hexyl)-carbamic acid tert-butyl ester (485) 
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NHBOC
O
NHBOC
O
463 485  
 
Enone (463) (56 mg, 0.232 mmol, 100 mol-%) was dissolved in THF (6 mL). Freshly 
prepared Raney Ni (W2) in EtOH (100 pipette drops) was added. Stirring was continued 
for 40 minutes at room temperature. After this, the reaction mixture was filtered through 
a short pad (2 cm) of silica. Ether (3 x 4 mL) was used for flushing the pad. The solvents 
were evaporated to give 61 mg of clear oil. The crude product was purified by flash 
chromatography. The eluent was 10% EtOAc in hexanes. The yield of 485 was 50 mg 
(89 %) as a white solid. Rf 485 (32 % EtOAc in hexanes) = 0.45. GLC (Supelco γ-dex) 
(inj. 250 °C, vel. 28 cm/sec, 100-200 8 °C/min, det. 240 °C). The retention times were 
(485) 14.0 min, (enantiomer) 14.3 min. The enantiomeric excess was 96 %. [α]20D = -0.4 
(c 1.38, CHCl3). 1H NMR (CDCl3, 400.132 MHz) δ 5.31 (s, 1H), 4.32 (t, 1H, J = 7.0 Hz), 
2.50 (m, 2H), 1.53 (m, 3H), 1.44 (s, 9H), 1.33 (d, 3H, J = 7.2 Hz), 0.89 (dd, 6H, J = 6.2, 
1.1 Hz). 13C NMR (CDCl3, 100.62 MHz) δ 209.8, 155.1, 79.6, 55.0, 37.1, 32.3, 28.3, 
27.6, 22.3, 22.2, 17.9. HRMS (ES+) calculated for C13H25NO3Na: 266.1732, found 
266.1717.         
6.5.4 (1S,2S/R)-(2-Hydroxy-1,5-dimethyl-hexyl)-carbamic acid tert-butyl ester 
(486a,b) 
 
NHBOC
O
NHBOC
OH
+
NHBOC
OH
485 486a 486b  
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ZnBr2 (13.0 mg, 0.058 mmol, 123 mol-%) was dissolved in dry ether (1 mL). Amino 
ketone 485 (11.4 mg, 0.047 mmol, 100 mol-%) in dry ether (1.5 mL) was added at 0 °C. 
The resulting mixture was stirred for 40 minutes. After this, the reaction mixture was 
cooled to – 78 °C and 1.0 M solution of DIBAL-H in toluene (140 µl, 0.140 mmol, 300 
mol-%) was added dropwise. Stirring was continued for 35 minutes at – 78 °C and 
MeOH (0.5 mL) was added to quench the reaction. This was followed by a 1 M solution 
of HCl (2 mL). The reaction mixture was allowed to warm to r.t. and the stirring was 
continued for 15 minutes. The product was extracted with EtOAc (3 x 3 mL). The 
combined organics were washed with brine (2 mL), dried with MgSO4, filtered and 
concentrated to give 10 mg (77 %) of 486a,b as a white solid. Rf (32 % EtOAc in 
hexanes) = 0.20. GLC (Supelco γ-dex) (inj. 240 °C, vel. 28 cm/sec, 100-200 8 °C/min, 
det. 270 °C). RT (S,R-486b) 15.20 min, RT(S,S-486a) = 15.70 min. The ratio of (S,R-
486b) to (S,S-486a) was 1:7.1 The enantiomeric excess was 75 %. 1H NMR 486a 
(CDCl3, 400.132 MHz) δ 4.78 (m, 1H), 3.70 (m, 1H), 3.62 (m, 1H), 2.14 (m, 1H), 1.65-
1.18 (m,  H), 1.44 (s, 9H), 1.09 (d, 3H, J = 7.0 Hz), 0.89 (d, 6H, J = 6.6 Hz). 13C NMR 
(CDCl3, 100.62 MHz) δ 155.8, 79.4, 74.7, 50.5, 35.1, 31.3, 28.4, 28.1, 22.5 (d), 14.3. 
HRMS (ES+) calculated for C13H27NO3Na: 268.1889, found 268.1883. 
 
6.5.5 (1S,2S/R)-(2-Hydroxy-1,5-dimethyl-hexyl)-carbamic acid tert-butyl ester 
(486a,b) 
 
Amino ketone 485  (13.5 mg, 0.055 mmol, 100 mol-%) was dissolved in dry THF (2 
mL). ZnBr2 (15.4 mg, 0.068 mmol, 123 mol-%) was added at 0 °C. The resulting mixture 
was stirred for 60 minutes. After this, the reaction mixture was cooled to – 78 °C and a 
1.0 M solution of DIBAL-H in toluene (280 µl, 0.280 mmol, 500 mol-%) was added 
dropwise. Stirring was continued for 45 minutes at – 78 °C and MeOH (0.5 mL) was 
added to quench the reaction. This was followed by a 1 M solution of HCl (2 mL). The 
reaction mixture was allowed to warm to r.t. and stirring was continued for 15 minutes. 
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The product was extracted with EtOAc (3 x 3 mL). The combined organics were washed 
with brine (2 mL), dried with MgSO4, filtered and concentrated to give 17 mg of crude 
product. The product was analyzed by chiral GLC. The ratio of (S,R-486b) to (S,S-486a) 
was 1:4.1. For analytical data see 6.5.4. 
6.5.6 (1S,2S/R)-(2-Hydroxy-1,5-dimethyl-hexyl)-carbamic acid tert-butyl ester 
(486a,b) 
 
Amino ketone 485 (10.3 mg, 0.042 mmol, 100 mol-%) was dissolved in dry THF (1.5 
mL). The reaction mixture was cooled to – 95 °C (MeOH/N2(l)) and 1.0 M solution of L-
Selectride in THF (150 µl, 0.150 mmol, 355 mol-%) was added dropwise. Stirring was 
continued for 35 minutes at – 95 °C and H2O (0.5 mL) was added to quench the reaction. 
The reaction mixture was allowed to warm to room temperature. The product was 
extracted with EtOAc (3 x 3 mL). The combined organics were washed with brine (2 
mL), dried with MgSO4, filtered and concentrated to give 26 mg of clear oil. The crude 
product was purified by flash chromatography (15 % EtOAc in hexanes) to give 486a,b 
was (11.5 mg, >99 %) as a white solid. The product was analyzed by chiral GLC. The 
ratio of (S,R-486b) to (S,S-486a) was 1:3.5. [α]20D = -1.0 (c 0.99, CHCl3). For analytical 
data see 6.5.4. 
6.5.7 (1S,2S/R)-(2-Hydroxy-1,5-dimethyl-hexyl)-carbamic acid tert-butyl ester 
(486a,b) 
 
Amino ketone 485 (34.9 mg, 0.143 mmol, 100 mol-%) was dissolved in dry THF (1 mL) 
and freshly prepared D-B-Me-CBS catalyst in toluene (143 µl, 0.143 mmol, 100 mol-%) 
was added. The reaction mixture was cooled to – 24 °C (ethylene glycol/CO2). A 2.0 M 
solution of BH3⋅SMe2 in THF (80 µl, 0.160 mmol, 112 mol-%) was added dropwise. 
Stirring was continued for 1 hour and MeOH (0.5 mL) was added to quench the reaction. 
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This was followed by 1M HCl (1 mL). The reaction mixture was allowed to warm to 
room temperature. The product was extracted with EtOAc (4 x 3 mL). The combined 
organics were washed with brine (3 mL), dried with MgSO4, filtered and concentrated to 
give 47 mg of white solid. The product was analyzed by GLC. The ratio of (S,R-486b) to 
(S,S-486a) was 1:1.4. For analytical data see 6.5.4. 
6.5.8 (1S,2S/R)-(2-Hydroxy-1,5-dimethyl-hexyl)-carbamic acid tert-butyl ester 
(486a,b) 
 
ZnBr2 (11.0 mg, 0.058 mmol, 123 mol-%) was dissolved in dry THF (1 mL). Amino 
ketone 485 (9.5 mg, 0.039 mmol, 100 mol-%) in dry ether (1.5 mL) was added at 0 °C. 
The resulting mixture was stirred for 55 minutes. After this, the reaction mixture was 
cooled to – 78 °C and a 1.0 M solution of L-Selectride in THF (140 µl, 0.140 mmol, 300 
mol-%) was added dropwise. Stirring was continued for 30 minutes at – 78 °C and 1M 
HCl (1 mL) was added to quench the reaction. The reaction mixture was allowed to warm 
to r.t. and stirring was continued for 15 minutes. The product was extracted with EtOAc 
(3 x 3 mL). The combined organics were washed with brine (2 mL), dried with Na2SO4, 
filtered and concentrated to give 9.1 mg (95 %) of pure product. The product was 
analyzed by chiral GLC. The ratio of (S,R-486b) to (S,S-486a) was 1:3.8. For analytical 
data see 1.5.3. 
6.5.9 (1S,2S/R)-(2-Hydroxy-1,5-dimethyl-hexyl)-carbamic acid tert-butyl ester 
(486a,b) 
 
Amino ketone 485 (12.0 mg, 0.049 mmol, 100 mol-%) was dissolved in dry toluene (2 
mL). The reaction mixture was cooled to – 78 °C and a 1.0 M solution of DIBAL-H in 
toluene (148 µl, 0.148 mmol, 300 mol-%) was added dropwise. Stirring was continued 
for 20 minutes at – 78 °C and MeOH (0.5 mL) was added to quench the reaction. This 
was followed by a 1 M solution of HCl (2 mL). The reaction mixture was allowed to 
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warm to r.t. and stirring was continued for 15 minutes. The product was extracted with 
EtOAc (3 x 3 mL). The combined organics were washed with brine (2 mL), dried with 
MgSO4, filtered and concentrated to give 12.2 mg (>99 %) of 486a,b. The product was 
analyzed by chiral GC. The ratio of (S,R-486b) to (S,S-486a) was 1:3.3.  For analytical 
data see 6.5.4. 
6.5.10 (1S,2S/R)-(2-Hydroxy-1,5-dimethyl-hexyl)-carbamic acid tert-butyl ester 
(486a,b) 
 
Amino ketone 485 (10.9 mg, 0.045 mmol, 100 mol-%) was dissolved in MeOH (1 mL). 
CeCl3⋅7H2O (18.4 mg, 0.049 mmol, 120 mol-%) was added. The mixture was stirred until 
CeCl3 dissolved. NaBH4 (4.3 mg, 0.114 mmol, 276 mol-%) was added and stirring was 
continued for 20 minutes. After this, a 5 w-% solution of citric acid (2 mL) was added 
and stirring was continued for 5 minutes. The product was extracted with EtOAc (3 x 3 
mL). The combined organics were washed with brine (2 mL), dried with MgSO4, filtered 
and concentrated to give 13.9 mg crude product. The product was analyzed by chiral GC. 
The ratio of (S,R-486b) to (S,S-486a) was 1:5.3.  For analytical data see 6.5.4. 
6.5.11  (1S,2S/R)-(2-Hydroxy-1,5-dimethyl-hex-3-enyl)-carbamic acid tert-butyl 
ester (487a,b) 
 
NHBOC
O
NHBOC
OH
NHBOC
OH
+
463 487a 487b  
 
Ether was distilled from Na/benzophenone to 4Å molecular sieves. A 10 mL flask was 
flame dried and filled with argon. (1,5-Dimethyl-2-oxo-hex-3-enyl)-carbamic acid tert-
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butyl ester 463 (16 mg, 0.065 mmol, 100 mol-%) was dissolved in dry ether (3 mL) and 
the resulting mixture was cooled to – 78 °C (acetone/CO2(s)). A 1.0 M solution of L-
selectride in THF (200 µl, 0.200 mmol, 310 mol-%) was added dropwise into the 
reaction mixture. The reaction mixture was stirred for 1 hour and H2O (0.5 mL) was 
added dropwise and the mixture was allowed to warm to r.t. Ether was evaporated and 
the product was partitioned between CH2Cl2 (10 mL) and brine (5 mL). The water layer 
was extracted thrice with CH2Cl2 (3 x 5 mL). The combined organics were dried with 
Na2SO4, filtered and concentrated to give 23 mg of clear oil. The crude product was 
purified by flash chromatography (13 % EtOAc in hexanes) to give 487a,b (15 mg, 92 
%) as a clear oil. Rf (50 % EtOAc in hexanes) = 0.44. [α]20d = - 8.0 (c 1.00, CHCl3). λmax 
= 202 nm. HPLC (5 % i-PrOH in hexanes, λ = 235 nm). RT (S,R-487b) 4.45 min, RT 
(S,S-487a) 6.34 min. The ratio of (S,R-487b) to (S,S-487a) was 1:1.1. 1H NMR (S,R-
487a) (CDCl3, 400.132 MHz) δ 5.69 (dddd, 1H, J = 15.5, 6.7, 2.9, 1.2 Hz), 5.41 (dddd, 
1H, J = 15.5, 14.7, 7.2, 1.4 Hz), 4.65 (s, 1H), 4.11 (m, 1H), 3.65 (q, 1H, J = 6.6 Hz) 2.30 
(m, 2H), 1.44 (s, 9H), 1.07 (d, 3H, J = 6.8 Hz),1.00 (dd, 6H, J = 6.8, 1.9 Hz). 13C NMR 
(CDCl3, 100.62 MHz) δ 157.0, 141.6, 126.1, 80.3, 76.5, 51.8, 31.6, 29.1, 23.0, 22.9, 16.2. 
LRMS (EI+) 240, 205, 172, 144, 128, 109, 99, 88, 81, 69, 57(100). HRMS (EI+) 
calculated for C13H25NO3: 244.1913, found 244.1914.   
6.5.12 (1S,2S/R)- (2-Hydroxy-1,5-dimethyl-hexyl)-carbamic acid tert-butyl ester 
(486a,b) 
 
NHBOC
OH
NHBOC
OH
+
NHBOC
OH
NHBOC
OH
+
487a 487b 486a 486b
 
A mixture diastereomers 487a,b (7.1 mg, 0.03 mmol, 100 mol-%) was dissolved in 
MeOH (1 mL). Cyclohexene (2.2 mg, 0.03 mmol, 100 mol-%) was added in THF (0.5 
mL). The reaction mixture was bubbled with argon to remove oxygen for 5 minutes. 5% 
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Pd on CaCO3 was added and the reaction flask was flushed with H2 gas. The reaction 
mixture was stirred for 21 hours under H2 atmosphere. After this, the reaction mixture 
was filtered through a Celite pad. The Celite pad was flushed with MeOH. The solvents 
were evaporated to give 6.3 mg of clear oil. Cyclohexene reacted to cyclohexane during 
the reaction. Rf 486a,b (23 % EtOAc in hexanes) = 0.27. For analytical data see 6.5.4. 
6.5.13 (1S)-[1-Methyl-2-oxo-3-(triphenyl-Λ-phosphanylidene)-propyl]-carbamic 
acid tert-butyl ester (465) 
 
OH
O
NHBOC
O
NHBOC
P(Ph)3
464 465  
 
Methyltriphenylphosphonium bromide (2.19 g, 6.0 mmol, 300 mol-%) was diluted with 
dry benzene (60 mL) in a flame dried flask, filled with argon. The previously prepared 
phenyllithium (0.758 M, 8.0 mL, 6.1 mmol, 305 mol-%) was added dropwise in 10 
minutes. The white slurry changed to brownish yellow clear solution during the addition. 
N-BOC-(L)-alanine 464 (0.38 g, 2.0 mmol, 100 mol-%) was dissolved in dry benzene (23 
mL). To this flask, 1,1-carbonyldiimidazole (0.40 g, 2.5 mmol, 125 mol-%) was added in 
one portion. The flask containing methylene phosphorane was cooled to – 78 °C, this 
resulted freezing of the mixture. The reaction mixture was allowed to warm until the 
solution was homogenous. After this, the solution of imidazole derivative of 464 was 
added dropwise into the cooled flask containing methylene phosphorane in 15 minutes. 
Stirring was continued at r.t. for 1 hour. The product was partitioned between brine (100 
mL) and EtOAc (100 mL). The layers were separated and the water phase was extracted 
once with EtOAc (50 mL). The combined organics were dried with Na2SO4, filtered and 
concentrated to give 1.72 g of brown oil and clear oil in two different phases. The crude 
product was purified by flash chromatography (85 % EtOAc in hexanes) to yield 465 
(0.49 g, 54 %) as an yellow solid. M.p. 48-50 °C. Rf (EtOAc) = 0.19. [α]20D = - 1.5 (c 
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1.00, CHCl3). 1H NMR (CDCl3, 400.132 MHz) δ 7.63-7.46 (m, 15 H), 5.73 (d, 1 H, J = 
6.5 Hz), 4.33-4.30 (m, 1 H), 3.71 (d, 1 H, J = 24.4 Hz), 1.42 (s, 12 H). 13C NMR (CDCl3, 
100.613 MHz) δ 191.6, 156.2, 133.7, 133.6, 132.8, 132.8, 132.7, 132.6, 129.6, 129.5, 
129.2, 129.1, 127.9, 127.0, 79.0, 61.0, 53.6, 53.4, 29.1, 22.0, 21.7. LRMS (EI+) 447, 374, 
304(100), 277, 262, 228, 201, 183, 165, 152, 108, 77, 57. HRMS (EI+) calculated for 
[M+1] C27H31NO3P: 448.2042, found 448.2075. 
6.5.14 (1S)-(1-Methyl-2-oxo-4-phenyl-but-3-enyl)-carbamic acid tert-butyl ester 
(466) 
 
O
NHBOC
P(Ph)3
O
NHBOC
465 466  
 
Benzaldehyde was distilled in reduced pressure (bp = 8 mmHg/61 °C). Benzaldehyde (11 
mg, 0.16 mmol, 100 mol-%) was diluted with dry benzene (2 mL). (1S)-[1-Methyl-2-oxo-
3-(triphenyl-Λ-phosphanylidene)-propyl]-carbamic acid tert-butyl ester 465 (104 mg, 
0.23 mmol, 150 mol-%) was added and the reaction mixture was refluxed for 46 hours 
under argon atmosphere. Benzene evaporated during the reflux period and the residue 
was treated with EtOAc (5 mL). The organics were washed with brine (5 mL) and the 
separated water phase was extracted twice with EtOAc (5 mL). The combined organics 
were dried with Na2SO4, filtered and concentrated to give 122 mg of orange oil. The 
crude product was purified by flash chromatography (15 % MTBE in hexanes) to yield 
466 (33 mg, 76%) as a thick clear oil. Rf (30 % MTBE in hexanes) = 0.26. [α]20D = +6.5 
(c 1.57, CHCl3). 1H NMR (CDCl3, 400.132 MHz) δ 7.71 (d, 1 H, J = 16.0 Hz), 7.58 – 
7.40 (m, 5 H), 6.82 (d, 1 H, J = 16.0 Hz), 5.46 (d, 1 H, J = 6.5 Hz), 4.68 (t, 1 H, J = 7.2 
Hz), 1.46 (s, 9 H), 1.41 (d, 3 H, J = 7.2 Hz). 13C NMR (CDCl3, 100.62 MHz) δ 199.0, 
155.9, 145.1, 134.9, 131.5, 129.7, 129.2, 123.0, 80.4, 54.5, 29.0, 19.3. LRMS (EI+) 276 
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(M+1), 202, 158, 144, 131, 103, 88, 77, 57(100), 51. HRMS (EI+) calculated for [M+1] 
C16H22NO3: 276.1600, found 276.1591. 
 
 
6.6 Synthesis of amaminol analog by HWE and Kociensky-Julia 
approach 
6.6.1 [(3aS’,4R’,5S’,7aR’),1S]-[4-(5-Benzyloxymethyl-2,3,3a,4,5,7a-hexahydro-
1H-inden-4-yl)-1-methyl-2-oxo-but-3-enyl]-carbamic acid tert-butyl ester 
(489a,b) 
 
OBn
O
OBn
O
NHBOC
OBn
O
NHBOC
+
480 489a 489b  
 
(3-tert-Butoxycarbonylamino-2-oxo-butyl)-phosphonic acid dimethyl ester 413 (1.15 g, 
3.89 mmol, 105 mol-%) was dissolved in EtOH (94 w-%) (15 mL) and K2CO3 (0.54 g, 
3.89 mmol, 105 mol-%) was added. The reaction mixture was stirred for 2 minutes and 5-
benzyloxymethyl-2,3,3a,4,5,7a-hexahydro-1H-indene-4-carbaldehyde 480 (0.96 g, 3.55 
mmol, 100 mol-%, 72% ee) in EtOH (94 w-%) (22 mL) was added. Stirring was 
continued for 29 hours. A second portion of K2CO3 (0.23 g, 1.67 mmol, 47 mol-%) was 
added. Stirring was continued for 18 hours and the reaction mixture was filtered. The 
solids were washed with EtOH (Aa-grade) (20 mL). The solvents were evaporated and 
the resulting orange oil was diluted with CHCl3 (70 mL) and the organic phase was 
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washed twice with a saturated aqueous solution of NH4Cl (2 x 25 mL). PH of the aqueous 
phase was 4 at this point. The combined organics were washed with H2O (20 mL), dried 
with MgSO4, filtered and concentrated to give 2.05 g of yellow oil. The crude product 
was purified by flash chromatography (10 % EtOAc in hexanes) to give 489a,b (1.24 g, 
79 %) as a clear oil. The product was a mixture of diastereomers (489a:489b) with ratio 
1.3:1. This was determined by 1H NMR. It was possible to separate diastereomers, but the 
separation of conformers was not achieved by flash chromatography or chiral HPLC. The 
yield of 489a was 44 % as a clear oil. Rf (20 % MTBE in hexanes) = 0.43. [α]20D = + 
33.2 (c 1.16, CHCl3). 1H NMR (CDCl3, 400.132 MHz) δ 7.33-7.26 (m, 5H), 7.01 (dd, 
1H, J = 15.9, 8.9 Hz), 6.19 (d, 1H, J = 15.9 Hz), 5.96 (d, 1H, J = 10.0 Hz), 5.49 (dt, 1H, J 
= 10.1, 2.9 Hz), 5.42 (d, 1H, J = 5.0 Hz), 4.59-4.45 (m, 3H), 3.46-3.34 (m, 2H), 2.88 (d, 
1H, J = 8.8 Hz), 2.50 (m, 1H), 1.83 (m, 2H), 1.70-1.55 (m, 4H), 1.44 (s, 9H), 1.32 (d, 3H, 
J = 7.0 Hz), 1.28-1.10 (m, 2H). 13C NMR (CDCl3, 100.62 MHz) δ 198.2, 155.1, 149.5, 
138.3, 132.5 (d), 128.4, 127.6 (d), 126.0 (d), 79.5, 72.9 (d), 72.7 (d), 53.2, 42.9 (d), 41.8, 
39.8, 39.2 (d), 28.7 (d), 28.3, 26.1, 22.0, 19.0. LRMS (EI+) 440 (M+1), 383, 339, 295, 
275, 248, 231, 218, 187, 159, 144, 131, 105, 91, 79, 65, 57(100). HRMS (ES+) calculated 
for C27H37NO4Na: 462.2620, found 462.2624. 
6.6.2 [(3aS’,4R’,5S’,7aR’),1S]-[4-(5-Benzyloxymethyl-2,3,3a,4,5,7a-hexahydro-
1H-inden-4-yl)-1-methyl-2-oxo-butyl]-carbamic acid tert-butyl ester (512) 
 
OBn
O
NHBOC
OBn
O
NHBOC
489a 512  
 
[4-(5-Benzyloxymethyl-2,3,3a,4,5,7a-hexahydro-1H-inden-4-yl)-1-methyl-2-oxo-but-3-
enyl]-carbamic acid tert-butyl ester 489a (171 mg, 0.39 mmol, 100 mol-%) was dissolved 
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in THF (23 mL) and the mixture was cooled to 0 °C. A suspension of Raney Ni in EtOH 
(0.6 g/mL) (5 mL) was added dropwise in 10 minutes. The resulting mixture was stirred 
for 90 minutes at 0 °C. A second portion of Raney Ni in EtOH (2 mL) was added and 
stirring was continued for 15 minutes at 0 °C. After this, the cooling bath was removed 
for 15 minutes and the reaction mixture was filtered through a thin pad of silica (3 cm). 
Ether (3 x 5 mL) was used for washing the pad. The solvents were evaporated to give 167 
mg of clear oil. The crude product was purified by flash chromatography (15% MTBE in 
hexanes) to give 512 (154 mg, 89 %) as a clear oil. Rf (20 % MTBE in hexanes) = 0.20. 
[α]20D = + 8.9 (c 1.00, CHCl3). 1H NMR (CDCl3, 400.132 MHz) δ 7.32 (m, 5H), 5.90 (d, 
1H, J = 9.8 Hz), 5.41 (dt, 1H, J = 9.7, 3.2 Hz), 5.25 (m, 1H), 4.51 (m, 2H), 4.29 (m, 1H), 
3.37 (m, 1H), 3.28 (t, 1H, J = 9.2 Hz), 2.56 (m, 2H), 2.31 (m, 1H), 1.85-1.44 (m, 9H), 
1.43 (s, 9H), 1.26 (m, 5H). 13C NMR (CDCl3, 100.62 MHz) δ 210.0 (d), 155.2, 138.6, 
138.5, 132.6, 128.4 (d), 127.6 (d), 126.3, 79.6, 73.3, 73.0, 55.1 (d), 43.6, 41.9, 38.5 (d), 
37.3 (d), 35.5, 29.2, 28.3, 25.7, 22.3, 20.9 (d), 17.8. LRMS (EI+) 442 (M+1), 385, 342, 
297, 277(100), 259, 246, 233, 220, 198, 185, 171, 159, 144, 119, 105, 91, 79, 65, 57. 
HRMS (ES+) calculated for C27H39NO4Na: 464.2777, found 464.2774.  
6.6.3 [(3aS’,4R’,5S’,7aR’),1S,2S]-[4-(5-Benzyloxymethyl-2,3,3a,4,5,7a-hexahydro-
1H-inden-4-yl)-2-hydroxy-1-methyl-butyl]-carbamic acid tert-butyl ester 
(513) 
 
OBn
O
NHBOC
OBn
OH
NHBOC
512 513  
 
ZnBr2 (96 mg, 0.424 mmol, 123 mol-%) was dissolved in dry ether (7 mL) and cooled 
with an ice bath to 0 °C. [4-(5-Benzyloxymethyl-2,3,3aR,4S,5R,7aS-hexahydro-1H-
inden-4-yl)-1S-methyl-2-oxo-butyl]-carbamic acid tert-butyl ester 512 (153 mg, 0.346 
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mmol, 100 mol-%) in dry ether (11 mL) was added. The resulting mixture was stirred for 
50 minutes at 0 °C. After this, the reaction mixture was cooled to – 78 °C. A 1.0 M 
solution of DIBAL-H in toluene (1.9 mL, 1.90 mmol, 549 mol-%) was added dropwise 
into the reaction mixture in portions until the reaction was ready by TLC (32% EtOAc in 
hexanes). The reaction was ready after addition by TLC. After 1 hour, the reaction 
mixture was quenched with MeOH (3 mL) and a solution of 1 M HCl (5 mL). The 
cooling bath was removed and stirring was continued for 25 minutes. The product was 
extracted with EtOAc (3 x 15 mL), washed with brine (15 mL), dried with Na2SO4, 
filtered and concentrated to give 160 mg of yellowish oil. The crude product was purified 
by flash chromatography (6 % i-PrOH in hexanes) to yield 513 (130 mg, 85 %) as a clear 
oil. Rf (10% i-PrOH in hexanes) = 0.27. [α]20D = + 5.4 (c 1.00, CHCl3). 1H NMR (CDCl3, 
400.132 MHz) δ 7.33-7.26 (m, 5H), 5.89 (d, 1H, J = 9.9 Hz), 5.43 (m, 1H), 4.77 (m, 1H), 
4.56-4.47 (m, 2H), 3.62 (m, 2H), 3.41-3.38 (m, 1H), 3.33 (t, 1H, J = 9.2 Hz), 2.41 (m, 
1H), 1.90-1.44 (m, 11H), 1.44 (s, 9H), 1.14-1.08 (m, 2H), 1.05 (d, 3H, J = 6.8 Hz). 13C 
NMR (CDCl3, 100.62 MHz) δ 155.8, 138.6 (d), 132.3 (d), 128.3, 127.5 (d), 126.7 (d), 
79.4, 74.9, 74.5, 73.6, 72.9, 50.6, 43.8, 41.6 (d), 38.6 (d), 35.6 (d), 31.6 (d), 29.2, 28.4, 
25.7, 23.8, 23.3, 22.3, 14.3 (d). HRMS (ES+) calculated for C27H41NO4Na: 466.2933, 
found 466.2913.            
 
6.6.4 [(3aS’,4R’,5S’,7aR’),1S,2S]-[4-(5-Benzyloxymethyl-2,3,3a,4,5,7a-hexahydro-
1H-inden-4-yl)-2-(tert-butyl-dimethyl-silanyloxy)-1-methyl-butyl]-carbamic 
acid tert-butyl ester (515) 
 
OBn
OTBDMS
NHBOC
OBn
OH
NHBOC
513 515  
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[4-(5-Benzyloxymethyl-2,3,3a,4,5,7a-hexahydro-1H-inden-4-yl)-2-hydroxy-1-methyl-
butyl]-carbamic acid tert-butyl ester 513 (40 mg, 0.090 mmol, 100 mol-%) was dissolved 
in dry CH2Cl2 (2 mL). The mixture was cooled to 0 °C and 2,6-lutidine (24 mg, 0.225 
mmol, 250 mol-%) was added. The resulting mixture was stirred for 5 minutes and neat 
tert-butyldimethylsiloxy triflate (48 mg, 0.180 mmol, 200 mol-%) was added dropwise. 
The mixture was stirred for 20 minutes at 0 °C. After this, a saturated solution of K2CO3 
(2 mL) was added. Stirring was continued for 15 minutes at 0 °C. The layers were 
separated and the water layer was extracted with ether (3 x 5 mL). The combined 
organics were washed with 0.5 M H3PO4 (3 x 10 mL). The combined organics were 
washed with brine (10 mL), dried with MgSO4, filtered and concentrated to give 79 mg 
of yellowish oil. The crude product was purified by flash chromatography (5-20 % 
MTBE in hexanes) to yield 515 (40 mg, 80 %) as a clear oil. Rf (32 % EtOAc in hexanes) 
= 0.58. [α]20D = + 7.2 (c 1.01, CHCl3). 1H NMR (CDCl3, 400.132 MHz) δ 7.33-7.26 (m, 
5H), 5.89 (d, 1H, J = 9.9 Hz), 5.44 (m, 1H), 4.65-4.50 (m, 1H), 4.52 (q, 2H, J = 13.3 Hz), 
3.73-3.60 (m, 2H), 3.41-3.32 (m, 2H), 2.39 (m, 1H), 1.82-1.61 (m, 6H), 1.44 (s, 9H), 
1.44-1.20 (m, 5H), 1.04 (dd, 3H, J = 6.6, 5.3 Hz), 0.92-0.87 (m, 11H), 0.05-0.04 (m, 6H). 
13C NMR (CDCl3, 100.62 MHz) δ 154.3 (d), 138.7, 132.3, 128.3, 127.4 (d), 126.8 (d), 
74.6, 74.4, 73.7, 72.7, 50.0, 49.6, 43.8, 41.6 (d), 38.7 (d), 36.1 (d), 31.8 (d), 29.7, 29.2, 
28.4, 25.9, 25.6 (d), 23.0 (d), 22.3, 18.1, 17.5, 13.2 (d), -3.0, -3.6, -4.1, -4.6. HRMS 
(ES+) calculated for C33H55NO4NaSi: 580.3798, found 580.3795.           
6.6.5 [(3aS’,4R’,5S’,7aR’),1S,2S]-[4-(5-Benzyloxymethyl-2,3,3a,4,5,7a-hexahydro-
1H-inden-4-yl)-2-(tert-butyl-dimethyl-silanyloxy)-1-methyl-butyl]-carbamic 
acid tert-butyl-dimethyl-silyl ester (514) 
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OBn
OTBDMS
NH
OBn
OH
NHBOC
O
O
Si
513 514  
 
[4-(5-Benzyloxymethyl-2,3,3a,4,5,7a-hexahydro-1H-inden-4-yl)-2-hydroxy-1-methyl-
butyl]-carbamic acid tert-butyl ester 513 (130 mg, 0.294 mmol, 100 mol-%) was 
dissolved in dry CH2Cl2 (6 mL). The mixture was cooled to 0 °C and 2,6-lutidine (110 
mg, 1.029 mmol, 350 mol-%) was added. The resulting mixture was stirred for 5 minutes 
and tert-butyldimethylsiloxy triflate (233 mg, 0.882 mmol, 300 mol-%) was added 
dropwise. The mixture was stirred for 20 minutes at 0 °C. After this, a saturated solution 
of K2CO3 (10 mL) and ether (10 mL) was added. The layers were separated and the water 
layer was extracted with ether (3 x 15 mL). The combined organics were washed with 0.5 
M H3PO4 (3 x 10 mL). The water phase was extracted once with ether (15 mL). The 
combined organics were washed with brine (10 mL), dried with Na2SO4, filtered and 
concentrated to give 189 mg of yellowish oil. The crude product was purified by rapid 
filtration through a silica pad (2 cm). The pad was flushed with CH2Cl2 to yield 514 (176 
mg, 97 %). Rf (32 % EtOAc in hexanes) = 0.57. [α]20D = + 2.0 (c 1.37, CHCl3). 1H NMR 
(CDCl3, 400.132 MHz) δ 7.33-7.26 (m, 5H), 5.89 (d, 1H, J = 9.9 Hz), 5.43 (m, 1H), 4.78 
(m, 1H), 4.51 (q, 2H, J = 12.0 Hz), 3.72-3.66 (m, 2H), 3.41-3.32 (m, 2H), 2.39 (m, 1H), 
1.85-1.25 (m, 11H), 1.14-1.08 (m, 2H), 1.04 (dd, 3H, J = 6.6, 5.3 Hz), 0.92-0.87 (m, 
20H), 0.27-0.26 (m, 6 H), 0.10-0.02 (m, 6H). 13C NMR (CDCl3, 100.62 MHz) δ 155.1 
(d), 138.7, 132.2 (d), 128.3, 127.3 (d), 126.8, 78.9, 74.6, 73.7, 72.7, 49.4 (d), 43.9 (d), 
42.0, 41.7 (d), 41.4, 38.7 (d), 36.1 (d), 32.7, 29.2, 28.4, 25.9 (d), 25.7 (d), 22.9, 22.0, 18.1 
(d), 14.3 (d), 0.68, -2.3, -3.5, -3.9. HRMS (ES+) calculated for C35H61NO4NaSi2: 
638.4037, found 638.4050.           
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6.6.6 [(3aS’,4R’,5S’,7aR’),1S,2S]-[2-(tert-Butyl-dimethyl-silanyloxy)-4-(5-
hydroxymethyl-2,3,3a,4,5,7a-hexahydro-1H-inden-4-yl)-1-methyl-butyl]-
carbamic acid tert-butyl ester (516) 
 
OBn
OTBDMS
NHBOC
OH
OTBDMS
NHBOC
515 516  
 
Gaseous ammonia was condensed into a flask immersed in a cooling bath to – 78 °C. A 
small sodium peaces was added into ammonia liquid (5 mL) until blue color developed. 
Dried ammonia was condensed into the reaction flask, which was cooled to –78 °C. A 
small sodium peaces were added until blue color developed. After this, [4-(5-
Benzyloxymethyl-2,3,3a,4,5,7a-hexahydro-1H-inden-4-yl)-2-(tert-butyl-dimethyl-
silanyloxy)-1-methyl-butyl]-carbamic acid tert-butyl ester 515 (17 mg, 0.031 mmol, 100 
mol-%) in dry THF (1 mL) was added. This resulted decoloration of the reaction mixture. 
Sodium peaces were added until blue color developed. The addition was repeated if color 
disappeared. The reaction mixture was stirred for 80 minutes and solid NH4Cl was added 
until blue color disappeared. Excess ammonia was allowed to evaporate. Water (25 mL) 
was added and the product was extracted with ether (3 x 75 mL). The combined organics 
were washed with 0.5 M solution of H3PO4 (20 mL) and brine (40 mL). The organics 
were dried with MgSO4, filtered and concentrated to give 27 mg of white solid. The 
crude product was purified by flash chromatography (20% EtOAc in hexanes) to yield 
516 (8 mg, 56 %) as a clear oil. Rf (20 % EtOAc in hexanes) = 0.17. [α]20D = -7.2 (c 1.07, 
MeOH). 1H NMR (CDCl3, 400.132 MHz) δ 5.93 (d, 1H, J = 9.9 Hz), 5.43 (m, 1H), 4.58 
(d, 1H, J = 7.3 Hz), 3.78 (m, 1H), 3.65 (m, 1H), 3.62-3.42 (m, 2H), 2.25 (m, 1H), 1.85-
1.33 (m, 11H), 1.44 (s, 9H), 1.14-1.08 (m, 2H), 1.03 (d, 3H, J = 7.1 Hz), 0.90-0.89 (m, 
9H), 0.05 (m, 6H). 13C NMR (CDCl3, 100.62 MHz) δ 155.3 (d), 132.7 (d), 126.3 (d), 
79.2, 74.1 (d), 66.3 (d), 49.6 (d), 44.0 (d), 38.6, 35.6, 35.1, 32.4, 29.1 (d), 28.4, 25.9 (d), 
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25.7, 22.2, 18.1 (d), 14.3 (d), -4.1. HRMS (ES+) calculated for C26H49NO4NaSi: 
490.3329, found 490.3350.  
6.6.7 [(3aS’,4R’,5S’,7aR’),1S,2S]-[2-(tert-Butyl-dimethyl-silanyloxy)-4-(5-formyl-
2,3,3a,4,5,7a-hexahydro-1H-inden-4-yl)-1-methyl-butyl]-carbamic acid tert-
butyl ester (517) 
 
OOTBDMS
NHBOC
OH
OTBDMS
NHBOC
516 517  
 
Oxalyl chloride (5 mg, 0.040 mmol, 120 mol-%) was diluted with dry CH2Cl2 (0.5 mL) 
and cooled to –78 °C. Dry DMSO (6 mg, 0.080 mmol, 240 mol-%) was diluted with dry 
CH2Cl2 (0.2 mL) and added into the flask containing oxalyl chloride. 2-(tert-Butyl-
dimethyl-silanyloxy)-4-(5-hydroxymethyl-2,3,3a,4,5,7a-hexahydro-1H-inden-4-yl)-1-
methyl-butyl]-carbamic acid tert-butyl ester 516 (16 mg, 0.033 mmol, 100 mol-%) was 
dissolved in dry CH2Cl2 (0.6 mL) and added into the reaction flask. Stirring was 
continued for 40 minutes at –78 °C and triethylamine (17 mg, 0.167 mmol, 506 mol-%) 
was added. The mixture was stirred for 5 minutes and the cooling bath was removed for 1 
hour. CH2Cl2 (3 mL) was added and the organics were washed with 0.5 M H3PO4 (2 x 1.5 
mL). The combined water layers were extracted with CH2Cl2 (2 x 3 mL). The combined 
organics were washed with brine (2 mL), dried with Na2SO4, filtered and concentrated to 
give 15 mg (97 %) of 517 as pure product. The product was highly volatile. Rf (32 % 
EtOAc in hexanes) = 0.49. [α]20D = + 30.7 (c 1.13, CHCl3). 1H NMR (CDCl3, 400.132 
MHz) δ 9.63 (d, 1H, J = 2.0 Hz), 6.12 (d, 1H, J = 9.9 Hz), 5.62 (m, 1H), 4.55 (m, 1H), 
3.74-3.64 (m, 2H), 2.91 (m, 1H), 2.25 (t, 1H, J = 9.7 Hz), 1.90-1.80 (m, 2H), 1.72-1.64 
(m, 2H), 1.60-1.47 (m, 3H), 1.44 (s, 9H), 1.38-1.32 (m, 3H), 1.15-1.06 (m, 2H), 1.03 (dd, 
3H, J = 10.4, 6.8 Hz), 0.90-0.89 (m, 9H), 0.07-0.03 (m, 6H). 13C NMR (CDCl3, 100.62 
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MHz) δ 201.4 (d), 155.1 (d), 134.9 (d), 120.9 (d), 79.1, 74.5 (d), 54.7 (d), 44.8, 38.4, 34.5 
(d), 32.9, 28.7, 28.4, 25.9 (d), 25.7, 22.2, 21.9, 18.1, 14.3 (d), -4.2 (d), -4.50, -4.58. 
HRMS (ES+) calculated for C26H47NO4NaSi: 488.3172, found 488.3155.        
6.6.8 1-Phenyl-5-propylsulfanyl-1H-tetrazole (508) 
 
N
NN
N SH N
NN
N S
507 508  
 
Triphenyl phosphine (0.87 g, 3.3 mmol, 110 mol-%), 1-PrOH (0.18 g, 3.0 mmol, 100 
mol-%) and 1-phenyl-1H-tetrazole-5-thiol 507 (0.59 g, 3.3 mmol, 110 mol-%) was 
dissolved in dry THF (45 mL) and the resulting mixture was cooled to 0 °C. Diethyl 
azodicarboxylate (0.58 g, 3.3 mmol, 110 mol-%) was diluted with dry THF (3 mL) and 
added dropwise into the reaction mixture. Stirring was continued for 1.5 hours and the 
reaction mixture was taken to room temperature. Stirring was continued for 18 hours. The 
solvents were evaporated and the product was partitioned between a 5 w-% solution of 
NaHCO3 (50 mL) and ether (100 mL). The organics were washed with brine (50 mL), 
dried with MgSO4, filtered and concentrated to give 2.38 g of white solid. The crude 
product was purified by flash chromatography (10 % EtOAc in hexanes) to yield 508 
(0.58 g, 87 %) as a clear oil. Rf (50 % EtOAc in hexanes) = 0.48. 1H NMR (CDCl3, 
400.132 MHz) δ 7.60-7.53 (m, 5 H), 3.38 (t, 2 H, J = 7.3 Hz), 1.86 (s, 2 H, J = 7.3 Hz), 
1.06 (t, 3 H, J = 7.3 Hz). 13C NMR (CDCl3, 100.62 MHz) δ 155.1, 134.4, 130.7, 130.4, 
124.5, 35.9, 23.2, 13.8.  LRMS (EI+) 220, 192, 150, 136, 118(100), 104, 91, 77, 65, 51. 
HRMS (ES+) calculated for C10H13N4S: 221.0861, found 221.0841.         
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6.6.9 1-Phenyl-5-(propane-1-sulfonyl)-1H-tetrazole (509) 
 
N
NN
N S N
NN
N S
O2
508 509  
 
1-Phenyl-5-propylsulfanyl-1H-tetrazole 508 (0.51 g, 2.3 mmol, 100 mol-%) was 
dissolved in CH2Cl2 (23 mL). NaHCO3 (1.93 g, 23.0 mmol, 1000 mol-%) and partially 
dissolved 70 w-% aqueous slurry of m-chloroperbenzoic acid (2.84 g, 11.5 mmol, 500 
mol-%) treated with CH2Cl2 (15 mL) was added. Stirring was continued for 2.5 hours and 
CH2Cl2 (20 mL) was added. Stirring was continued for 20.5 hours and a saturated 
aqueous solution of NaHCO3 (30 mL) and a saturated aqueous solution of Na2S2O3 was 
added. The layers were separated and the organic layer was washed with brine/H2O (1:1) 
(80 mL). The organics were dried with Na2SO4, filtered and concentrated to give 1.08 g 
of white solid. The crude product was purified by flash chromatography (15 % EtOAc in 
hexanes) to yield 509 (0.48 g, 83 %) as an yellowish solid. Mp. 49-51 °C. Rf (20 % 
EtOAc in hexanes) = 0.32. 1H NMR (CDCl3, 400.132 MHz) δ 7.70-7.60 (m, 5 H), 3.74-
3.70 (m, 2 H), 2.06-1.96 (m, 2 H), 1.14 (t, 3 H, J = 7.5 Hz). 13C NMR (CDCl3, 100.62 
MHz) δ 154.2, 133.7, 132.1, 130.4, 125.8, 58.2, 16.6, 13.5. FT-IR (cm-1) 3338, 3019, 
2400, 1599, 1520, 1424, 1223, 1215, 1208, 1153, 1046, 929, 748, 668. LRMS (EI+) 253 
(M+1), 145, 131, 119(100), 103, 91, 77, 65, 51. HRMS (EI+) calculated for 
C10H13O2N4S. 252.0681, found 252.0666. 
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6.6.10 [(3aS’,4R’,5S’,7aR’),1S,2S]-[4-(5-But-1-enyl-2,3,3a,4,5,7a-hexahydro-1H-
inden-4-yl)-2-(tert-butyl-dimethyl-silanyloxy)-1-methyl-butyl]-carbamic 
acid tert-butyl ester (518) 
 
OOTBDMS
NHBOC
OTBDMS
NHBOC
517 518  
 
Potassium hexamethyldisilazane (16 mg, 0.082 mmol, 117 mol-%) was dissolved in dry 
DME (0.5 mL) and cooled to –55 °C (CHCl3/N2(l)). 1-Phenyl-5-(propane-1-sulfonyl)-
1H-tetrazole 509 (21 mg, 0.084, 120 mol-%) in dry DME (0.8 mL) was added into the 
reaction flask, which resulted formation of yellowish solution. Stirring was continued for 
30 minutes and aldehyde 517 (33 mg, 0.070 mmol, 100 mol-%) in dry DME (1.0 mL) 
was added. A clear solution was obtained. Stirring was continued for 2.5 hours at –35 – 
55 °C. After this, the reaction mixture was immersed in an ice bath for 2 hours. The 
reaction was not complete at this point and more KHMDS (15 mg, 0.073 mmol, 104 mol-
%) was dissolved in dry DME (0.5 mL) and added into the reaction mixture at –55 °C. 
The reaction mixture turned from colorless to yellowish solution at this point. Stirring 
was continued for 30 minutes and a saturated solution of NaHCO3 (1 mL) was added. 
This resulted formation of clear solution. The mixture was stirred 25 minutes at r.t. and 
the mixture was diluted with EtOAc (5 mL). The layers were separated and the water 
layer was extracted with EtOAc (2 x 3 mL). NaCl was added to help the phase separation. 
The combined organics were washed with brine (3 mL), dried with Na2SO4, filtered and 
concentrated to give 46 mg of yellow oil/slurry. The crude product was purified by flash 
chromatography (4-10 % EtOAc in hexanes) to yield 518 (24 mg, 70 %) as a clear oil. 
The product was highly volatile and it was easily evaporated in an oil pump vacuo. Rf (20 
% EtOAc in hexanes) = 0.61. [α]20D = +41.3 (c 1.21, CH2Cl2).  1H NMR (CDCl3, 400.132 
MHz) δ 5.84 (d, 1H, J = 9.9 Hz), 5.42-5.36 (m, 3H), 4.58 (m, 1H), 3.69 (m, 2H), 2.67 (m, 
1H), 2.01 (m, 2H), 1.81-1.44 (m, 6H), 1.44 (s, 9H), 1.38-1.32 (m, 5H), 1.15-1.06 (m, 2H), 
 
 
 
 
 
 
 
223 
 
1.03 (dd, 3H, J = 10.4, 6.8 Hz), 0.97 (t, 3H, J = 7.3 Hz), 0.90-0.89 (m, 9H), 0.06-0.04 (m, 
6H). 13C NMR (CDCl3, 100.62 MHz) δ 155.2, 133.0, 131.8, 130.1 (d), 128.7 (d), 120.9 
(d), 79.0, 74.7, 49.0 (d), 43.9 (d), 42.8, 40.5, 38.6, 38.4, 33.0, 29.7, 29.2, 28.5, 26.0, 25.6, 
23.1, 22.2, 18.2, 14.2, 13.9, -4.1 (d), -4.50, -4.59. HRMS (ES+) calculated for 
C29H53NO3NaSi: 514.3692, found 514.3704.    
6.6.11 [(3aS’,4R’,5S’,7aR’),3S,4S]-4-Amino-1-(5-but-1-enyl-2,3,3a,4,5,7a-
hexahydro-1H-inden-4-yl)-pentan-3-ol (519) 
 
OH
NH2
OTBDMS
NHBOC
518 519
OH
NH2
+
1  
  
[4-(5-But-1-enyl-2,3,3a,4,5,7a-hexahydro-1H-inden-4-yl)-2-(tert-butyl-dimethyl-
silanyloxy)-1-methyl-butyl]-carbamic acid tert-butyl ester 518 (12 mg, 0.024 mmol, 100 
mol-%) was dissolved in dioxane (0.9 mL) and 32 w-% HCl (1.1 mL) was added. The 
reaction mixture was stirred at r.t. for 3.5 hours. Water (2 mL) and ether (4 mL) was 
added. The layers were separated and the water phase was basified with a sat. solution of 
NaHCO3 until pH was 8-9. The free amine product was extracted with CHCl3 (4 x 10 
mL). The water phase was saturated with NaCl to help the product isolation. The 
combined organics were dried with Na2SO4, filtered and concentrated to give 3.9 mg (58 
%) of 519 and amaminol A 1 as a yellowish oil. Data for 519: [α]20D = +62.0 (c 0.39, 
MeOH). 1H NMR (MeOD/TMS, 400.132 MHz) δ 5.85 (d, 1H, J = 9.9 Hz), 5.49-5.42 (m, 
3H), 3.40 (m, 1H), 2.84 (m, 1H), 2.76 (m, 1H), 2.00 (m, 2H), 1.86-0.97 (m, 16H), 1.03 
(dd, 3H, J = 10.4, 6.8 Hz), 0.97 (t, 3H, J = 7.3 Hz). 13C NMR (MeOD, 100.62 MHz) δ 
134.4 (d), 132.9 (d), 131.0 (d), 129.9 (d), 76.4 (d), 52.3 (d), 45.1 (d), 44.1, 41.6 (d), 39.9 
(d), 32.5 (d), 30.3 (d), 26.9 (d), 26.6, 24.7 (d), 23.1, 17.1 (d), 14.4. HRMS (ES+) 
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calculated for (M+1) C18H32NO: 278.2484, found 278.2463. Amaminol A 1: 1H NMR 
(MeOD/TMS, 400.132 MHz) δ 3.48 (dd, 1H), 3.13 (m). Other peaks were not observed, 
because of overlapping with peaks of the product 519.  
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